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Abstract 
Forming patterned nanoparticles with modified biological interactions is of wide academic 
interest, generating a fine level of control at the nano- and bio-interface. Targeted and 
combinatorial nanoscale therapies are the future of personalised disease therapy, with recent 
advances providing information about molecular profiles and biomarkers of various diseases. 
This information will aid the fabrication of novel multifunctional nanoscale delivery systems 
with the potential to integrate imaging, targeting and treatment moieties on the surface and in 
the core, resulting in precise targeted drug delivery to the disease site. 
The complexity of reported patterned nanoparticle syntheses results in prohibitively high 
predicted associated cost; direct syntheses may therefore facilitate scalable synthetic 
processes. The novel polymer architecture, hyperbranched polydendrons (HPDs), combines 
the benefits of dendrimers and branched vinyl polymerisation; with recent mixed initiation 
studies introducing a new concept for controlled chain-end chemistry. Here, different HPD 
strategies for zoned and statistical functionality have been investigated, utilising xanthate 
chemistry for the controlled introduction of multifunctionality. Simple nanoprecipitation of 
HPDs was applied for nanoparticle (NP) synthesis (~60 nm); the novel direct surface imaging 
of functional group patterning using 3 nm gold nanoparticles (GNPs) showed statistically 
higher grouping of GNPs for patchy HPD NPs (60% ≥twos) than statistical HPD NPs (31% 
≥twos). Direct cellular accumulation comparisons of nanoparticles with patchy and statistical 
distributions of surface functional groups (benzyl- and dimethylamino- groups) showed  
>3-fold higher accumulation of patchy particles in phagocytic and non-phagocytic cells.  
This direct synthesis approach was not trivial; however, it demonstrates the value of NPs with 
zoned surface chemistry and suggests truly scalable syntheses combining commercial 
dendron synthesis, vinyl chemistry and nanoprecipitation could be developed. 
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1.1 Dendritic macromolecules 
Dendritic (Greek: branched) macromolecules are highly branched polymer architectures with 
a high number of functional groups and a complex tertiary structure. They can be divided into 
monodisperse dendrons and dendrimers, and polydisperse hyperbranched polymers, 
dendrigrafts and linear-dendritic hybrids (LDHs) (Fig. 1.1).
1
 
 
Fig. 1.1 Schematic representation of dendritic polymer subclasses (adapted from Walter and Malkoch)
1
 
These subgroups reflect differing relative degrees of structural control over their 
architectures. Dendrons and dendrimers are highly symmetric macromolecules synthesised in 
the same manner, with or without a core molecule. Hyperbranched polymers are irregularly 
branched polymeric architectures with varying degrees of branching, polydisperse structure 
and size.
2
 Dendrigraft polymers, also known as arborescent polymers, possess a multi-level 
branched architecture assembled from macromolecular branching units. Linear-dendritic 
hybrids are comprised of two dissimilar polymer architectures; a flexible linear polymer 
chain and a dense, rigid dendron segment.  
Since the first reported synthesis by Vögtle and coworkers in 1978
3, “cascade molecules” or 
dendrimers (from Greek: dendros; tree and meros; part), have gained increasing interest due 
to their quantised nanoscale dimensions, dictated by generation number (approximately 2-10 
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nm in diameter)
4
, perfectly branched structures, formed as a result of carefully controlled 
iterative coupling reactions. Dendrimers are monodisperse macromolecules and are typically 
symmetric around the core, adopting a spherical, three-dimensional morphology consisting of 
a core, branch points and peripheral groups and are usually described in terms of generation 
(G); the number of layers of repeat units (Fig. 1.2).
5
 
 
Fig. 1.2 Schematic representation of a generation 4 (G4) dendrimer and corresponding dendron 
Control over chemical functionality at the periphery and within dendrimers can be achieved 
at any step during the growth process, enabling incorporation of desired functionality for 
pharmaceutical, chemical, electronic and materials applications.
6,7
 Their multivalency, 
modifiable surface functionality and internal cavity also makes them attractive for drug 
delivery applications.
4
 However, multivalency of higher generations requires precisely 
controlled, target-specific regioselective functionalisation.
8
 A major drawback of these 
perfectly branched polymers is their limited industrial viability due to lengthy syntheses and 
high manufacturing costs. 
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1.1.1 Dendrimer synthesis 
Dendrimers are synthesised via a complex series of iterative reactions involving 
protection/deprotection and coupling reactions, which becomes increasingly complicated and 
expensive with higher generation numbers. Synthesis involves the repetition of a sequence of 
reactive steps, producing dendrimers one generation larger with each repetition. Mono- or 
multi-functional core molecules and ABn (n ≥ 2) monomers are used - where A and B denote 
different functional groups; with either focal point or peripheral protecting groups, depending 
upon the synthetic route employed. The choice of ABn monomer helps determine physical 
properties including solubility and viscosity.
9
 Synthetic methodologies for dendrimer 
construction are based on two defined approaches: The divergent approach, described as 
"starburst" and "arborol" structures by Tomalia et al.
10
 and Newkome et al.
11
 respectively, 
reported independently in 1985; and the convergent approach reported by Hawker and 
Fréchet in 1990
12
. These two approaches to dendrimer synthesis can be considered as 
complimentary, with respect to dendrimer size, purity and functionality. These developments 
gave rise to a new class of polymer topology which rapidly expanded to a diverse array of 
chemical structures, applications and modifications.  
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1.1.1.1 Divergent approach 
Divergent synthesis (core first) starts from a multifunctional core molecule, Bn (n ≥ 2) and 
involves at least a two-step process; the activation of surface functional groups and reaction 
with branching monomer units, ABn (n ≥ 2), creating a new generation. Repetition of this 
addition process leads to the synthesis of dendrimers of successive generations. The final step 
involves the addition of surface functional groups, as shown in Scheme 1.1. This method 
usually involves the protection of reactive groups, which once coupled to the core are 
deprotected for the next reactive step. 
 
Scheme 1.1 Schematic representation of divergent dendrimer synthesis (adapted from Sowinska and 
Urbanczyk-Lipkowska)
8
 
The first example of an iterative synthetic procedure to produce well-defined branched 
architectures was reported by Buhleier et al. (1978) who applied it to the construction of non-
cyclic low molecular weight dendritic amines and described the method as a “cascade” 
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approach.
3
 This approach was also adopted by a number of research groups including 
Denkewalter, Tomalia and Newkome.
3,10,11,13
 
The first publication describing the synthesis of “dendrimers” was presented in 1985 by 
Tomalia et al.
10
, describing the synthesis of a series of poly(amidoamine) (PAMAM) 
dendrimers. The originally reported synthesis of PAMAM dendrimers, trademarked as 
“Starburst™ polymers” (Dow Chemical Company), was so successful that it remains the 
preferred commercial route.
14
 
The synthesis of PAMAM dendrimers involves the reaction of an amine-functional core 
molecule (e.g. ammonia, NH3) with an excess of methyl acrylate via exhaustive Michael 
addition, followed by complete amidation of the terminal ester functionalities with a large 
excess of ethylenediamine (EDA) (to avoid cross-linking terminal groups and cycle 
formation), yielding primary amines at the surface, Scheme 1.2. This reaction sequence can 
be repeated to produce dendrimers with very high molecular weights. An EDA core can also 
be applied in the first step to yield dendrimers via a divergent growth approach up to the 10
th
 
generation, G10 (molecular weight, MW = 934,720 g mol
-1
; 4,096 peripheral amine groups), 
although an extremely large excess of reagents is required in order to prevent gelation via 
dendrimer bridging during amidation.
10,15
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Scheme 1.2 Divergent synthesis of ammonia-core PAMAM dendrimers 
The divergent growth approach can be used to quickly synthesise a library of various 
generation dendrimers, however, it does have some disadvantages. As the number of terminal 
groups increases exponentially with each generation, the volume of the dendrimer increases 
(proportional to the cube of the radius, 𝑉 =
4
3
𝜋𝑟3) much more rapidly than the surface area 
(proportional to the square of the radius, 𝑆 = 4𝜋𝑟2), resulting is dense packing and hence, 
steric hindrance, as predicted by de Gennes and Hervet.
16
 Therefore, dendrimers adopt a 
globular architecture at higher generation numbers.
17
 As a result of de Gennes dense packing, 
the possibility of 100% conversion for each reactive step decreases with increasing dendrimer 
generation. Any incomplete reactions during a chemical step can lead to imperfections or 
failure sequences in the subsequent generation. In order to assure completion and to prevent 
possible side reactions, an extremely large excess of reagents is required, however, a small 
number of statistical defects cannot be avoided, leading to difficulties during purification due 
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to the small differences in properties (e.g. polarity, molecular mass, size) of the products. A 
convergent approach was therefore developed in response to the limitations of divergent 
growth. 
 
1.1.1.2 Convergent approach 
The convergent synthesis method (periphery first), developed by Hawker and Fréchet in 
1990,
12,18
 starts from the surface functional groups of the resulting dendrimer and proceeds 
towards the core, where dendritic segments (dendrons) are selectively activated at the focal 
point and coupled to a polyfunctional core, as shown in Scheme 1.3. 
 
Scheme 1.3 Schematic representation of convergent dendrimer synthesis (adapted from Sowinska and 
Urbanczyk-Lipkowska)
8
 
The convergent approach affords outstanding control over growth and structure due to the 
relatively low number of coupling reactions at each growth step, less imperfections and 
without the need of a large excess of reagents
8
, in contrast to divergent growth.
10
 Imperfect 
growth leads to significant differences in molecular weight and polarity, whereas 
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imperfections in divergent growth have little effect on polarity, number of surface groups or 
molecular weight. As a result, dendrimers obtained via convergent growth tend to be of 
higher structural purity as materials with imperfect branching can be removed much more 
easily during purification, e.g. by liquid chromatography. 
Hawker and Fréchet reported convergent dendrimer synthesis up to the sixth generation (G6), 
based upon the branching ‘monomer’ unit 3,5-dihydroxybenzyl alcohol to form poly(aryl 
ether) dendrimers, or Fréchet-type dendrimers, Scheme 1.4.
12,18,19
 
 
Scheme 1.4 Convergent synthesis of a G3 poly(aryl ether) dendrimer
12,18 
The dendrimer bears a series of ether linkages between aromatic rings formed via Williamson 
etherification reactions between benzyl bromide and 3,5-dihydroxybenzyl alcohol. The focal 
point of the first generation dendron is then activated with carbon tetrabromide (CBr4) and 
triphenyl phosphine (PPh3), then coupled to 3,5-dihydroxybenzyl alcohol to yield the 
deactivated second generation dendron. This sequence of reactive steps is repeated until the 
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desired dendron generation is achieved. Dendrimers are formed by coupling dendrons to a 
multifunctional phenolic (Fréchet) core. 
The convergent route allows exceptional control over location of functionality as the core is 
installed during the final step, enabling incorporation of a range of functionalities with 
regional variation in the final dendrimer (dendrons with different molecular composition 
and/or generation), giving rise to numerous novel architectures. This has led to the synthesis 
of dendrimers consisting of different blocks, chemically varied layers, encapsulated 
functionalities, differentiated surface functionalities and the opportunity to synthesise linear-
dendritic hybrid materials and “dendronised” macromolecules.20-22 An example of this is 
"Janus dendrimers" which are constructed from two different dendrons, resulting in 
macromolecules with two distinct parts either with different polymer backbones, or bearing 
different functional groups.  
The major limitation of convergent synthesis is that as the size of dendrons increase, steric 
hindrance restricts coupling to the core and hence decreases yield. The convergent method is 
therefore restricted to the synthesis of lower generation dendrimers (i.e. below G6). 
Variations of the convergent approach and its combination with divergent dendrimer 
synthesis has led to the development of synthetic strategies which reduce the number of 
reactive steps required to produce high generation dendrimers.
9
 These "accelerated 
syntheses"
1
 include: The hypermonomer approach
23
, in which an AB4 or AB8 monomer is 
typically employed; Double-stage convergent synthesis
24
 where a larger core, known as a 
"hypercore", is reacted with smaller dendrons to reduce steric hindrance; Double-exponential 
growth and orthogonal approaches which take advantage of chemoselectivity to orthogonally 
protect/deprotect reactive groups and quickly build dendrons which are later coupled to a 
core (orthogonal protection is a synthetic strategy which affords independent deprotection of 
functional groups). 
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1.1.2 Dendrimers based on 2,2’-bis(hydroxymethyl)propionic acid 
Since the work presented within this thesis is mainly focussed on materials based on the 
monomer 2,2-bis(hydroxymethyl)propionic acid (bis-MPA), it is prudent to look in more 
detail at literature examples of this family of dendrimers.  
Bis-MPA dendrimers have been proven to be non-toxic and non-invasive and are therefore 
promising candidates for drug delivery applications.
25-27
 The polyester dendrimer scaffold 
possesses hydrolytically labile ester linkages and is therefore biodegradable.
28,29
 
The first example of dendrimers based on the AB2 monomer bis-MPA was presented by Ihre 
et al. in the mid-1990s.
30
 In this first iteration, a convergent route was applied to synthesise a 
fourth generation (G4) dendrimer with a trisphenolic core and 48 peripheral acetyl groups. In 
this case, oxalyl chloride was used to activate the focal point at each growth step, with 10 
reactive steps and an overall yield of 15%.
31
 Unfortunately, attempts to remove peripheral 
acetyl protecting groups resulted in degradation of the dendrimer backbone. To alleviate this 
problem, a double-exponential growth strategy was developed, employing acetonide 
protecting groups which can be removed under milder conditions, without damage to the 
dendrimer backbone and yielding a dendrimer with reactive surface groups, Scheme 1.5.  
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Scheme 1.5 Preparation of a G4 polyester dendrimer using 2,2-bis(hydroxymethyl)propionic acid (bis-MPA)
31
 
Fourth generation bis-MPA dendrimers with 48 peripheral hydroxyl groups were synthesised 
in high recovered yields (56% in 7 reactive steps) using N,N'-dicyclohexylcarbodiimide 
(DCC) as the esterification agent for coupling acetonide protected bis-MPA to hydroxyl 
functional groups.
32
 The presence of 4-(dimethylamino)pyridinium 4-toluenesulfonate 
(DPTS), which is formed from an equimolar ratio of DMAP and p-toluenesulfonic acid 
monohydrate
33
, suppresses the formation of inactive N-acylurea byproducts. Although this 
method was successful, it suffered low yields at high dendrimer generations, resulting in the 
introduction of a novel anhydride monomer unit based on bis-MPA.
34
 The application of 
anhydride chemistry to the synthesis of dendrimers has proven to be an efficient strategy due 
to their greater tolerance of water residues than acid chlorides and acid bromides, enhanced 
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reactivity towards hydroxyl groups and high recovered yields, facilitating dendrimer 
synthesis on a large scale. Reactions between anhydrides and alcohols to yield polyester 
dendrimers are normally carried out at ambient temperature in the presence of catalytic 
DMAP, thus minimising transesterification and degradation.
35
 The synthesis of a 2
nd
 
generation bis-MPA based dendrimer using the anhydride approach is shown in Scheme 1.6, 
below. 
 
Scheme 1.6 Preparation of a G2 polyester dendrimer using 2,2-bis(hydroxymethyl)propionic anhydride
34
 
 
1.1.3 Dendrimers in therapeutic applications 
Due to the structural properties of dendrimers, hydrophobic drugs can be loaded into the 
hydrophobic internal cavity, whilst hydrophilic drugs, antibodies, DNA, reactive chemical 
groups or other desired ligands can be attached to the multivalent surface via covalent 
conjugation or electrostatic interaction.
36,37
 Dendrimers have shown to be promising 
candidates for the treatment of neurodegenerative disease and as antiviral agents for the 
treatment of Human Immunodeficiency Virus (HIV) due to their ability to disrupt protein 
aggregates.
38
 Starpharma Holdings Ltd developed SPL7013 gel (VivaGel
®
); a 4
th
 generation 
dendrimer with a benzhydryl amide (BHA) core and polylysine backbone, capped with 32 
naphthalene disulphonic acid groups which provide hydrophobicity and high anionic charge 
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to the surface of the dendrimer.
39
 VivaGel
®
 is a vaginal microbicide for the prevention of 
HIV and HSV infections.
40
 This water based antimicrobial/antiviral gel has EU regulatory 
approval for the topical treatment of bacterial vaginosis (BV) and is under clinical 
development for the prevention of recurrent BV. VivaGel
®
 has also been shown to have 
potent antiviral activity against the Zika virus in laboratory studies.
41
 Dendrimer-enhanced 
(DEP
™
) drug delivery (passive and targeted) of existing drugs is also under development, 
with a dendrimer-enhanced version of docetaxel (marketed under the name Taxotere
®
) for 
treatment of solid tumours in the advanced stages of Phase 1 clinical testing (Trial ID: 
ACTRN12614000171617). Docetaxel is attached to the surface of the dendrimer with a 
linker which controls its release. In pre-clinical studies, DEP
™ 
docetaxel was shown to have 
enhanced efficacy and reduced toxicity compared to docetaxel alone, with an absence of 
neutropenia, a major dose-limiting factor of the drug.
42
 
 
1.1.4 Limitations of dendrimers 
Dendrimers display interesting materials properties due to their compact, globular structure 
and very high surface functionality, as a result of complete synthetic control. Although there 
are a wide range of potential applications of dendrimers, their future applications rely on 
efficient and practical synthetic procedures.  
Divergent dendrimer growth is generally limited to the 10
th
 generation, with the exception of 
a G13 dendrimer, with dimensions comparable to small viruses, reported by Lim et al. in 
2013.
43
 This synthesis utilises a hypermonomer approach to incorporate two generations per 
iteration, yielding G13 dendrimers with a theoretical molecular weight exceeding 8.4 MDa, 
and 16,384 amine groups at the surface. This triazine dendrimer platform utilises 18 flexible 
atoms per branching unit (P = 18), resulting in a limiting generation (the maximum 
generation achieved before defects) of 13 when applied to Eq. 1.1.
16
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𝑙𝑖𝑚𝑖𝑡𝑖𝑛𝑔 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛 = 2.88(𝑙𝑛𝑃 + 1.5)    (Eq. 1.1) 
This limitation is due to steric hindrance, as described by de Gennes dense packing
16
, 
resulting in self-limiting dendrimer dimensions as a function of generation unit length. Ideal 
dendritic growth without branching defects is only possible for generation numbers below the 
limiting generation, also known as the dense packed state. By application of site-specific 
stable isotope labelling of G1-5 benzyl ether dendrimers, distances between the chain ends 
(
13
C) and focal point (
19
F) were evaluated with rotational-echo double resonance (REDOR) 
NMR.
44
 At higher generation numbers (G3-5), inward-folding of the chain ends and 
interpenetration between dendrimers occurs; decreasing interpenetration is observed with 
increasing generation. 
Another major limitation in the commercialisation of dendrimers is the large excess of 
reagents often required to achieve perfect growth, particularly for divergent dendrimer 
synthesis, Fig. 1.3. Convergent dendrimer synthesis suffers from steric hindrance when 
coupling large dendrons to a small core molecule, often resulting in incomplete reactions. 
 
Fig. 1.3 Reagent excess for divergent synthesis of aniline-cored PAMAM dendron up to G4 (32 terminal 
groups)
45
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Both convergent and divergent approaches have the disadvantage of time consuming and 
expensive syntheses, limiting their commercial applications. There are currently only a small 
number of commercially available dendrimers; PAMAM
®
, DAB
®
, Phosphorus PMMH and 
bis-MPA dendrimers
46
, therefore, a continuous improvement in synthetic procedures is key to 
their commercial success.  
Materials such as hyperbranched polymers possess similar characteristics to dendrimers, with 
highly branched polymer structures, but lack the same structural uniformity due to statistical 
branching of ABn (n≥2) monomers during their one-pot synthesis.
47
 They are often used as 
dendrimer "mimics", due to their similar structural and globular properties, without the need 
for multistep synthetic strategies
2
, however their poorly controlled structure contains both 
dendritic and linear sites. Hyperbranched polymers will not be discussed further in this 
introduction, instead the reader is directed to a recent review of these types of materials.
48
 
 
1.2 Dendritic hybrid architectures 
Dendrons and dendrimers provide a high degree of structural uniformity, however, despite 
synthetic advances in this field, dendrimers remain exceptionally difficult to synthesise in 
high purity. New synthetic protocols for the construction of more sophisticated functional 
dendritic hybrids have been developed in order to combine well-defined dendritic 
architectures with the synthetic ease of traditional polymer synthesis, as discussed below. 
 
1.2.1 Linear dendritic hybrids 
Linear dendritic hybrids (LDHs) are macromolecular copolymers consisting of two or more 
structurally dissimilar blocks; linear polymer chains (L) and dendrons (D). This difference in 
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structure is reflected in their differing physical properties; linear polymer chains display a 
higher viscosity and hydrodynamic volume than corresponding dendritic structures with the 
same molecular weight.
49
 Covalent bonding of two or more blocks of sufficient size (linear 
block ≥1000 g mol-1, dendron block ≥G2) gives rise to novel qualities of the resulting 
copolymer, with higher generation dendritic blocks significantly altering solid state and 
solution properties.
50
 These materials have shown promise for applications in catalysis, as 
bioreactors and in the biomedical field.
51-53
 
 
Fig. 1.4 Possible architectural types of linear(red) dendritic(black) hybrids (LDHs): (i) LD; (ii) DLD; (iii) LDn; 
(iv) L-graft-D; (v) star-D(L)n; (vi) star-(LD)n; (vii) network DnLm m≥n; (viii) superdendrimer D
1
-[L(DLn)]m 
(focal point of dendrons represented by green squares) 
(i) (ii) 
(iii) 
(v) 
(iv) 
(vi) 
(vii) (viii) 
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A range of structures can be achieved depending upon the relative position of the linear (L) 
and dendritic (D) blocks, outlined in Fig. 1.4. As can be seen in Fig 1.4, LDHs can be 
synthesised from dendrons that possess a reactive group at the focal point and dendrimers 
with reactive groups at the surface. The combination of linear polymers with dendrons will be 
the focus of this discussion. Synthetic routes to LDHs include: (a) coupling of preformed 
linear and dendron blocks; (b) growth of dendritic structures on linear chains with reactive 
groups along the backbone or at the ends ("chain-first"); (c) linear chain growth by dendritic 
macroinitiators ("dendron-first") and (d) polymerisation of dendritic macromonomers.
52
 To 
preserve the monodisperse nature of the dendritic block, efficient coupling chemistries and 
controlled polymerisation techniques are typically used. 
 
(a) Coupling of preformed linear and dendron blocks 
 
Scheme 1.7 Schematic representation of LDHs synthesised by coupling of preformed linear and dendron blocks: 
(a) LD; (b) DLD and (c) L-graft-D type 
Coupling of preformed reactive linear and dendron blocks was the first method of LDH 
synthesis utilised and could theoretically be used to synthesise all macromolecular structures 
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from (i)-(vii) (Fig. 1.4), Scheme 1.7. In the first reported synthesis by Gitsov et al., 
poly(styrene) was initially synthesised via "living" polymerisation with potassium 
naphthalene, modified with 1,1-diphenylethylene, then terminated with poly(benzyl ether) 
dendrons possessing a benzyl bromide at the focal point, generating a DLD-type hybrid (Fig. 
1.4 (ii)).
54,55
 This method of LDH formation benefits from a one-step synthesis, easy 
purification by extraction/precipitation or liquid chromatography and unambiguous structure 
analysis by a combination of SEC, MALDI-TOF, FTIR and NMR. However, limited reaction 
chemistries and difficulties associated with the detection of a low number of covalent bond 
formations in large structures limits this approach.
52,54
 
 
(b) Growth of dendritic structures on linear chains with reactive groups along the backbone 
or at the ends ("chain-first") 
LD, DLD and L-graft-D (Fig. 1.4 (i), (ii) and (iv)) structures may also be synthesised via a 
"chain first" route, whereby dendrons are divergently grown from the end or at specific 
reactive sites along the backbone of a preformed linear polymer chain, Scheme 1.8. This 
method suffers from the same drawbacks as traditional divergent dendrimer synthesis; a large 
excess of reagents is required in order to avoid branching defects - a problem encountered by 
Yin et al. when synthesising dendronised polymers based on PAMAM dendrons, using the 
"graft-from" approach.
56
 PAMAM dendrons up to the 4th generation were constructed at the 
side chains of poly(ethylene imine) linear chains formed by "living" cationic polymerisation 
(number average degree of polymerisation, DPn = 10-500), however, a 10,000 fold excess of 
ethylene diamine (EDA) was required for complete amidation, with reaction times of 5-8 
days. 
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Scheme 1.8 Schematic representation of "chain-first" LDH synthesis: (a) LD; (b) DLD and (c) L-graft-D  
 
(c) Linear chain growth by dendritic macroinitiators ("dendron-first")  
The "dendron-first" method of LD synthesis is based on a macroinitiator approach, which 
involves focal point modification of the dendron block to incorporate functionality to initiate 
polymerisation, Scheme 1.9. Polymerisation techniques such as anionic ring-opening 
polymerisation (ROP) and controlled radical polymerisation (CRP) methods such as ATRP 
(for more information, see section 2.8.1), RAFT and NMP ensure good control over chain 
length and monomer composition of the linear block. It is also possible to tailor the nature of 
the end groups by various polymerisation techniques and modification chemistries. 
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Scheme 1.9 Schematic representation of "dendron-first" synthesis of LD hybrid 
This method of LDH synthesis was first reported by Gitsov et al.
57
 and involved the ring-
opening polymerisation (ROP) of ε-caprolactone with poly(benzyl ether) dendrons possessing 
a benzyl alcohol functionality at the focal point. LDHs with high molecular weights and 
narrow dispersities were obtained. 
 
(d) Polymerisation of dendritic macromonomers 
Dendronised polymers, or L-graft-D hybrids (Fig. 1.4 (iv)), can also be synthesised via the 
macromonomer approach, Scheme 1.10.
58,59
 
 
Scheme 1.10 Schematic representation of macromonomer approach to L-graft-D dendronised polymer hybrids 
 In the macromonomer route, first reported by Hawker and Fréchet in 1992
60
, dendrons of 
desired generations are modified at the focal point to introduce polymerisable functionality. 
This macromonomer is then utilised in a polymerisation reaction, yielding a dendronised 
polymer with the desired dendron present in every repeat unit, giving rise to an extremely 
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high density of functionality at the surface. However, the macromonomers are increasingly 
difficult to synthesise with increasing generation and must be highly reactive with respect to 
propagation, the comonomer (if used) must have a small and favourable shape and the 
polymer backbone must be reasonably stiff.
52,58
 
 
1.2.2 Hyperbranched polydendrons 
 
Fig. 1.5 Schematic representation of: A) A hyperbranched polydendron (HPD); B) a co-initiated HPD; 
 and nanoparticles formed via nanoprecipitation of C) HPD; and D) coinitiated HPD 
A new dendritic-polymer hybrid architecture known as hyperbranched polydendrons (HPDs) 
(Fig. 1.5A) was recently reported by Hatton et al.
61
; these structures consist of multiple 
dendron blocks attached to a soluble, branched polymer core, synthesised via the 
macroinitiator route. First and second generation ATRP macroinitiators were prepared using 
A) B)
C) D)
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the secondary symmetrical alcohol 1,3-dibenzyloxy-2-propanol and modified at the focal 
point with α-bromoisobutyryl bromide. These macroinitiators were then utilised in the ATRP 
of 2-hydroxypropyl methacrylate (HPMA) in the presence of bifunctional monomer ethylene 
glycol dimethacrylate (EGDMA), with a ratio of <1 brancher unit per intitiator molecule to 
avoid cross-linking the core, resulting in very high molecular weight polymers. These 
hyperbranched polydendron structures were able to form remarkably uniform nanoparticles in 
water via nanoprecipitation (see section 1.6.2), despite their very high molecular weight and 
broad dispersities. These materials offer an alternative to dendrimers, maintaining desirable 
surface chemistry at molecular sizes not currently achievable by convergent or divergent 
growth strategies. Hyperbranched polydendrons also hold the potential to overcome the 
disadvantage of limited drug payload of dendrimer systems as physical encapsulation into the 
core is an additional option for these materials. It was hypothesised that these polymeric 
nanoparticles contain a hydrophobic core for the non-covalent encapsulation of hydrophobic 
guest molecules and dendron moieties to introduce high surface functionality, thus emulating 
dendrimer-like structures on a much larger scale (Fig. 1.5C). Encapsulation provides a 
significant advantage as there is no need to chemically modify the structure of the drug 
molecule. 
In another report
62
, the G2 dendron macroinitiator was utilised in a co-initiated 
polymerisation with a poly(ethylene glycol)-derived (PEG16) ATRP initiator for the 
copolymerisation of HPMA and EGDMA (Fig. 1.5B). It was found that by varying the ratio 
of the dendron and PEG initiator molecules, nanoparticles with varying surface and internal 
chemistry could be formed via nanoprecipitation (Fig. 1.5D), resulting in the ability to tailor 
particles for encapsulation of hydrophobic molecules and permeation through a gut 
epithelium model. 
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1.3 Nanomedicine 
The application of nanotechnology to medical and pharmaceutical challenges has led to the 
broad field of nanomedicine which targets the diagnosis, screening, prophylaxis and 
treatment of diseases with unprecedented precision and accuracy.
63-65
 This development is in 
response to unsuitable physicochemical properties of existing drug molecules, such as poor 
solubility, and hence low bioavailability, and to provide different routes of administration 
with safer and more effective therapies compared to conventional methods. One of the 
primary goals of nanomedicine is to achieve localised drug delivery and specific targeting, 
which is essential in tumour treatment and gene therapy. The use of nanomedicine facilitates 
the creation of a differential drug distribution between the disease site and the rest of the 
body, thus maximising the therapeutic effect whilst minimising off-target adverse effects 
(Fig. 1.6 (i)). 
 
Fig. 1.6 Drug delivery approaches of nanomedicines: (i) Site specific targeting and (ii) Improving 
pharmacokinetics
66
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Improving drug pharmacokinetics (Fig. 1.6 (ii)) by increasing bioavailability, distribution or 
residence time within systemic circulation aims to reduce toxicity or drug resistance as a 
result of incorrect dosing. This is of particular importance when treating chronic diseases 
such as HIV; where toxicity leads to negative side-effects and ultimately poor adherence to 
drug regimes, and drug resistance requires modifying the anti-retroviral drug therapy 
combination to prevent proliferation of the virus.
67
 Sustained release of antiretroviral drugs is 
desirable for the treatment or prevention of HIV, reducing the number and frequency of doses 
taken by patients.
68
 
The goal of sophisticated drug delivery systems is to carry sufficient drug loads and 
efficiently cross various physiological barriers. Targeted delivery systems are designed to 
reach specific disease sites intact via a medium that can control administration by means of a 
chemical or physical trigger.
69
 As most physiological barriers prohibit permeation or 
internalisation of particles or drug molecules with large sizes and undesirable surface 
chemistry, nanomedicine aims to miniaturise and multifunctionalise drug carriers for 
improved drug delivery in a controlled, site-specific manner. Polymeric nanoparticles made 
from natural and synthetic polymers have gained interest recently for applications in the 
pharmaceutical industry as a mode of targeted drug delivery due to their stability and ease of 
surface modification.
70
 Nanosized drug delivery vehicles can be divided into; polymeric 
nanoparticles, liposomes, solid lipid nanoparticles, polymeric micelles and dendrimers. 
Polymeric nanoparticles are submicron-sized colloidal particles and can be in the form of 
nanospheres; matrix systems in which drugs are dispersed throughout the particles, or 
nanocapsules; where the drug is confined in an aqueous or oily cavity surrounded by a 
polymeric membrane (a core-shell structure) (Fig. 1.7), resulting in differing release profiles. 
CHAPTER 1 
26 
 
 
 
Fig. 1.7 Schematic representation of a nanocapsule and a nanosphere
71
 
Polymer-based nanoparticles should be biocompatible (non-toxic) and biodegradable in order 
for them to serve as viable carriers for site specific drug delivery. Route of administration 
either by intravenous or oral intake can initiate different immune reactions.
72
 PEG is a 
biocompatible, non-toxic polymer which is often used to modify the surface of nanoparticles 
to introduce "stealth" character at the surface, reducing protein (opsonin) adsorption by 
masking undesired charge or surface properties.
73
 Opsonisation, enhanced by the 
hydrophobicity of a particle’s surface, is a rapid process for mononuclear phagocyte system 
(MPS) recognition and clearance whereby particles are marked with proteins (opsonins) to 
enhance interactions with cell surface receptors on phagocytes; this can result in increased 
uptake of nanoparticles by the phagocytic cells of the MPS, which in turn determines the 
route of nanoparticle internalisation. These factors highlight the importance of surface effects 
for nanoparticles to be used as a carrier for drug delivery. 
 
 
 
 
Nanocapsule          Nanosphere 
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1.4 Active vs. Passive targeting 
Targeted drug delivery refers to drug accumulation in a specific site of disease, independent 
of the method and route of administration.
74
 For drug delivery vehicles to work, they should 
be able to reach the desired location within the body, either by passive or active targeting, 
through the various routes and biological barriers with minimal loss of their volume and 
functional integrity. Once in the desired location, they should be able to release their drug 
cargo without creating negative side effects in the surrounding healthy cells or tissue via 
controlled and targeted release mechanisms. If successful, these delivery systems would 
improve patient survival rates, reduce adverse side effects associated with the administered 
drug, reduce dosage frequency and size, and hence wastage, and improve the overall 
therapeutic effect. Targeted drug carriers can be designed to incorporate different physical 
and chemical properties including hydrophobicity/hydrophilicity, charge, size, morphology 
and targeting ligands. 
Passive targeting of nanocarriers is based on a size-flow-filtration phenomenon, usually 
limited to tumours, the MPS and lymph nodes.
75
 In cancer therapy, passive targeting takes 
advantage of the leaky vasculature in tumour tissue and compromised lymphatic drainage, 
resulting in higher accumulation; this is known as the enhanced permeation and retention 
(EPR) effect. This effect allows macromolecules/nanoparticles to enter and preferentially 
accumulate in the tumour interstitial fluid whilst suppressed lymphatic filtration blocks their 
clearance from the tumour.
76
 Extravasation of nanoparticles from systemic circulation can 
occur by convection (dominant, blood pressure dependant) or diffusion (slower, 
concentration dependant). However, the EPR effect is influenced by factors such as the 
structure of the tumour (vascular bed, stroma and extracellular matrix), tumour size, the 
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presence or absence of functional lymphatics, interstitial pressure and location, resulting in 
variability across patients. 
An advantage of active targeted drug delivery is that the drug is internalised and released 
intracellularly, dramatically diminishing the efflux of drug. 
 
1.5 Treatment of chronic disease 
Healthcare systems face a number of extremely costly and burdensome chronic medical 
conditions, such as arthritis, asthma, heart disease, diabetes, cancer and HIV/AIDS; 
accounting for 70% of deaths and 75% of direct healthcare costs in the United States in 
2005.
77
 Chronic drug regimens for conditions which generate long-term morbidity often 
require frequent dosing through daily administration of single or combination drug therapies. 
Current research focuses heavily on the development of nanomedicine platforms for the 
treatment of cancer
78
, although few have been approved due to strict approval procedures.
79
 
Research aims to decrease dosage and hence toxicity, whilst increasing drug concentrations at 
the tumour site; avoiding exposure of healthy tissue to toxic drug levels.
80
 Cancer presents an 
obvious target for nanomedicines which can take advantage of the EPR effect; increasing 
drug accumulation around a tumour in a localised disease site. However with diseases such as 
HIV, for which there is no cure, the viral infection occupies cellular and tissue sites widely 
distributed throughout the body and in systemic circulation.
81
 According to the World Health 
Organisation (WHO), 36.7 million people globally were living with HIV at the end of 2015.
82
 
Highly active antiretroviral therapy (HAART) provides effective treatment for HIV by 
combining different classes of antiretroviral agents, transforming a lethal disease into a 
chronic pathology; maintaining the function of the immune system and preventing 
opportunistic infections that often result in death.
83
 HAART provides effective treatment 
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options for treatment-experienced and new patients. Several classes of antiretroviral agents 
currently exist: 
 Nucleoside reverse transcriptase inhibitors (NRTIs)  
 Non-nucleoside reverse transcriptase inhibitors (NNRTIs)  
 Protease inhibitors (PIs)  
 Integrase strand transfer inhibitors (INSTIs)/Allosteric integrase inhibitors (ALLINIs) 
 Fusion inhibitors (FIs)  
 Chemokine receptor antagonists (CCR5 or CXCR4 antagonists)  
Most current HAART drug regimens consist of a combination of 3 antiretroviral agents; two 
NRTIs and one PI/NNRTI/INSTI.
84
 Strict adherence to antiretroviral therapy (ART) is 
critical for sustained HIV suppression and reduced risk of drug resistance.
85
 
 
Fig. 1.8 Stages of the HIV-1 life cycle targeted by antiretroviral drugs
86
 
Restricted access of antiretroviral drugs to sanctuary sites such as the brain and the lymphatic 
system impedes viral clearance and is believed to be the main cause of resurgence of 
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suppressed HIV replication from below detection level in patients with interrupted 
treatment.
87,88
 The narrow therapeutic index – the ratio between the therapeutic and toxic 
dose of a drug – of many antiretroviral drugs such as efavirenz (NNRTIs), lopinavir/ritonavir 
(PIs), maraviroc (CCR5 inhibitor) and tenofovir (NRTIs), often limits their effectiveness as 
they are administered to patients in sub-optimal doses to prevent side-effects. Some 
antiretroviral therapies have considerable interpatient pharmacokinetic variability while 
others have known drug concentrations associated with efficacy and/or toxicity.
89
 To 
overcome these problems, smart nanocarriers with targeting moieties and stimuli responsive 
release are being developed for the delivery of antiretrovirals.
90-93
 Orally dosed nanomedicine 
formulations aim to reduce drug dose whilst maintaining therapeutic exposure, leading to a 
decrease in side-effects and cost per dose. 
 
1.5.1 Passive targeting of macrophages 
Passive targeting takes advantage of the inherent biophysicochemical properties of the 
nanoparticle such as size, shape, charge and flexibility to influence tissue accumulation, 
adhesion and cell uptake.
94
 Passive targeting of nanocarriers to lymph nodes, an important 
induction and HIV-1 replication site, is key to improved drug delivery for the treatment of 
HIV/AIDS.
75
 Macrophages are also an important replication and sanctuary site which play a 
significant role in the pathogenesis of HIV-1. Once infected, macrophages generate new 
virus, have low drug permeation, die during rapid viral replication and negatively impact 
immune system activity.
95
 HIV infected macrophages are more phagocytic than non-infected 
macrophages
96
, thus providing a potential passive targeting option for drug delivery vehicles. 
Long-term successful treatment of HIV infected macrophages requires potent strategies to 
prevent entry and persistence in these cells.
97
 Several research groups
98-102
 have used 
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macrophages to target the MPS, particularly lymph nodes. Drug-loaded nanocarriers are 
engulfed by macrophages, which then migrate to the lymph nodes (or other MPS tissues); the 
drugs slowly diffuse out of the macrophages, producing a sustained high drug concentration 
within the lymph node. In all cases, frequency of administration of the drug carriers was 
decreased, total amount of drugs delivered is low, resulting in reduced toxicity, yet the 
efficacy is high. One study involved the intravenous (IV) injection of indinavir (IDV) 
nanoparticles entrapped in macrophages in vitro into humanised mice; the in vivo studies 
showed accumulation in the lung, liver and spleen. This resulted in a reduction of HIV-
infected cells in plasma, lymph nodes, spleen, liver and lung, as well as CD4
+
 T-cell 
protection.
100
 
Reliance on passive diffusion limits effective drugs to those that are soluble in both polar 
extracellular environments and non-polar cell membrane environments. 
 
1.5.2 Opportunities for active targeting of HIV 
Physical targeting of nanomaterials makes use of external sources or fields to guide 
nanoparticles to target sites and to control the therapeutic effect, for example in photothermal 
and magnetic hyperthermia therapy.
103
 
Targeted delivery of nanocarriers for the treatment of HIV requires specific ligands that 
interact with specific HIV receptor targets. This approach has been applied extensively in 
preclinical studies of cancer targeting where certain receptors are over-expressed at various 
stages of the disease.
78,104,105
 HIV receptor targets are lacking on infected cells, however, the 
disease only targets a limited number of cell types (CD4
+
 T cells, CD4
+
 
monocytes/macrophages, dendritic cells). HIV receptor CD4, co-receptors CCR5 and 
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CXCR4, and others (e.g. folate) relatively specific to macrophages provide potentially 
valuable surface targets for drug delivery to all HIV-susceptible cells in patients.
75
 
A combination of both active and passive targeting may ultimately prove to be the most 
effective when targeting the treatment of HIV. 
 
1.6 Nanoparticles with heterogeneous surface functionality for drug 
delivery 
Nanoparticles are solid, colloidal particles with dimensions of less than 1 μm, in which 
therapeutic agents can be encapsulated or attached onto the surface.
106,107
 The preparation of 
well-defined particles on the scale of nanometers to micrometers can be achieved using a 
range of techniques such as self-assembly, (mini/micro)emulsion systems, suspension and 
interfacial polymerisation.
108
 Nanoparticles can be biodegradable, biocompatible and 
functionalised depending upon material selection and manufacturing technique. The choice of 
technique depends upon the desired material properties; solubility, morphology, size and 
dispersity can be tailored for the targeted application.
109,110 
Multivalent interactions occur naturally in many biological systems and are characterised by 
the simultaneous binding of multiple ligands to multiple receptors.
111
 Nanoparticles with 
numerous targeting ligands can provide multivalent binding with cells that present a high 
density of receptors at the surface, e.g. cancer cells, providing enhanced interactions over 
single targeting ligands of molecular conjugates (Fig. 1.9).
112
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Fig. 1.9 Multivalent interaction between nanocarriers possessing multiple targeting ligands and multiple 
receptors on a cell surface leading to endocytosis 
Drug delivery systems are specifically engineered to deliver therapeutic agents in a targeted 
and/or controlled manner and must therefore; avoid capture by the immune system, target 
diseased tissue, infiltrate the diseased tissue, release the drug, avoid drug resistance 
mechanisms and avoid releasing drug in healthy tissue, as this would lead to side effects.
69,113
 
Therefore, particles with multiple surface chemistries (denoted as “patches”) are required to 
aid navigation through the body. Various inorganic and organic colloids (objects with at least 
one dimension in the order of 1 nm – 1 μm, dispersed in a continuous medium)114 can be 
produced with good control over dispersity of size and shape, however, their surfaces remain 
chemically homogeneous.
115
 Janus particles, which possess two distinct regions of 
contrasting polarity or surface chemistry (Fig. 1.10), have been widely studied as a 
subcategory of patchy particles, after being popularised by de Gennes in 1992.
116 
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Fig. 1.10 Possible Janus particle architectures; (a) sphere, (b,c) cylinders and (d,e) discs 
Two-faced Janus particles introduce asymmetry and directionality within a single particle for 
self-assembly
117-119
 or emulsion stabilisation at fluid-fluid interfaces
120
. Three main strategies 
are employed for the synthesis of Janus particles; masking, phase separation and self-
assembly.
121
 Masking involves protection of one side of a particle, followed by modification 
of the unprotected side by evaporative deposition
122
 or suspension at an interface
123
. 
Preparation of Janus particles by phase separation involves the mixing of two incompatible 
substances, usually either two polymers or a polymer and an inorganic material, that separate 
into their own domains within a single particle. Synthesis via self-assembly of block 
copolymers was first described in 2001 by Erhardt et al.
124
, and involved the self-organisation 
of a polystyrene-block-polybutadiene-block-poly(methyl methacrylate) triblock copolymer 
into spherical Janus micelles possessing polystyrene and poly(methyl methacrylate) 
hemispheres. 
Patchy particles are defined as having 1 or more patches of less than 50% of the total surface 
area of the particle which exhibit different properties.
125
 Patchy particles are colloidal 
particles with an anisotropic distribution of surface functional groups, resulting from tailoring 
the particle's surface or modification of components during fabrication.
126
 As a result of the 
heterogeneously patterned surface, patches are able to form highly directional and specific 
bonding interactions, Fig. 1.11.
127
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Fig. 1.11 Patchy particles (adapted from Glotzer et al.)
127
 
Patchiness is introduced onto the surface of colloidal particles via a range of chemical and 
physical processes, including: templating or masking (as described for Janus particles)
125
; 
particle lithography, which involves attaching small particles to larger particles
128
; glancing 
angle deposition (GLAD) where vapour deposition is carried out at an inclined angle with 
respect to the particle monolayer
125
; colloidal clusters, where microspheres are attached to the 
surface of liquid emulsion droplets, followed by removal of the liquid, leading to packing of 
the spheres
129
; nanosphere lithography, involving three dimensional close-packed arrays of 
particles where the top layer of particles acts as a mask which determines the patterning of 
metal deposited on the lower layer(s)
130
. 
Experimental simulations have concluded that the size and nature of the patches of 
functionality on the surface of nanoparticles affects insertion and penetration across a flat 
membrane.
131
 It has been shown that particles of similar size and overall surface composition 
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with patterned and non-patterned surfaces display remarkably different membrane 
penetration behaviour. Gold nanoparticles (~6 nm) with ordered, ribbon-like domains of 
hydrophobic and hydrophilic moieties on the surface were shown to penetrate cell 
membranes at 37°C and 4°C without evidence of membrane disruption; whereas particles 
lacking structural order showed no evidence of cell membrane penetration.
132
 
The combination of different functionalities onto one single particle may lead to the 
development of multifunctional nanomedical platforms for simultaneous targeting, imaging 
and therapy administration.
133
 The availability of multiple terminal groups allows dendritic 
structures to carry a higher payload of functional moieties, enhancing targeted toxicity. 
 
1.6.1 Surface modifications 
Multifunctional materials are often required for advanced applications.
134
 The highly 
branched nature of dendrimers provides enormous surface functionality with well-defined 
interior and exterior regions, enabling multifunctionality on the same macromolecule and 
therefore multivalent interactions with microorganisms in vivo. The interior environment of 
dendrimers is usually unreactive and therefore unavailable for post-synthesis modification, 
however there are some examples where dendrimers have been treated with strong acids
135
 or 
super bases
136
 to generate active sites within the dendrimer interior for further modification. 
The incorporation of "temporary" groups, or protected precursors, into the dendrimer 
structure allows for selective transformation post-synthesis.
137-139
 McGrath and coworkers 
presented dendrimers with dormant hydroxyl functional groups in the interior, which can be 
activated under moderate acidic conditions.
140,141
 However, the most common modifications 
take place at the surface where a large number of terminal groups are presented. Many of the 
properties that dendrimers exhibit are determined by end-group chemistry, e.g. 
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hydrophobicity/hydrophilicity, solubility, thermal stability.
142
 Due to the equivalent nature of 
these end groups, only reagents with high reactivity and selectivity can be used. Some 
examples of reactions that have been established for the surface modification of bis-MPA 
dendrimers include copper-catalysed azide-alkyne cycloaddition (CuAAC) click chemistry
143
 
and incorporation of peripheral hydroxyl groups that can be converted to reactive 
intermediates including alkenes
144,145
, alkynes
143,146,147
 and p-nitrophenyl carbonates
26,148
. 
CuAAC click chemistry combines exceptional chemoselectivity with a lack of byproducts 
and high yields, and has been used to efficiently functionalise dendrimers with peptides
149
 
and carbohydrates
150,151
. However, highly reactive, potentially explosive and toxic azide 
substrates, and the strict purification procedures required for removal of cytotoxic copper 
used in the synthesis, has limited the application of CuAAC click chemistry and resulted in 
the development of alternative click reactions including retro Diels-Alder cycloaddition and 
thiol-based click reactions. 
 
1.6.2 Nanoprecipitation 
Nanoparticle formation by nanoprecipitation, also known as solvent displacement or 
interfacial deposition, was developed by Fessi et al. in 1989
152
, and involves the addition of a 
polymer in a "good" solvent (e.g. THF, acetone) to a miscible anti-solvent (usually water) 
with stirring. Nanoprecipitation occurs by rapid desolvation of the polymer in the anti-solvent 
by diffusion and evaporation of the "good" solvent, resulting in a decrease in interfacial 
tension and subsequent phase separation. Nanoprecipitation offers the advantage of simple 
and mild formulation under ambient conditions without the use of chemical additives and 
harsh chemical or physical processes. Nanoprecipitation is insensitive to the chemical 
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specificity of the components, making it a widely applicable nanoparticle formation 
technique.  
Lince et al.
153
 described nanoprecipitation in terms of three stages; nucleation, growth and 
aggregation. The rate of each step determines the resulting particle size distribution and relies 
on super-saturation, defined as the ratio of polymer concentration and the solubility of the 
polymer in the solvent mixture. Nanoparticle size may be controlled by; addition speed of 
solvent to anti-solvent, mixing velocity, the concentration and/or ratio of polymer(s) and 
other components (e.g. drug molecules) in the “good” solvent, types of solvent used, and the 
ratio of solvent to anti-solvent. 
Hatton et al. recently demonstrated that nanoprecipitation can be directed by large, highly 
branched macromolecules, even in polymer samples with very broad molecular weight 
distributions, containing a significant linear portion.
154
 This has implications for materials 
used in a medical setting; significantly reducing the need for stringent control over polymer 
synthesis and nanoparticle formation, to obtain nanoparticles with controlled size and narrow 
polydispersities. 
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1.7 Research hypothesis 
Properties such as nanoparticle size, surface charge, solubility, and surface functionality 
influence uptake and clearance by macrophages.
155
 In several cases, the passive targeting of 
macrophages may be highly beneficial to therapeutic outcomes and one such opportunity has 
been highlighted through the observation that HIV-infected macrophages are more 
phagocytic than uninfected macrophages.
96
 This potentially offers a higher statistical delivery 
of drug-containing nanoparticles to target cells in a mixed population containing healthy and 
infected cells. 
Polymer nanoparticles can be specifically designed to achieve both controlled drug release 
and site-specific localisation by tuning the polymer properties and surface chemistry.
156
 
Important characteristics for drug delivery using nanoparticles include; high water solubility 
and drug loading capacity, biodegradability, low toxicity, favourable retention and 
biodistribution characteristics, specificity and appropriate bioavailability.
157
 Dendrimers are 
considered as promising drug delivery vehicles as they enable simultaneous incorporation of 
drugs and biological ligands at the surface for active targeting. However, their complex and 
expensive synthesis and purification procedures as well as poor drug loading efficiency 
render them not widely commercially viable. It has also been shown that flexible, elongated 
nanocarriers might be more successful in drug delivery applications than dense, radially 
symmetric dendrimers.
158,159
 HPDs provide a promising alternative to dendrimers as they 
maintain a high level of surface functionality with a tuneable polymer core. These materials 
have also been shown to nanoprecipitate to form nanoparticles which display exceptional size 
control, stability and uniformity of behaviour, despite the broad dispersity and high molecular 
weight of the branched polymer structures.
61
 HPDs can potentially improve the carrier-to-
active ratio, compared to dendrimers, whilst maintaining surface functionality for multivalent 
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interactions.
160
 Multivalent interactions between nanoparticles and macrophages may result in 
enhanced cellular uptake via the simultaneous binding of multiple ligands at the nanoparticle 
periphery with multiple receptors on the cell surface. In addition, patchy particles 
simultaneously present multiple different surface functionalities on the same construct, 
making them promising for multivalent guest-host interactions. Controlling the size and 
distribution of patches on nanocarriers may enhance efficacy and specificity of targeted 
delivery.
161
 
The HPD platform provides a relatively simple method of connecting multiple chain ends 
bearing diverse chemistry by branching between primary polymer chains, thereby producing 
materials with very high molecular weight and surface functionality. In previous studies, 
tailoring the initiator feed ratio of two different functional macroinitiators (dendron- and 
PEG-derived) resulted in materials with varying nanoparticle size and permeation through a 
human gut epithelium model.
62
 The presented hypothesis suggests an opportunity to expand 
this concept to include multiple-initiation of a PEG macroinitiator with more than one 
functional dendron initiator, potentially of different generations, to induce “patchiness” on 
the surface of nanoprecipitates. Using this modular synthesis approach, it may be possible to 
build patchy, multifunctional nanoparticles with isolated functional groups and aqueous 
stabilisation which enable targeting of infected macrophages, Fig. 1.12. 
 
Fig. 1.12 Co-initiation of two dendron macroinitiators with different peripheral functionality with a PEG-
derived macroinitiator to synthesise patchy multifunctional nanoparticles 
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Increasing the generation number of the dendron, and hence the number of functional groups 
per “patch”, it may be possible to maximise the avidity of multivalent ligands, Fig. 1.13. The 
precise, spatial control of functionalities may result in directional interactions with receptors 
on the macrophage surface. 
 
Fig. 1.13 Schematic representation of the multivalency effect that may occur with biological systems in the 
presence of dendritic structures compared to monomeric interactions (adapted from Caminade and Turrin)
162 
 
1.8 Research objectives 
To systematically and rigorously investigate the presented research hypothesis, a combination 
of dendrimer chemistry for the construction of dendron macroinitiators, controlled radical 
polymerisation (CRP) for the rapid formation of HPDs, and facile thiol-Michael addition 
reactions will be required. This builds considerably on the previous advances in HPD 
synthesis and allows access to the unique opportunities for simple, modular nanoparticle 
design and production. The potential for targeted nanocarriers for drug delivery applications 
is clearly enabled by the simplicity of this synthesis strategy if the targeted biological benefits 
can be realised. 
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ATRP (see section 2.8.1), which has been successfully applied to the formation of LDHs
163
 
and the recently reported HPDs
61
, was selected for the synthesis of these specifically 
engineered polymer structures. ATRP is compatible with a wide range of monomers, 
initiators, functional groups and solvent systems, and allows good control over molecular 
architecture. Surface modification by incorporation of xanthate functional groups at the 
dendron periphery has previously been reported.
163,164
 These xanthate groups are able to 
undergo facile orthogonal deprotection and functionalisation with a range of hydrophobic, 
hydrophilic and polymeric acrylates to introduce different functionalities into complex 
polymer structures and offer the potential to create feedstock materials that can be readily 
modified to generate a range of test materials without the need for repeated synthesis. 
 
1.8.1 Develop a control strategy; statistical multifunctionalisation 
In order to test the research hypothesis, a series of materials is required that vary only in the 
spatial arrangement of surface functionality, with as little variation in other physical and 
chemical properties as possible. This is shown schematically in Fig. 1.14, where structures 
with the same molar ratio of functionality either statistically mixed or grouped into “patches” 
across the HPD structure are presented. Modification of the cellular interactions of 
nanoparticles with either patchy or statistical multifunctionalisation could therefore be 
compared directly within appropriate biological assays. 
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A) 
 
B) 
 
Fig. 1.14 Target materials: A) Patchy; and B) Statistically multifunctional HPDs 
To establish a statistical functionalisation of the nanoprecipitates is not a trivial synthetic 
challenge as final analytical confirmation of the distribution is difficult to achieve. By 
combining previously reported work for the synthesis of HPDs via ATRP
61
 and the use of 
xanthate functional groups for surface modification of dendritic materials
163,164
, xanthate 
functional HPDs which can be statistically modified after polymerisation using mixtures of 
functional acrylates are achievable, Fig. 1.15. 
 
Fig. 1.15 Schematic representation of the aims of this project; HPD synthesis, post-functionalisation 
Model studies that establish the outcomes of such a statistical modification are not readily 
available within the literature, therefore, a key aim of this research is to study this process. A 
detailed understanding of the statistical nature of the functionalisation is required in order to 
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provide evidence of the statistical distribution and confidence that the approach will create 
materials able to address the main research hypothesis. 
1.8.2 Probing the distribution of surface functional groups 
As seen previously in Fig. 1.11 (section 1.6), a wide range of patchy particles have been 
reported. Within each material, it is a key issue to develop analytical methods that probe the 
functional group distribution and, if possible, generate clear evidence that “patchiness” has 
been created. This can be achieved through imaging the distribution of surface functional 
groups but this is extremely difficult at the single functional group scale. The xanthate 
functionality does present a clear opportunity as once deprotected, the resulting thiols are able 
to bind gold nanoparticles. In this case, it may be possible to utilise a combination of 
nanoparticle binding and electron microscopy imaging to directly quantify the differences 
between statistical and patchy thiol spatial arrangements, Fig. 1.16. 
 
Fig. 1.16 Probing the distribution of surface functional groups by coordination of GNPs to thiol-functional HPD 
nanoprecipitates 
Confirming the distribution of xanthate functional groups at the nanoparticle surface would 
provide confidence that patchy particles with other functional groups could also be generated 
in a “bottom-up” HPD synthesis approach. 
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1.8.3 Preparation of patchy particles with mixed functional groups and interaction 
with macrophages 
If incorporation of functional dendron initiators, isolation of surface groups by varying 
PEG:dendron ratios in a branched polymerisation, and post-polymerisation modification of 
xanthate functional HPDs is possible, a statistically multifunctionalised HPD and a  
corresponding patchy multifunctionalised HPD should also be possible, Fig. 1.17. Tailoring 
of the mixed initiator feed will allow the same molar functionality to be maintained between 
these multifunctional materials and nanoparticle structures varying predominantly in the 
spatial arrangement of functional groups should be achievable.  
A) 
 
 
B) 
 
Fig. 1.17 Schematic representation of the construction of; A) statistically multifunctional, and B) patchy 
multifunctional nanoparticle formation 
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This is highly speculative and depends on the ability to synthesise and multifunctionalise 
xanthate functional HPDs and probe the distribution of surface functional groups to confirm 
“patchiness”. 
The rational design and combinatorial synthesis of co-initiated HPDs with regions of distinct 
chemical surface heterogeneity will be applied for systematic evaluation and optimisation of 
nanocarriers. Whilst most drug delivery systems aim to avoid uptake by the MPS – part of the 
immune system that consists of phagocytic cells such as monocytes and macrophages – we 
are targeting the treatment of HIV, which resides in macrophages. This project aims to 
elucidate the synergism of functional group co-localisation and multivalency on particle-cell 
interaction and uptake into monocyte derived macrophages (ATHP-1). The detection of 
polymer nanoparticles and monitoring their uptake into cells (cellular accumulation ratio; 
CAR) may be achieved using fluorescence or dye labelling, however, such modifications may 
alter the chemistry of the nanoparticle. Through the application of radiochemistry, polymer 
nanoparticles containing significant amounts of the 
3
[H] isotope would allow quantification 
of nanoparticle uptake without significant chemical modification of the polymer structure, 
limiting the potential for interference of the biological assay by the presence of new chemical 
moieties. Radiolabelling of the patchy and statistically multifunctionalised polymers before 
nanoprecipitation, therefore, enables the monitoring of the nanocarriers directly. An idealised 
biological assay outcome after quantifying the CAR of patchy and statistically 
multifunctionalised nanocarriers is shown in Fig. 1.18, and would strongly indicate the 
difference between the cellular interactions of these materials with phagocytic cells. 
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Fig. 1.18 Predicted difference in CAR of patchy and statistically multifunctionalised nanocarriers as a result of 
multivalency effect 
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CHAPTER 2 
 
 
Xanthate functional dendritic material synthesis  
 
 
 
 
Recently published in part as: 
 “Model studies of the sequential and simultaneous statistical modification of dendritic functional groups and 
their implications within complex polymer architecture synthesis.”  
F. Y. Hern, S. E. R. Auty, O. C. J. Andrén, M. Malkoch and S. P. Rannard, Polym. Chem., 2017, 8, 1644-1653. 
Individual contributions: S. E. R. Auty – Initial studies to establish xanthate chemistry;  
O. C. J. Andrén – recorded MALDI-TOF spectra; M. Malkoch and S. P. Rannard – supervisors. 
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2.1 Introduction 
Highly functional polymers for advanced applications may be prepared by the polymerisation 
of specifically designed functional monomers or the post-polymerisation modification of a 
polymer possessing reactive functional groups. Although polymerisation of functional 
monomers ensures a high degree of functionality, this method is hindered by solubility issues, 
difficulty to polymerise and incompatibility with polymerisation conditions.
1-3
 
Post-polymerisation modification represents a versatile platform for the preparation of a 
library of diversely functionalised materials from a single well-defined precursor. Combining 
controlled polymerisation techniques with highly efficient coupling chemistries facilitates 
quantitative and orthogonal functionalisation of complex polymer architectures at the 
periphery and at side-chains, affording the opportunity for obtaining desired material 
properties. Highly efficient chemistries including “click” reactions have successfully been 
applied to the preparation of functional polymers via a post-polymerisation strategy.
2-9
  
“Click” chemistry, as described by Sharpless et al., represents a range of reactions that should 
be equimolar, easy to purify, rapid, high yielding and, perhaps most importantly, 
chemoselective.
10
 The ability to perform these types of reaction in the presence of other 
commonly reactive moieties makes “click” reactions an invaluable tool.  
Xanthate functional dendrons, dendrimers and linear dendritic hybrids (LDHs) were recently 
shown to undergo a facile ambient temperature one-pot deprotection and surface 
functionalisation via thiol-acrylate Michael addition, without the need for direct handling of 
highly reactive thiols.
9,11
 This platform presents the opportunity for extending post-
modification reactions to highly complex polymer architectures, such as recently reported 
hyperbranched polydendrons (HPDs)
12
, and for controlled multifunctionalisation of a range 
of dendritic materials. 
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In Chapter 2, the synthesis and full characterisation of four generations of xanthate peripheral 
dendrons (G0, G1, G2, G3) is presented. These functional dendrons were used to prepare 
xanthate functional dendrimers, linear dendritic hybrids (LDHs) and hyperbranched 
polydendrons (HPDs). ATRP polymerisation of n-butyl methacrylate (nBMA) and tert-butyl 
methacrylate (tBMA) is investigated with xanthate functional dendron macroinitiators, Fig. 
2.1.
 
Fig. 2.1 Schematic representation of the aims within this chapter: G0-G3 xanthate peripheral dendrons; dendron 
focal point modification; dendrimer synthesis; bromoinitiator synthesis and polymerisation to form linear 
dendritic hybrids (LDH) and hyperbranched polydendrons (HPD) 
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2.2 Synthesis of bis-MPA scaffold by divergent route 
Both divergent and convergent synthetic strategies offer respective advantages and 
disadvantages (Chapter 1.1.1). A divergent growth approach was adopted for the construction 
of the 2,2-bis(hydroxymethyl)propionic acid (bis-MPA) dendron scaffold with subsequent 
xanthate functionalisation. Focal point manipulation to produce dendrimers or macroinitiators 
via a convergent strategy is also possible by this route, as discussed later in this chapter 
(sections 2.6 and 2.7). The synthetic strategy is outlined schematically in Fig. 2.2. 
 
Fig. 2.2 Schematic representation of the divergent approach to polyester dendrons based on 2,2-
bis(hydroxymethyl)propionic acid (bis-MPA) and subsequent xanthate functionalisation 
Polyester dendrons and dendrimers based on AB2 monomer bis-MPA have been extensively 
explored for biological applications as they are known to be biocompatible and biodegradable 
with non-toxic degradation products (Chapter 1.1.2).
13
 
Dendron synthesis requires focal point and peripheral protecting groups that facilitate 
independent and quantitative deprotection. Focal point protecting group para-toluenesulfonyl 
ethanol (p-TSe) was utilised for the construction of the dendron scaffold as it is stable during 
activation and growth procedures developed by Ihre et al.
14
, and is easily removed under 
conditions which do not degrade the xanthate peripheral groups.
9,11,15
 Its facile removal is 
achieved using non-nucleophilic base 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU).  
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Acetonide protected bis-MPA anhydride, which employs acid hydrolysis for acetonide 
removal, was used for the construction of the bis-MPA scaffold, Scheme 2.1.
16
 
 
Scheme 2.1 Synthesis of acetonide protected bis-MPA anhydride [Acet1-G1-Anhy];[2] 
In the first step, hydroxyl groups of the bis-MPA monomer were protected by the formation 
of an acetonide group with 2,2-dimethoxypropane in the presence of p-toluenesulfonic acid 
(pTsOH) in acetone [Acet1-G1-COOH];[1]. Acetonide protected anhydride monomer [Acet2-
G1-Anhy];[2] was prepared in high yields (99%) by self-condensation of [1] with  
N,N’-dicyclohexylcarbodiimide (DCC). 13C NMR spectroscopy was used to monitor reaction 
progress; the change in chemical shift of the carbonyl environment at δ = 180.3 ppm to  
169.6 ppm indicating anhydride formation. 
Anhydride monomer [2] was used to construct a range of dendritic macromolecules ([3]-[8]) 
up to the third generation hydroxyl functional dendron [(OH)8-G3-TSe];[8], using a two-step 
divergent growth approach, Scheme 2.2.  
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Scheme 2.2 Divergent synthesis of core-protected hydroxyl-functional G1, G2 and G3 dendrons;  
[(OH)2-G1-TSe];[4], [(OH)4-G2-TSe];[6], [(OH)8-G3-TSe];[8] 
Each growth step was achieved by reacting each hydroxyl group with 1.3-1.5 equivalents of 
anhydride monomer [2], 0.2 equivalents of 4-dimethylaminopyridine (DMAP) and  
5 equivalents of pyridine (per hydroxyl group) in a 1:3 ratio of pyridine:CH2Cl2 (v/v). The 
first generation dendron [Acet1-G1-TSe];[3] was synthesised in 97% recovered yield, with 
structural confirmation by electrospray mass spectrometry (ESI-MS) (Fig. S2.7), 
1
H and 
13
C 
NMR spectroscopy (Fig. S2.5 and S2.6, respectively), and elemental microanalysis. 
Removal of the acetonide protecting groups was achieved using a DOWEX-50W X2 resin in 
methanol, heated to 50°C and stirred for 3 hours. Progress was monitored by thin layer 
chromatography (TLC) and resulted in quantitative recovered yields for each generation. The 
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structure of first generation hydroxyl functional dendron [(OH)2-G1-TSe];[4] was confirmed 
by ESI-MS, 
1
H and 
13
C NMR, with no evidence of TSe focal point protecting group 
degradation, Fig. S2.8-S2.10. Purification by liquid chromatography was required for higher 
generation acetonide protected bis-MPA dendrons [5] and [7] to remove lower molecular 
weight impurities. Structural integrity was confirmed by 
1
H and 
13
C NMR and mass 
spectrometry. 
 
2.3 Characterisation of bis-MPA scaffold by a divergent route 
Each dendritic macromolecule was characterised using 
1
H and 
13
C NMR spectroscopy and 
mass spectrometry. Although NMR was useful to indicate the presence of symmetrical 
chemical environments, the technique was not sensitive enough to detect structural defects in 
higher dendron generations. Mass spectrometry is therefore essential for full analysis of 
higher generation dendrons since the technique easily identifies branching defects. 
 
2.3.1 Analysis by NMR spectroscopy 
Dendritic macromolecules [3] to [8] were fully characterised by 
1
H and 
13
C NMR 
spectroscopy; acetonide protected materials were analysed in CDCl3, and hydroxyl functional 
dendrons in CD3OD. 
1
H NMR analysis of acetonide protected G3 dendron [Acet4-G3-
TSe];[7] confirmed 12 proton environments, with expected integrals relative to the TSe focal 
point protecting group moiety and expected multiplicity, Fig. 2.3. Proton environments at 
different generations within the structure give rise to unique resonances, as seen previously
9
, 
for example the methyl resonances at δ = 1.14, 1.18 and 1.27 ppm (environments 3, 7 and 5 
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respectively, Fig. 2.3). Similar features are also present in lower generation dendrons,  
Fig. S2.5 and S2.11. 
 
Fig. 2.3 
1
H NMR (400 MHz, CDCl3) of [Acet4-G3-TSe];[7] 
 
13
C NMR analysis of acetonide protected dendrons similarly resulted in extra resonances 
after each growth step. The 
13
C NMR spectrum of acetonide protected G3 dendron [Acet4-G3-
TSe];[7] indicates 21 carbon environments, including different resonances for ester carbonyl, 
methyl, tertiary carbon and methylene environments for each generation within the structure, 
Fig. S2.17. This was also observed in lower generation acetonide protected dendrons [3] and 
[5], Fig. S2.6 and S2.12. 
1
H NMR analysis of hydroxyl functional dendrons [4], [6] and [8] indicated the 
disappearance of a pair of singlets at approximately δ = 1.35 and δ = 1.41 ppm, confirming 
the complete removal of the acetonide protecting group, shown here for the 
1
H NMR 
spectrum of [(OH)8-G3-TSe];[8], Fig. 2.4. This is also seen for lower generation dendrons, 
Fig. S2.8 and S2.14. 
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Fig. 2.4 
1
H NMR (400 MHz, CD3OD) of [(OH)8-G3-TSe];[8] 
Disappearance of the acetonide protecting group resonances is also seen in 
13
C NMR spectra 
of hydroxyl functional dendrons [4], [6] and [8], with the loss of resonances at δ = 22, 25 and 
98 ppm, Fig. S2.9, S2.15 and S2.18.  
No degradation of the focal point protecting group functionality (TSe) was observed after 
deprotection of the peripheral groups in either 
1
H or 
13
C NMR spectra of the hydroxyl 
functional dendrons ([4], [6] and [8]). 
 
2.3.2 Analysis by mass spectrometry 
Dendritic macromolecules [3] to [8] were analysed by ESI-MS, with desired adducts 
observed in each case. Acetonide protected G1 dendron [Acet1-G1-TSe];[3] ([M] 
(C17H24O6S) = 356.13 Da) confirmed populations at [MNa]
+
 = 379.1 Da and [MK]
+
 = 395.1 
Da, Fig. S2.7. After acetonide protecting group removal, [(OH)2-G1-TSe];[4] ([M] 
(C14H20O6S) = 316.10 Da) confirmed populations at [MH]
+
 = 317.1 Da, [MNa]
+
 = 339.1 Da 
and [MK]
+
 = 355.1 Da, with no indication of lower molecular weight materials formed as a 
result of focal point protecting group degradation, Fig. S2.10. 
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Populations for G2 dendron [Acet2-G2-TSe];[5] ([M] (C30H44O12S) = 628.26 Da) were 
confirmed at [MNa]
+
 = 651.2 Da and [MK]
+
 = 667.2 Da, Fig. S2.13, and following 
deprotection, [(OH)4-G2-TSe];[6] ([M] (C24H36O12S) = 548.19 Da) confirmed populations at 
[MNa]
+
 = 571.2 Da and [MK]
+
 = 587.2 Da, Fig. S2.16. The G3 dendron [Acet4-G3-TSe];[7] 
([M] (C56H84O24S) = 1172.51 Da) indicated populations at [MNa]
+
 = 1195.5 Da and [MK]
+
 = 
1211.5 Da, and a low intensity signal at 1013.5 Da, which may correspond to the sodium 
adduct of focal point acid functional material [(M -TSe)Na]
+
 as a result of fragmentation,  
Fig. 2.5. After deprotection, [(OH)8-G3-TSe];[8] ([M] (C44H68O24S) = 1012.38 Da)  
confirmed populations at [MNa]
+
 = 1035.4 Da and [MK]
+
 = 1051.4 Da, Fig. 2.6. Some lower 
molecular weight impurities can be seen (approximately 750-900 Da), which are likely to be 
contaminants in the mass spectrometer, as they were seen in multiple spectra. 
 
Fig. 2.5 ESI MS (MeOH) of [Acet4-G3-TSe];[7] 
 
Fig. 2.6 ESI MS (MeOH) of [(OH)8-G3-TSe];[8] 
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2.4 Functionalisation of the scaffold with xanthate peripheral groups 
Dithiocarbonates, commonly known as xanthates, have recently been used as thiol protecting 
groups for efficient functionalisation using thiol Michael addition chemistry.
9,11,17-19
 Thiols 
are generated in situ by deprotection of xanthates with an excess of n-butylamine, followed 
by addition of a functional acrylate to perform a thiol acrylate Michael addition 
functionalisation. The in situ generation of thiols significantly reduces the chance of 
disulphide formation. 
Xanthate functional building block [Xan-COOH];[9] was prepared by a simple SN2 
alkylation reaction between bromoacetic acid and potassium ethyl xanthogenate, Scheme 2.3. 
The material was characterised by 
1
H and 
13
C NMR spectroscopy. 
 
Scheme 2.3 Preparation of xanthate acid building block [Xan-COOH];[9] 
The 
1
H NMR spectrum of [Xan-COOH];[9] confirmed 3 proton environments, with 
expected corresponding integration ratios and multiplicity, Fig. 2.7. Analysis by 
13
C NMR 
confirmed 5 carbon environments, including the acid resonance at δ = 174 ppm and the 
xanthate thiocarbonyl at δ = 212 ppm, Fig. S2.19. 
 
Fig. 2.7 
1
H NMR (400 MHz, CDCl3) of 2-((ethoxycarbonothioyl)thio)acetic acid [Xan-COOH];[9] 
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2.4.1 Xanthate functionalisation via DCC esterification 
Xanthate functionalisation of hydroxyl-peripheral dendritic macromolecules was achieved 
using xanthate acid building block [9] for lower generation (G0-G2) dendrons using 
DCC/DPTS coupling chemistry, Scheme 2.4.
9
 
 
Scheme 2.4 Synthesis of [Xan1-G0-TSe];[11], [Xan2-G1-TSe];[12] and [Xan4-G2-TSe];[13] 
4-(Dimethylamino)pyridinium p-toluenesulfonate (DPTS) was chosen as the esterification 
catalyst to prevent the 1,3-rearrangement of the O-acyl intermediate to an unreactive N-
acylurea by-product, by maintaining low pH.
20
 The catalyst was prepared using literature 
procedures
21
 via azeotropic distillation of p-toluenesulfonic acid monohydrate (pTsOH∙H2O) 
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in toluene, followed by addition of an equimolar ratio of DMAP, Scheme 2.5. Analysis via 
1
H and 
13
C NMR confirmed formation of the catalyst, Fig. S2.20 and S2.21. 
 
Scheme 2.5 Synthesis of 4-(dimethylamino)pyridinium p-toluenesulfonate (DPTS) 
Xanthate functional dendrons [Xan1-G0-TSe];[11], [Xan2-G1-TSe];[12] and [Xan4-G2-
TSe];[13] were prepared by reaction of p-toluenesulfonyl ethanol (p-TSe) or hydroxyl-
terminated dendrons [4] and [6] with xanthate acid [9] in the presence of DCC and a catalytic 
amount of DPTS in CH2Cl2, Scheme 2.4. No trace of urea side products was observed when 
DPTS was used. Following purification by liquid chromatography, confirmation of the target 
molecules was obtained using ESI-MS for G0 and G1 dendrons [11] and [12] (G0 [MNa]
+
 = 
395.0 Da and G1 [MNa]
+
 = 663.0 Da, Fig. S2.24 and S2.27, respectively) and MALDI-TOF 
mass spectrometry for the G2 dendron [13] ([MNa]
+
 = 1219.1 Da, Fig. S2.29). 
1
H NMR analysis of the xanthate functional dendrons (G0-G2, [11]-[13]) indicated the 
presence of a triplet at δ = 1.42 ppm and a quartet at δ = 4.64 ppm, confirming the presence 
of the xanthate functionality, shown here for G2 dendron [13], Fig. 2.8 (G0 and G1 Fig. S2.22 
and S2.25, respectively). 
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Fig. 2.8 
1
H NMR (400 MHz, CDCl3) of [Xan4-G2-TSe];[13] 
13
C NMR analysis confirmed 12 carbon environments for the G0 dendron [11], 16 carbon 
environments for the G1 dendron [12] and 20 carbon environments for the G2 dendron [13], 
including the ester carbonyl at δ = 167 ppm and the xanthate thiocarbonyl at δ = 212 ppm, 
Fig. S2.23, S2.26 and S2.28. 
 
2.4.2 Xanthate functionalisation via anhydride chemistry 
Poor solubility of hydroxyl functional G3 dendron [(OH)8-G3-TSe];[8] in CH2Cl2 led to the 
use of pyridine to act as a catalyst and co-solvent during anhydride esterification.
11
 Xanthate 
anhydride building block [Xan-Anhy];[10] was synthesised by self-condensation of xanthate 
acid [9] with DCC, Scheme 2.6. 
 
Scheme 2.6 Preparation of xanthate anhydride building block [Xan-Anhy];[10] 
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13
C NMR spectroscopy was used to monitor reaction progress, with the shift of acid 
resonance at δ = 174 ppm to 163 ppm indicating anhydride formation (Fig. S2.31). Xanthate 
functional G3 dendron [Xan8-G3-TSe];[14] was prepared via anhydride esterification of 
hydroxyl functional G3 dendron [(OH)8-G3-TSe];[8] with xanthate anhydride [10], Scheme 
2.7. 
 
Scheme 2.7 Preparation of xanthate functional G3 dendron [Xan8-G3-TSe];[14] 
Hydroxyl functional G3 dendron [8] was dissolved in a 1:2 ratio of pyridine:CH2Cl2 (v/v), 
then reacted with 1.3 equivalents (per hydroxyl group) of xanthate anhydride [10] and 0.2 
equivalents of DMAP. Purification by liquid chromatography generated xanthate functional 
dendron [Xan8-G3-TSe];[14] in 61% yield. Confirmation of the target molecule was obtained 
by 
1
H and 
13
C NMR spectroscopy, MALDI-TOF mass spectrometry and elemental 
microanalysis. 
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1
H NMR analysis of [14] indicated 14 proton environments, each with corresponding 
expected integrals relative to the TSe focal point protecting group moiety and expected 
multiplicity, Fig. 2.9. Integrals of the characteristic xanthate resonances at δ = 1.42 ppm and 
4.64 ppm confirmed the incorporation of 8 xanthate functional groups. 
 
Fig. 2.9 
1
H NMR (400 MHz, CDCl3) of [Xan8-G3-TSe];[14] 
13
C NMR analysis confirmed 24 carbon environments, including ester carbonyl backbone 
resonances at δ = 171.5, 171.6 and 171.7 ppm and the xanthate thiocarbonyl at δ = 212 ppm, 
Fig. S2.32. Structural confirmation by MALDI-TOF analysis ([M] (C84H116O40S17) = 2308.23 
Da) showed a major population; [MNa]
+
 = 2331.7 Da, Fig. 2.10. Matrix-related peaks in the 
low mass region (m/z <1500 Da) can also be seen.  
 
Fig. 2.10 MALDI-TOF analysis (HABA) of [Xan8-G3-TSe];[14] 
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2.4.3 Analysis by SEC 
Triple detection size exclusion chromatography (SEC) of the xanthate functional G1-G3 
dendrons, [12]-[14] with a THF/2% TEA (v/v) eluent system showed narrow dispersity (Ð) in 
the region 1.12-1.19 for all samples, Table 2.1. The calculated molecular weight (MCalc) had a 
good agreement with the observed molecular weight (MObs) and the SEC-derived Mn values 
for each dendron, despite a lower resolution of molar mass determination using SEC. The 
SEC chromatograms for each dendron display a monomodal distribution, Fig. 2.11. 
Table 2.1 Triple detection SEC analysis of xanthate functional G1-3 dendrons, [Xan2-G1-TSe];[12], [Xan4-G2-
TSe];[13] and [Xan8-G3-TSe];[14] 
  MS [MNa]
+ 
SEC (THF)
a 
Dendron MCalc (Da) MObs (Da) Mn Mw Ð 
[Xan2-G1-TSe];[12] 640.1 663.0 626 702 1.12 
[Xan4-G2-TSe];[13] 1196.1 1219.1 1193 1413 1.19 
[Xan8-G3-TSe];[14] 2308.2 2331.4 2355 2697 1.15 
a
THF containing 2% TEA (v/v) at 35°C, 1mL min
-1
 flow rate. 
Mn – number average molecular weight; Mw – weight average molecular weight 
 
Fig. 2.11 SEC chromatogram overlay (refractive index) of xanthate functional dendrons [Xan2-G1-TSe];[12] 
(red), [Xan4-G2-TSe];[13] (blue) and [Xan8-G3-TSe];[14] (green) 
Retention Volume (mL)
18 19 20 21 22 23
[14]   [13]   [12] 
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2.5 Removal of TSe protecting group 
Complete removal of focal point protecting group p-toluenesulfonyl ethyl (TSe) was 
achieved using an excess (1.3 equivalents) of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and 
stirring at ambient temperature for 16 hours, Scheme 2.8. DBU has been shown to effectively 
remove the focal point protecting group without degradation of the bis-MPA dendron 
backbone
15
 or xanthate functional groups.
9,11
 
 
Scheme 2.8 Removal of TSe focal point protecting group, resulting in acid functional dendrons [Xan2-G1-
COOH];[15], [Xan4-G2-COOH];[16] and [Xan8-G3-COOH];[17] 
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Isolation of the acid functional dendron was achieved by acid washing (1M NaHSO4) and 
precipitation into hexane:ethyl acetate (90:10). Confirmation by mass spectrometry showed 
no evidence of degradation of the bis-MPA backbone or peripheral xanthate functionality 
([15] and [16] Fig. S2.35, S2.38 and [17] Fig. 2.13).  
1
H NMR analysis of the focal point acid functional materials ([15]-[17]) confirmed the loss of 
CH2 resonances at δ = 4.46 ppm and 3.44 ppm and aromatic resonances at δ = 7.80 ppm and 
7.39 ppm, correlating to the loss of the TSe protecting group, shown here for [17] Fig. 2.12 
([15] and [16] Fig. S2.33 and S2.36, respectively). Some evidence of the vinyl sulfone  
by-product (
1
H NMR overlay of [14] and [17], Fig. S2.39) generated during deprotection was 
indicated at δ = 7.77 ppm and 7.35 ppm (aromatic resonances) and δ = 6.65, 6.44 and 6.01 
ppm (vinyl resonances), although no additional purification was implemented as the by-
products would not lead to side reactions and would be removed via liquid chromatography 
in the next step. Confirmation by 
13
C NMR revealed a characteristic carbonyl resonance at δ 
= 173 ppm, corresponding to the newly formed acid functionality, Fig. S2.40 ([15] and [16] 
Fig. S2.34 and S2.37).  
 
Fig. 2.12 
1
H NMR (400 MHz, CDCl3) of [Xan8-G3-COOH];[17] 
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Analysis of [Xan8-G3-COOH];[17] ([M] (C75H106O38S16) = 2126.19 Da) by MALDI-TOF 
mass spectrometry confirmed a single population at [MNa]
+
 = 2151.7 Da with no evidence of 
higher molecular weight species, indicating complete removal of the TSe protecting group, 
Fig. 2.13. No degradation of the bis-MPA dendron backbone or xanthate functionality was 
observed by 
1
H or 
13
C NMR analysis or mass spectrometry. 
 
Fig. 2.13 MALDI-TOF analysis (dithranol) of [Xan8-G3-COOH];[17] 
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2.6 Synthesis of xanthate peripheral dendrimers 
Convergent coupling of focal point acid functional G2 xanthate dendron [Xan4-G2-
COOH];[16] to trifunctional core 1,1,1-tris(4-hydroxyphenyl)ethane (THPE) yielded 
xanthate functional G2 dendrimer [Xan12-G2-THPE];[18], Scheme 2.9. 
 
Scheme 2.9 Synthesis of G2 dendrimer [Xan12-G2-THPE];[18] 
1.3 equivalents of acid focal point functional dendron [Xan4-G2-COOH];[16] per hydroxyl 
group of trifunctional Frechét core THPE was reacted using DCC/DPTS chemistry to ensure 
complete coupling occurred. After purification by liquid chromatography, the xanthate 
functional G2 dendrimer was obtained in 44% yield.  
1
H NMR analysis of [18] indicated 10 proton environments, Fig. 2.14. Integration of the core 
aromatic environment at δ = 7.11 ppm (environment 9, Fig. 2.14) indicated the presence of 
12 xanthate functional groups, confirmed by the integral of the characteristic xanthate 
resonance at δ = 4.64 ppm. Further confirmation was also illustrated by the difference in 
methyl resonances (environments 5 and 7, Fig. 2.14) at δ = 1.29 ppm and 1.44 ppm. 
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13
C NMR analysis of [18] confirmed 19 carbon environments including backbone ester 
carbonyl environments at δ = 171.2 and 171.7 ppm, Fig. S2.42. 
 
Fig. 2.14 
1
H NMR (400 MHz, CDCl3) of [Xan12-G2-THPE];[18] 
Extra resonances at δ = 6.68-6.77 ppm and 6.89-6.97 ppm are evident in the 1H NMR 
spectrum of the dendrimer product, which may be due to partial reaction of the core molecule 
(
1
H NMR overlay of [16] and [18], Fig. S2.41). The xanthate functional G2 dendrimer ([M] 
(C125H162O54S24) = 3294.32 Da) was therefore analysed by MALDI-TOF mass spectrometry 
to ensure structural perfection, and indicated populations at [MNa]
+
 = 3316.4 Da, 
corresponding to the targeted material, and a lower intensity peak at approximately 2320 Da, 
which is likely to be partially reacted material with only two dendrons attached to the core 
molecule ([(M-(Xan4-G2))Na]
+
 = 2320.25 Da), Fig. 2.15. 
 
Fig. 2.15 MALDI-TOF analysis (DCTB) of [Xan12-G2-THPE];[18] 
CHAPTER 2 
80 
 
2.7 Dendritic ATRP macroinitiators 
ATRP has previously been applied for the synthesis of dendritic hybrid architectures 
including linear dendritic hybrids (LDHs) and hyperbranched polydendrons (HPDs).
11,12
 
 
2.7.1 Synthesis of xanthate functional macroinitiators 
Conversion of the xanthate functional dendrons to ATRP macroinitiators involves activation 
of the focal point by removal of the TSe protecting group, as described earlier (Section 2.5), 
then conversion to a tertiary alkyl bromide ATRP initiator site. This was achieved by 
synthesis of 2-hydroxyethyl-2-bromoisobutyrate [HEBiB];[19], via an asymmetric 
modification of ethylene glycol with α-bromoisobutyryl bromide, Scheme 2.10. 
 
Scheme 2.10 Preparation of [HEBiB];[19] 
[HEBiB];[19] was used to react with xanthate acid [Xan-COOH];[9] and focal point acid 
functional dendrons [15]-[17] using DCC/DPTS chemistry to form four generations of 
dendritic ATRP macroinitiators (G0-G3 [20]-[23]), in relatively high recovered yields (55-
75%) after purification by liquid chromatography, Scheme 2.11. 
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Scheme 2.11 Preparation of xanthate functional dendritic ATRP macroinitiators  
[Xan1-G0-BiB];[20], [Xan2-G1-BiB];[21], [Xan4-G2-BiB];[22] and [Xan8-G3-BiB];[23] 
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2.7.2 Characterisation of xanthate functional macroinitiators 
2.7.2.1 Analysis by NMR spectroscopy 
Synthesis of [HEBiB];[19] was confirmed by NMR spectroscopy; the 
1
H NMR spectrum of 
this material indicated 3 proton environments with corresponding expected integrals, Fig. 
S2.43, and the 
13
C NMR spectrum indicating 5 carbon environments, Fig. S2.44. 
Characterisation of the xanthate functional dendron macroinitiators [20]-[23] by 
1
H NMR 
spectroscopy indicated the formation of a singlet at approximately 1.90 ppm corresponding to 
the two symmetrical methyl environments on the bromoisobutyrate moiety, shown here for 
[Xan8-G3-BiB];[23], Fig. 2.16, ([20]-[22] Fig. S2.45, S2.48 and S2.51). A broad resonance is 
also observed at approximately 4.40 ppm, corresponding to the two OCH2 environments from 
the HEBiB unit. 
 
Fig. 2.16 
1
H NMR (400 MHz, CDCl3) of [Xan8-G3-BiB];[23] 
13C NMR analysis indicated the presence of new resonances at δ = 34.0, 55.5 and 65.5 ppm 
corresponding to the HEBiB unit, the loss of the acid carbonyl resonance at approximately  
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δ = 173 ppm and the subsequent formation of a new ester carbonyl resonance at 
approximately δ = 171 ppm, confirming the incorporation of the bromoinitiator functionality, 
Fig. S2.46, S2.49, S2.52 and S2.54. 
2.7.2.2 Analysis by mass spectrometry 
Although NMR can give insight into the presence of symmetrical functional groups, mass 
spectrometry is a more sensitive tool for confirming the structural integrity of dendritic 
materials; this is increasingly important at higher dendron generations as NMR analysis 
becomes more complicated, and mass spectrometry techniques are able to easily identify 
branching defects within the structures. ESI-MS was performed on G0 and G1 initiators 
[Xan1-G0-BiB];[20] ([M] (C11H17BrO5S2) = 371.97 Da) and [Xan2-G1-BiB];[21] ([M] 
(C21H31BrO10S4) = 650.00 Da), indicating populations at [MNa]
+
 = 395.0 Da and [MNa]
+
 = 
673.0 Da, respectively, Fig. S2.47 and S2.50. MALDI-TOF analysis was performed on G2 
and G3 initiators [Xan4-G2-BiB];[22] ([M] (C41H59BrO20S8) = 1206.05 Da) and [Xan8-G3-
BiB];[23] ([M] (C81H115BrO40S16) = 2318.17 Da), indicating populations at [MNa]
+
 = 1229.2 
Da and [MNa]
+
 = 2341.4 Da, respectively, Fig. S2.53, 2.17. Some additional adducts were 
observed for [23] with increasing multiples of 16 Da, believed to have occurred during 
analysis due to thio-ether oxidation
22
, although this can easily be mistaken for the 16 Da 
difference between sodium and potassium adducts. Bromine, present at the initiator focal 
point, has two isotopes (
79
Br and 
81
Br) in an approximately 1:1 ratio, resulting in two peaks in 
the molecular ion region, which further complicates analysis. 
 
Fig. 2.17 MALDI-TOF analysis (HABA) of [Xan8-G3-BiB];[23] 
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2.8 Polymer synthesis 
2.8.1 Atom Transfer Radical Polymerisation (ATRP) 
The synthesis of well-defined macromolecules requires a combination of efficient coupling 
chemistries and polymerisation techniques with good control over polymer chain length, 
dispersity and chain-end functionality. This can be achieved by employing controlled 
polymerisation techniques such as atom transfer radical polymerisation (ATRP). ATRP is one 
of the most studied reversible-deactivation radical polymerisation (RDRP) techniques due to 
its versatility and compatibility with a wide range of commercially available monomers 
(styrenes, (meth)acrylates, meth(acrylamides), acrylonitriles, etc.), catalysts and ligands.
23
 
The mechanism was first reported in 1995 by concurrent studies of Kato et al.
24
, Wang and 
Matyjaszewski
25
 and Percec and Barboiu
26
. In conventional radical polymerisation, 
continuous initiation, rapid propagation and termination reactions result in broad dispersities 
with no control over chain-end functionality. In ATRP, termination reactions are significantly 
suppressed with respect to propagation, allowing propagation to continue until all the 
monomer has been consumed. Rapid initiation and suppression of termination events, 
achieved by establishment of a dynamic equilibrium between active and dormant species, 
ensures polymer chains are propagating simultaneously, as outlined in Scheme 2.12 below. 
 
Scheme 2.12 – Dynamic equilibrium of ATRP, involving a propagating radical (Pn•) (n = number of monomers 
in polymer chain), transition metal catalyst (Mt
m
) (m = oxidation state), ligand (L) and a halogen atom (X). kact, 
kdeact, kp and kt represent the rate constants of activation, deactivation, propagation and termination, respectively.  
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The transition metal catalyst (Mt
m
/L) abstracts the halogen atom from the dormant radical 
species (Pn-X) to generate a radical active centre Pn• and an oxidised metal complex (X-Mt
m+1
 
/L), with a rate constant of activation kact. This active radical species (Pn•) is then able to 
propagate by further reaction with monomer units with a rate constant of propagation kp. 
Termination events (kt) may also occur by combination or disproportionation, but this is 
minimal throughout the reaction. Success of the mechanism depends on the reversible 
activation of the dormant radical species. Since the dormant species is strongly preferred, the 
concentration of propagating radicals remains very low and equilibrium shifts towards the 
dormant species, suppressing possible side reactions and hence preserving the reactive nature 
of the end groups.
27
 This control over possible side reactions allows the synthesis of polymers 
with narrow Ð, whose Mn is dependent upon the ratio of monomer and initiator used during 
the reaction. Care must be taken to ensure no oxygen is present during the polymerisation as 
oxygen is a potent radical scavenger and can therefore terminate the radical polymerisation 
and can also oxidise the transition metal catalyst.
23,28 
The high versatility of ATRP towards monomers and its tolerance to various functional 
groups (e.g. epoxides, hydroxyls, amines, cyanides) and solvents (can be performed in bulk 
or solution, using either organic or aqueous media), make this system ideal for the synthesis 
of a diverse range of polymers.
23
 The reactive character of the chain-end allows for further 
polymerisation or functionalisation, with the ability to synthesise complex polymer 
architectures such as block or star polymers. 
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2.8.2 Synthesis and characterisation of xanthate functional LDHs and HPDs 
Xanthate functional G0-G3 initiators ([20]-[23]) were used to synthesise either linear or 
branched poly(butyl methacrylate) via ATRP. Recent studies have shown that initiators 
bearing similar xanthate functionalities can undergo ATRP polymerisations without loss of 
control.
11,29
 Monomers tBMA and nBMA were employed for dendritic polymer hybrid 
synthesis as the resulting polymer backbone and pendant methyl groups have proton 
resonances between approximately δ = 0.8-2.2 ppm by 1H NMR spectroscopic analysis. 
Since the characteristic xanthate resonance is at δ = 4.64 ppm, we are able to independently 
observe changes in the dendritic surface groups after thiol Michael addition reactions. 
The dendritic initiator functionality is present at one end of the polymer chain in linear hybrid 
structures, Scheme 2.13A. When a bifunctional monomer unit (ethylene glycol 
dimethacrylate, EGDMA) is incorporated into the polymerisation, highly branched polymer 
architectures result. The HPD structure is composed of a highly branched core with multiple 
dendritic initiator groups decorating the surface, Scheme 2.13B. 
A) 
 
B) 
Scheme 2.13 Schematic representation of: (A) linear dendritic hybrid (LDH); and (B) hyperbranched 
polydendron (HPD) syntheses 
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A number average degree of polymerisation (DPn) of 50 monomer units was targeted for the 
tBMA polymers. Two different DPn values were targeted for the nBMA polymers; 50 and 
100 monomer units per primary polymer chain. Analysis by triple detection SEC and 
1
H 
NMR spectroscopy for each polymer is summarised in Table 2.2. 
 
Table 2.2 
1
H NMR and SEC data for all LDHs synthesised 
Initiator 
Target Polymer 
Composition 
SEC (THF)
a 1
H NMR
b 
Mn 
(g mol
-1
) 
Mw 
(g mol
-1
) 
Ð 
Number 
average 
number of 
chainsc 
Weight 
average 
number of 
chainsd 
DPn DPn 
G1 tBMA50 13 700 17 000 1.24 - - 92 64 
G2 tBMA50 12 900 15 200 1.19 - - 82 65 
G1 tBMA50-co-EGDMA0.8 59 600 935 800 15.69 4 55 - 55 
G2 tBMA50-co-EGDMA0.8 46 500 340 700 7.29 4 22 - 59 
G1 nBMA50 13 200 15 500 1.17 - - 88 62 
G2 nBMA50 14 300 16 700 1.17 - - 92 64 
G3 nBMA50 20 900 23 200 1.11 - - 130 56 
G0 nBMA100 20 200 23 900 1.18 - - 140 136 
G0 nBMA100 21 700
e
 26 400
e
 1.21 - - 150 136 
G1 nBMA100 19 200
e
 23 000
e
 1.20 - - 130 108 
G2
 
nBMA100 20 500
e
 25 200
e
 1.22 - - 136 109 
G3 nBMA100 26 600
e
 31 800
e
 1.19 - - 170 93 
G0 nBMA100-co-EGDMA0.7 44 500 162 000 3.64 2 7 - 159 
G1 nBMA100-co-EGDMA0.8 628 000 3 730 000 5.94 33 162 - 168 
G2 nBMA100-co-EGDMA0.8 105 800 1 380 000 13.01 5 55 - 142 
G3 nBMA100-co-EGDMA0.8 61 600 299 700 4.86 2 9 - 121 
aTHF containing 2% TEA (v/v) at 35°C, 1mL min-1 flow rate. bDetermined by 1H NMR analysis in CDCl3 
cCalculated from Mn, 
dCalculated from Mw 
eSample analysed in DMF containing 0.01 M LiBr at 60°C, 1mL min-1 flow rate. 
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2.8.3 Model reactions of polymerisation 
2.8.3.1 Xanthate compatibility 
In order to demonstrate that the xanthate moiety does not inhibit or induce chain transfer 
reactions during the ATRP of nBMA, a model polymerisation was carried out in the presence 
of xanthate acid [9], using the commercially available ATRP initiator ethyl  
α-bromoisobutyrate (EBiB), Scheme 2.14. 
 
Scheme 2.14 ATRP of nBMA in the presence of xanthate acid [9] 
The polymerisation of nBMA with targeted DP50 was carried out at 60°C in methanol with 
CuCl:bipyridyl (bpy) (1:2) as the catalytic system. The EBiB initiator proton resonances 
overlap with the polymer resonances in the 
1
H NMR spectrum, and could not be adequately 
distinguished; anisole was therefore used as an internal reference for 
1
H NMR end group 
analysis by addition at the beginning of the reaction. Analysis of resulting polymer p[EBiB-
nBMA50];[24] by 
1
H NMR showed no evidence of xanthate functionality after purification, 
Fig. S2.55. This model reaction confirmed that the presence of xanthate acid [9] had no effect 
on the ATRP of nBMA. 
Lack of initiation was also confirmed by setting up an ATRP of nBMA with targeted DP100 
using G0 xanthate functional initiator, but without the presence of the CuCl catalyst. After 
24hrs, stirring at 60°C, no polymerisation was seen, evidenced by no decrease in the integral 
of methacrylate vinyl resonances at δ = 5.48 ppm and δ = 6.00 ppm, calibrated against the 
xanthate CH2 resonance of the initiator at δ = 4.64 ppm Fig. S2.56. 
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2.8.4 Synthesis and characterisation of xanthate functional LDHs 
Linear dendritic hybrid (LDH) polymers each possess the initiator functionality at one end of 
the polymer chain. The calculated DPn by 
1
H NMR end group analysis was less than the 
value obtained by SEC for all linear polymers. This discrepancy is thought to be due to 
<100% initiator efficiency for each dendron. Unreacted dendron remains in the sample when 
analysed by NMR (can be seen in SEC chromatograms at high retention volumes, Fig. 2.20), 
thus skewing DPn calculations to shorter chain lengths compared to values obtained by SEC 
analysis. This effect has previously been reported.
30,31
 
 
2.8.4.1 tBMA LDHs 
Based on previous reports for the ATRP of tBMA,
11
 an IPA/water (92.5:7.5 v/v) solvent 
system was used with G1 and G2 initiators, [Xan2-G1-BiB];[21] and [Xan4-G2-BiB];[22], 
respectively, represented here by the G2 initiator, Scheme 2.15. 
 
Scheme 2.15 Synthesis of LDH using G2 initiator [Xan4-G2-BiB];[22] 
Polymerisations of tBMA with a targeted DP50 were carried out at 30°C in IPA/water with 
CuCl:bpy (1:2) catalyst system. Reactions were terminated when conversion reached >95%, 
as indicated by integrals of the monomer vinyl resonances at δ = 5.48 and 6.00 ppm by  
1
H NMR end group analysis during the reaction. 
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2.8.4.2 nBMA LDHs 
The polymerisations of nBMA with targeted DP50 (G1-G3 dendron initiators [21]-[23]) and 
DP100 (G0-G3 dendron initiators [20]-[23]) were carried out at 60°C in methanol with 
CuCl:bpy (1:2) as the catalyst system, represented here by the G3 initiator, Scheme 2.16. For 
polymerisation kinetics studies, the reaction was regularly sampled (approx. 0.2 mL) and 
diluted in CDCl3 for 
1
H NMR analysis and THF for SEC analysis. 
 
Scheme 2.16 Synthesis of LDH using G3 initiator [Xan8-G3-BiB];[23] 
Polymerisations were terminated by exposure to oxygen when conversion reached >95%, as 
calculated by 
1H NMR analysis of monomer vinyl resonances at δ = 5.56 and δ = 6.11 ppm. 
Kinetics studies for the polymerisation of nBMA were performed for each dendron initiator 
(G0-G3; [20]-[23]) to confirm that each linear polymerisation proceeds via first order kinetics 
with respect to monomer concentration, and to monitor the evolution of molecular weight 
with respect to monomer conversion Fig. 2.18. 
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A)  
 
 
B) 
  
C) 
  
D) 
  
Fig. 2.18 Kinetic studies of the ATRP of nBMA: A) p[(Xan1-G0)-nBMA100];[32]; B) p[(Xan2-G1)-
nBMA50];[29]; C) p[(Xan4-G2)-nBMA50];[30]; D) p[(Xan8-G3)-nBMA50];[31]. Conversion vs. time (open 
triangles) with corresponding semi-logarithmic plots (closed black circles); dashed line represents linear 
regression of semi-logarithmic plot. Mn vs. conversion (closed black squares) and theoretical Mn vs. conversion 
(solid line). 
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The kinetics plots for each linear polymerisation show that high conversion is achieved 
within 7 hours (Fig. 2.18), and follows first order kinetics, as expected.
30
 A near-linear 
relationship between evolution of Mn and monomer conversion is observed, close to the 
theoretical values from targeted Mn. Variation in the refractive index increment (dn/dc) is 
expected during the polymerisation, although no correction was made here (carried out for 
linear polymerisation kinetics with PEG macroinitiator, see section 4.4.2). Triple detection 
SEC and 
1
H NMR analysis of the purified G0-G3 LDHs was performed, Table 2.2. 
Conversion reached >90% for G1 and G2 initiated DP50 polymers after 6 hours and Ð 
remained low (≤ 1.22) for all dendron initiated polymerisations (G0-G3). G3 initiated LDH 
(p[(Xan8-G3)-nBMA50];[31]) had a slower rate of conversion, reaching 76% after 7 hours, 
due to poor solubility in the polymerisation solvent and potential steric crowding around the 
initiating site. This suggests that increasing dendron size has an adverse effect on the ATRP 
equilibrium constant (KATRP = kact/kdeact). 
Fig. 2.19 shows the 
1
H NMR spectra of p[(Xan4-G2)-nBMA50] at various time points during 
the polymerisation. 
 
Fig. 2.19 
1
H NMR (400 MHz, CDCl3) spectra overlay of p[(Xan4-G2)-nBMA50];[30] kinetic time points 
6.0 5.0 4.0 3.0 2.0 1.0
0
time (min)
30
60
120
240
420
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As the reaction proceeds, the monomer vinyl resonances at δ = 5.56 and  
δ = 6.11 ppm decrease as the monomer is consumed. Conversion was calculated by 
calibrating the integral of the vinyl resonances to 1, and comparing to the integral of the 
polymer resonance at δ ≈ 0.8-1.1 ppm, corresponding to backbone and pendant methyl 
groups. 
Unreacted dendron initiator was present in each polymer sample after polymerisation had 
reached complete conversion. This could be seen in the refractive index (RI) SEC 
chromatograms, indicated by a small peak at high retention volumes (~20-22 mL), Fig. 2.20. 
A) 
 
B) 
 
C) 
 
D) 
 
Fig. 2.20 SEC RI chromatogram overlays of LDH (red solid line) and dendron initiator (black dashed line), 
analysed in THF: A) [Xan1-G0-BiB];[20] with p[(Xan1-G0)-nBMA100];[32]; B) [Xan2-G1-BiB];[21] with 
p[(Xan2-G1)-nBMA50];[29]; C) [Xan4-G2-BiB];[22] with p[(Xan4-G2)-nBMA50];[30]; and D) [Xan8-G3-
BiB];[23] with p[(Xan8-G3)-nBMA50];[31].  
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The SEC chromatograms for all linear-dendritic hybrids (LDHs) (Fig. 2.20 A-D and Fig. 2.21 
A-D) have monomodal distributions, indicating good control over molecular weight and 
composition. The G3 initiated LDH, p[(Xan8-G3)-nBMA50];[31], had a lower retention 
volume than corresponding lower generation dendron initiated LDHs, indicating a higher 
average molecular weight. This is thought to be due to <100% initiator efficiency due to 
solubility issues in methanol and steric hindrance around the initiating site, leading to fewer 
chains being successfully initiated, and hence higher than expected molecular weights. A 
slight shoulder is also visible for the G3 LDH with targeted DP50, which could be due to 
coupling of chain ends at high conversion.
32
 
G0-G3 dendron initiated LDHs, [32]-[35], with a targeted DPn of 100 monomer units were 
synthesised and analysed by triple detection SEC in a DMF eluent system, Fig. 2.21 A-D. 
A) 
 
B) 
 
C) 
 
D) 
 
Fig. 2.21 SEC RI chromatogram traces of G0-G3 dendron initiated DP100 LDH materials, analysed in DMF:  
A) p[(Xan1-G0)-nBMA100];[32]; B) p[(Xan2-G1)-nBMA100];[33]; C) p[(Xan4-G2)-nBMA100];[34]; and  
D) p[(Xan8-G3)-nBMA100];[35]. 
Retention Volume (mL)
10 12 14 16 18 20 22 24 26 28
Retention Volume (mL)
10 12 14 16 18 20 22 24 26 28
Retention Volume (mL)
10 12 14 16 18 20 22 24 26 28
Retention Volume (mL)
10 12 14 16 18 20 22 24 26 28
CHAPTER 2 
95 
 
Although these materials appear to elute at similar retention volumes to the DP50 LDHs (Fig. 
2.20 A-D), SEC analysis reveals much higher average molecular weights achieved for these 
DP100 LDH materials (Table 2.2). Comparison of G0 initiated DP100 analysed in both THF 
(Fig. 2.20A) and DMF (Fig. 2.21A) eluent systems reveals very similar average molecular 
weights, despite the difference in elution volume seen in the SEC RI chromatogram traces 
(Table 2.2). 
 
2.8.5 Synthesis and characterisation of xanthate functional HPDs 
Incorporation of bifunctional monomer EGDMA into the polymerisation leads to the 
formation of large, high molecular weight branched polymer architectures.
12,33-35
 A 1:1 
initiator:brancher ratio would theoretically lead to cross-linking of the polymer chains and 
ultimately, macroscopic gelation.
36,37
 A ratio of slightly less than 1 (e.g. 0.95) should lead to 
highly branched structures, however, due to the <100% initiator efficiency of the dendron 
macroinitiators, an optimum initiator:brancher ratio of 1:0.8 was applied for this system 
(identified through empirical experimentation). Polymerisation concentration is also key, 
with more dilute polymerisations increasing the probability of intramolecular looping, instead 
of the desired intermolecular branching. Therefore, polymerisations were conducted at a 
concentration of 50 v/v% with respect to the monomer. 
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2.8.5.1 tBMA HPDs 
The branched copolymerisation of tBMA and bifunctional monomer EGDMA, targeting DP50 
of the primary polymer chains of the G1 and G2 dendron initiated HPDs, was carried out 
under the same conditions as for LDHs, Scheme 2.17. 
 
Scheme 2.17 Synthesis of HPD p[(Xan4-G2)-tBMA50-co-EGDMA0.8];[28] 
The SEC chromatogram overlays of G1 and G2 initiated tBMA polymers highlight the 
difference between linear and branched architectures via the RI (Fig. 2.22A and C) and right 
angle light scattering (RALS) detectors (Fig. 2.22B and D). The RI detector is employed to 
calculate concentration, whereas the RALS detector is used to calculate the average size of 
polymers in solution, therefore, high molecular weight species at low concentration give rise 
to a small RI response, and a large RALS response as large polymers scatter much more light 
than smaller species in solution. Inclusion of bifunctional monomer EGDMA into the ATRP 
of tBMA results in high molecular weight polymers which elute at lower retention volumes 
than the corresponding linear polymers.  
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A) 
 
C) 
 
B) 
 
D) 
 
Fig. 2.22 SEC chromatogram overlays of: A) RI trace and B) RALS trace of p[(Xan2-G1)-tBMA50];[25] 
(dashed blue line) with p[(Xan2-G1)-tBMA50-co-EGDMA0.8];[27] (solid blue line) and; C) RI trace and D) 
RALS trace of p[(Xan4-G2)-tBMA50];[26] (dashed red line) with p[(Xan4-G2)-tBMA50-co-EGDMA0.8];[28] 
(solid red line) 
The linear and branched polymers were analysed by 
1
H NMR spectroscopy, as discussed 
previously. Fig. 2.23 shows the 
1
H NMR spectra overlay of G1 and G2 dendron initiated 
tBMA50 LDHs, with major peaks assigned. 
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Fig. 2.23 
1
H NMR (400 MHz, CDCl3) spectra overlay of p[(Xan2-G1)-tBMA50];[25] (blue) and p[(Xan4-G2)-
tBMA50];[26] (red) with major peaks assigned 
The G1 and G2 dendron initiated tBMA50 HPD 
1
H NMR spectra are overlaid in Fig. 2.24 with 
major peaks assigned. The difference between LDH and HPD species is the presence of 
bifunctional monomer EGDMA in branched polymers, which possess protons with similar 
resonances to the tBMA monomer, and are therefore indistinguishable in the 
1
H NMR 
spectra. 
 
Fig. 2.24 
1
H NMR (400 MHz, CDCl3) spectra overlay of p[(Xan2-G1)-tBMA50-co-EGDMA0.8];[27] (blue) and 
p[(Xan4-G2)-tBMA50-co-EGDMA0.8];[28] (red) with major peaks assigned 
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2.8.5.2 nBMA HPDs 
The branched copolymerisation of nBMA and bifunctional monomer EGDMA, targeting 
DP100, was conducted under the same conditions as for LDHs with G0-G3 dendron initiators, 
Scheme 2.18. 
 
Scheme 2.18 Synthesis of HPD p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] 
The SEC chromatogram overlays of RI and RALS traces for G0-G3 dendron initiated HPDs 
shows the distribution of materials formed during the branched copolymerisation, as a result 
of statistical branching, Fig. 2.25. Inclusion of a bifunctional monomer results in high 
molecular weight branched polymers, which elute at low retention volumes. The G2 dendron 
initiated branched polymerisation reaction was regularly sampled (approx. 0.2 mL) and 
diluted in CDCl3 for 
1
H NMR analysis and THF for SEC analysis in order to study the 
kinetics. 
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A) 
 
E) 
 
B) 
 
F) 
 
C) 
 
G) 
 
D) 
 
H) 
 
Fig. 2.25 SEC chromatogram overlays of RI (blue solid line) and RALS (blue dashed line) of HPDs and RI 
traces of HPDs (blue solid line) with corresponding LDHs (red solid line) of A)&E) p[(Xan1-G0)-nBMA100-co-
EGDMA0.7];[36]; B)&F) p[(Xan2-G1)-nBMA100-co-EGDMA0.8];[37]; C)&G) p[(Xan4-G2)-nBMA100-co-
EGDMA0.8];[38]; and D)&H) p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39]. 
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A kinetic plot for the branched polymerisation of G2 initiated nBMA, with targeted DP100, 
[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38], shows the change in Mn and Mw vs. conversion, 
Fig. 2.26. 
 
Fig. 2.26 Kinetic studies of the ATRP of nBMA-co-EGDMA: p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38]. 
Molecular weight (g mol
-1
) vs. conversion; Mn (closed black diamonds) and Mw (open downward triangles). 
The Mn and Mw increase linearly at the beginning of the polymerisation, until conversion 
reaches approximately 70%, where the Mw increases steeply, indicating intermolecular 
branching of linear chains to form large branched structures at high conversion. At low 
conversion, EGDMA is incorporated into the growing polymer chain by reaction of one of its 
double bonds; as monomer is consumed within the reaction mixture, the pendant vinyl group 
of incorporated EGDMA reacts with neighbouring polymer chains in solution, resulting in a 
branched polymer. Due to the statistical nature of branching during ATRP, a broad 
distribution of materials, from linear polymers to highly branched macromolecules, results.
33
 
The Mn of a polymer distribution is a measure for the chain length, whereas Mw is a measure 
for the expected statistical size of the polymer, based on the weight fraction of the sample. G2 
dendron initiated HPD p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] had an Mn value (Table 
2.2) of 105,800, corresponding to a number average of 5 primary polymer chains joined 
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together and an Mw value of 1,380,000, corresponding to a weight average of 55 primary 
polymer chains joined together, when compared to the equivalent LDH. These values have 
been represented graphically in Fig. 2.27 below, to give a visual representation of the 
distribution of materials within the sample. 
A) 
 
B) 
 
Fig. 2.27 A visual representation of; A) number average molecular weight (Mn), and B) weight average 
molecular weight (Mw) of p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] 
These HPD species, therefore, consist of number average molecular weight polymers each 
possessing 20 xanthate peripheral groups and weight average molecular weight polymers 
possessing 220 xanthate peripheral groups; originating from the G2 dendron at every primary 
polymer chain end, each with 4 xanthate functional groups. Clearly, species with lower and 
much higher molecular weights are present within the polymer sample, and would represent a 
higher level of structural dispersity than shown here. 
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2.9 Conclusions 
In order to test the research hypothesis outlined in Chapter 1, a library of materials has been 
synthesised. The application of dendrimer chemistry for the construction of four generations 
(G0-G3) of polyester dendron and addition of xanthate functionality at the periphery via 
DCC/DPTS coupling and anhydride chemistry has been described. These dendrons were then 
converted into ATRP macroinitiators by activation of the focal point and used to polymerise 
tBMA and nBMA at DPn = 50 and 100 monomer units per primary polymer chain during 
LDH synthesis, and copolymerise with bifunctional monomer EGDMA during HPD 
synthesis. These polymerisations proceeded via first order kinetics, as expected, and 
produced LDHs with a monomodal molecular weight distribution and HPDs with a much 
broader distribution of polymeric species. Very high molecular weight soluble polymers were 
formed, containing large numbers of conjoined chains, each bearing a dendron at one chain-
end. These synthesised HPD species contain, on average, a much larger number of peripheral 
xanthate groups than modifiable dendrimer species previously reported.
9
 The ability of these 
materials to undergo post-synthetic modification will be investigated in Chapter 3. 
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2.11 Appendix 
 
Scheme S2.1 Synthetic strategy for the synthesis of the focal-point protected dendrons used within the study 
 
CHAPTER 2 
108 
 
 
Figure S2.1 1H NMR (400 MHz, CDCl3) of [Acet1-G1-COOH];[1] 
 
 
Figure S2.2 13C NMR (100 MHz, CDCl3) of [Acet1-G1-COOH];[1] 
 
 
Figure S2.3 1H NMR (400 MHz, CDCl3) of [Acet1-G1-Anhy];[2] 
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Figure S2.4 13C NMR (100 MHz, CDCl3) of [Acet1-G1-Anhy];[2] 
 
 
 
Figure S2.5 1H NMR (400 MHz, CDCl3) of [Acet1-G1-TSe];[3] 
 
 
Figure S2.6 13C NMR (100 MHz, CDCl3) of [Acet1-G1-TSe];[3] 
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Figure S2.7 ESI MS (MeOH) of [Acet1-G1-TSe];[3] 
 
 
Figure S2.8 1H NMR (400 MHz, CDCl3) of [(OH)2-G1-TSe];[4] 
 
 
Figure S2.9 13C NMR (100 MHz, CDCl3) of [(OH)2-G1-TSe];[4] 
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Figure S2.10 ESI MS (MeOH) of [(OH)2-G1-TSe];[4] 
 
 
 
Figure S2.11 1H NMR (400 MHz, CDCl3) of [Acet2-G2-TSe];[5] 
 
 
Figure S2.12 13C NMR (100 MHz, CDCl3) of [Acet2-G2-TSe];[5] 
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Figure S2.13 ESI MS (MeOH) of [Acet2-G2-TSe];[5] 
 
 
Figure S2.14 1H NMR (400 MHz, CD3OD) of [(OH)4-G2-TSe];[6] 
 
 
Figure S2.15 13C NMR (100 MHz, CD3OD) of [(OH)4-G2-TSe];[6] 
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Figure S2.16 ESI MS (MeOH) of [(OH)4-G2-TSe];[6] 
 
 
Figure S2.17 13C NMR (100 MHz, CDCl3) of [Acet4-G3-TSe];[7] 
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Figure S2.18 13C NMR (100 MHz, CD3OD) of [(OH)8-G3-TSe];[8] 
 
 
Figure S2.19 13C NMR (100 MHz, CDCl3) of 2-((Ethoxycarbonothioyl)thio)acetic acid, [Xan-COOH];[9] 
 
 
Figure S2.20 1H NMR (400 MHz, CDCl3) of DPTS 
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Figure S2.21 13C NMR (100 MHz, CDCl3) of DPTS 
 
 
Figure S2.22 1H NMR (400 MHz, CDCl3) of [Xan1-G0-TSe];[11] 
 
 
Figure S2.23 13C NMR (100 MHz, CDCl3) of [Xan1-G0-TSe];[11] 
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Figure S2.24 ESI-MS (MeOH) of [Xan1-G0-TSe];[11] 
 
 
Figure S2.25 1H NMR (400 MHz, CDCl3) of [Xan2-G1-TSe];[12] 
 
 
Figure S2.26 13C NMR (100 MHz, CDCl3) of [Xan2-G1-TSe];[12] 
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Figure S2.27 ESI-MS (MeOH) of [Xan2-G1-TSe];[12] 
 
 
Figure S2.28 13C NMR (100 MHz, CDCl3) of [Xan4-G2-TSe];[13] 
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Figure S2.29 MALDI-TOF analysis (dithranol) of [Xan4-G2-TSe];[13] 
 
 
Figure S2.30 1H NMR (400 MHz, CDCl3) of 2-((Ethoxycarbonothioyl)thio)acetic anhydride, [Xan-Anhy];[10] 
 
 
Figure S2.31 13C NMR (100 MHz, CDCl3) of 2-((Ethoxycarbonothioyl)thio)acetic anhydride, [Xan-Anhy];[10] 
 
 
Figure S2.32 13C NMR (100 MHz, CDCl3) of [Xan8-G3-TSe];[14] 
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Figure S2.33 1H NMR (400 MHz, CDCl3) of [Xan2-G1-COOH];[15] 
 
 
Figure S2.34 13C NMR (100 MHz, CDCl3) of [Xan2-G1-COOH];[15] 
 
 
Figure S2.35 ESI MS (MeOH) of [Xan2-G1-COOH];[15] 
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Figure S2.36 1H NMR (400 MHz, CDCl3) of [Xan4-G2-COOH];[16] 
 
 
Figure S2.37 13C NMR (100 MHz, CDCl3) of [Xan4-G2-COOH];[16] 
 
CHAPTER 2 
121 
 
 
Figure S2.38 ESI MS (MeOH) of [Xan4-G2-COOH];[16] 
 
 
Figure S2.39 1H NMR (400 MHz, CDCl3) overlay of; A) [Xan8-G3-TSe];[14], and B) [Xan8-G3-COOH];[17] 
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Figure S2.40 13C NMR (100 MHz, CDCl3) of [Xan8-G3-COOH];[17] 
 
 
Figure S2.41 1H NMR (400 MHz, CDCl3) overlay of; A) [Xan4-G2-COOH];[16], and B) [Xan12-G2-THPE];[18] 
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Figure S2.42 13C NMR (100 MHz, CDCl3) of [Xan12-G2-THPE];[18] 
 
 
Figure S2.43 1H NMR (400 MHz, CDCl3) of [HEBiB];[19] 
 
 
Figure S2.44 13C NMR (100 MHz, CDCl3) of [HEBiB];[19] 
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Figure S2.45 1H NMR (400 MHz, CDCl3) of [Xan1-G0-BiB];[20] 
 
 
Figure S2.46 13C NMR (100 MHz, CDCl3) of [Xan1-G0-BiB];[20] 
 
 
Figure S2.47 ESI-MS (MeOH) of [Xan1-G0-BiB];[20] 
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Figure S2.48 1H NMR (400 MHz, CDCl3) of [Xan2-G1-BiB];[21] 
 
 
Figure S2.49 13C NMR (100 MHz, CDCl3) of [Xan2-G1-BiB];[21] 
 
 
Figure S2.50 ESI MS (MeOH) of [Xan2-G1-BiB];[21] 
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Figure S2.51 1H NMR (400 MHz, CDCl3) of [Xan4-G2-BiB];[22] 
 
 
Figure S2.52 13C NMR (100 MHz, CDCl3) of [Xan4-G2-BiB];[22] 
 
 
Figure S2.53 MALDI-TOF analysis (dithranol) of [Xan4-G2-BiB];[22] 
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Figure S2.54 13C NMR (100 MHz, CDCl3) of [Xan8-G3-BiB];[23] 
 
 
Figure S2.55 1H NMR (400 MHz, CDCl3) of p[EBiB-nBMA50];[24] 
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Figure S2.56 1H NMR (400 MHz, CDCl3) of [Xan1-G0-BiB] initiated polymerisation of nBMA (DP100) with no CuCl 
present; A) t = 0, and B) t = 24 hrs. 
 
 
Fig. S2.57 1H NMR (400 MHz, CDCl3) spectra overlay of p[(Xan2-G1)-nBMA50];[29] (green), p[(Xan4-G2)-nBMA50];[30] 
(red) and p[(Xan8-G3)-nBMA50];[31] (blue) with major peaks assigned 
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Fig. S2.58 1H NMR (400 MHz, CDCl3) spectra overlay of p[(Xan1-G0)-nBMA100];[32] (purple), p[(Xan2-G1)-
nBMA100];[33] (green), p[(Xan4-G2)-nBMA100];[34] (red) and p[(Xan8-G3)-nBMA100];[35] (blue) with major peaks 
assigned 
 
 
Fig. S2.59 1H NMR (400 MHz, CDCl3) spectra overlay of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] (purple), p[(Xan2-
G1)-nBMA100-co-EGDMA0.8];[37] (green), p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] (red) and p[(Xan8-G3)-nBMA100-
co-EGDMA0.8];[39] (blue) with major peaks assigned 
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CHAPTER 3 
 
 
Xanthate-mediated thiol-acrylate Michael 
addition: Sequential and Simultaneous strategies 
for multifunctionalisation 
 
 
Publication arising from this Chapter: 
 “Model studies of the sequential and simultaneous statistical modification of dendritic functional groups and 
their implications within complex polymer architecture synthesis.”  
F. Y. Hern, S. E. R. Auty, O. C. J. Andrén, M. Malkoch and S. P. Rannard, Polym. Chem., 2017, 8, 1644-1653. 
Individual contributions: S. E. R. Auty – Initial studies to establish xanthate chemistry;  
O. C. J. Andrén – recorded MALDI-TOF spectra; M. Malkoch and S. P. Rannard – supervisors. 
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3.1 Introduction 
Multivalency, also known as polyvalency, is a naturally occurring phenomenon where non-
covalent bonds form between multiple ligands and multiple receptors; the cumulative effect 
enables strong bonds to be made between molecules or molecules and substrates/surfaces.
1
 
Interactions between materials and biological systems often relies on the simultaneous 
binding of multiple different chemistries, rather than one single chemistry performing 
multiple tasks; the cooperative/synergistic nature of the multiple lower energy interactions 
often leads to higher binding strength.
2
 Although dendrimers, with their high density of 
spatially well-defined surface functionality, would be well suited to providing this 
multivalency of biologically relevant functionality, key challenges such as limited payload 
and complex synthetic procedures have limited their application within drug delivery and 
nanomedicine (see Chapter 1.1.1). The size and shape of nanomaterials is also known to 
impact their fate in vivo; affecting accumulation, residence time and biodistribution.
3,4
 
Opsonisation and subsequent recognition of nanomaterials by macrophages has  been shown 
to correlate strongly with size and surface functionality,
5,6
 whilst biodistribution and 
pharmacokinetics may be tuned by carefully controlling dendrimer size or synthesising 
dendritic hybrid materials.
7,8
 Incorporation of dendrons and their multiple surface functional 
groups into polymer hybrids may allow integration of multivalent regions of functionality. 
Post-polymerisation modification is based on polymerisations involving initiators or 
monomers bearing chemoselective handles, tolerant to polymerisation conditions, that are 
able to undergo subsequent quantitative conversion into a range of functional groups.
9
 This 
method of functionalisation allows the incorporation of functionality that is incompatible 
with polymerisation techniques. Post-modification of a single, well-defined precursor is 
particularly attractive for synthesising multifunctional and multi-responsive (co)polymers for 
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advanced applications since it facilitates the incorporation of a wide range of functional 
groups for different target applications.
10 
Deprotection and surface functionalisation via thiol-acrylate Michael addition to introduce a 
range of functionality at the dendron periphery has previously been reported
11
, as outlined in 
Fig. 3.1, illustrated using a G3 dendron. From three generations of xanthate peripheral 
polyester dendrimers, a library of materials with hydrophilic, hydrophobic and polymeric 
surface groups were readily generated through ambient temperature one-pot reactions. 
 
Fig. 3.1 Schematic representation of the one-pot xanthate deprotection/thiol-acrylate functionalisation strategy, 
illustrated using a G3 dendron.
11
 
This method of post-synthetic modification was extended to linear dendritic hybrids 
(LDHs)
12
, with a library of twenty different surface functional LDHs readily generated 
through individual one-pot reactions from just four initial polymers. 
To further expand the scope of post-polymerisation modification of xanthate functional 
materials, the work within this chapter is focussed on the efficient, orthogonal 
multifunctionalisation of a range of dendritic polymer architectures via sequential and 
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simultaneous methodologies. This allows for the accurate statistical placement of functional 
groups to allow comparisons with spatially-directed functionalisation and assessment of 
different polymer performance. 
Following on from the success of the thiol-acrylate Michael addition for full functional 
modification of xanthate-derived thiols,
11,12
 this chapter will explore the partial- and multi-
functionalisation of four generations of xanthate peripheral dendrons (G0, G1, G2, G3), linear 
dendritic hybrids (LDHs) and hyperbranched polydendrons (HPDs), with full 
characterisation, Fig. 3.2. 
 
Fig. 3.2 Schematic representation of the aims within this chapter: Statistical multifunctionalisation of dendrons, 
dendrimers, linear dendritic hybrids (LDH) and hyperbranched polydendrons (HPD), shown here for G2 
Two methods of statistical multifunctionalisation will be considered: Sequential modification 
involves partial deprotection of the xanthate peripheral groups, followed by thiol Michael 
addition with a functional acrylate and repetition of these steps to incorporate multiple 
functionalities (Fig. 3.3A); Simultaneous modification involves the complete deprotection of 
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xanthate groups followed by reaction with a stoichiometric mixture of functional acrylates 
(Fig. 3.3B).  
 
Fig. 3.3 Schematic representation of G3 dendron undergoing: (A) Sequential partial one-pot xanthate 
deprotection/thiol-acrylate functionalisation strategy, followed by deprotection of remaining xanthate groups/ 
thiol-acrylate functionalisation; (B) Simultaneous full xanthate deprotection/thiol-acrylate multifunctionalisation 
These methods offer respective advantages; sequential modification may allow incorporation 
of sensitive or highly reactive functionalities in the last step, whereas simultaneous 
modification reduces the number of reactive steps required for multifunctionalisation. It is 
unclear which of these strategies will be ideal for the main aims of this research, and a 
detailed examination is therefore required. 
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3.2 Statistical multifunctionalisation of xanthate functional dendrons 
Sequential and simultaneous multifunctionalisation strategies were evaluated using focal 
point protected xanthate peripheral G1-G3 dendrons [Xan2-G1-TSe];[12], [Xan4-G2-
TSe];[13] and [Xan8-G3-TSe];[14]. Following reported procedures, deprotection by 
aminolysis using n-butylamine and subsequent one-pot thiol-acrylate Michael addition were 
studied in tetrahydrofuran (THF).
11,12
 
 
3.2.1 Sequential modification 
3.2.1.1 Controlled deprotection of xanthate peripheral groups 
Xanthate peripheral dendrons [12], [13] and [14] (Fig. 3.4) were deprotected at ambient 
temperature in THF with varying equivalents of n-butylamine for 1.5 hours. 
 
Fig. 3.4 Xanthate peripheral dendrons [Xan2-G1-TSe];[12], [Xan4-G2-TSe];[13] and [Xan8-G3-TSe];[14] 
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After this time, the partially deprotected dendrons were analysed by 
1
H NMR spectroscopy, 
shown here for G3 dendron [14] with 1-8 equivalents of n-butylamine, Fig. 3.5. The 
characteristic xanthate CH2 resonance at δ = 4.64 ppm decreases with increasing equivalents 
of n-butylamine used. Following xanthate deprotection, the CH2 neighbouring the backbone 
thiol at δ ≈ 3.95 ppm shifts to δ ≈ 3.29 ppm. This is likely to be due to loss of the electron 
withdrawing xanthate group. 
 
Fig. 3.5 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially deprotected xanthate peripheral G3 dendron 
[14]. Equivalents of n-butylamine added: A) 1, B) 2, C) 3, D) 4, E) 5, F) 6, G) 7 and H) 8. 
A)
B)
C)
D)
E)
F)
G)
H)
5.0 4.5 4.0 3.5 3.0
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4+5+6
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Addition of 1 molar equivalent of n-butylamine per dendron resulted in deprotection of 48% 
of the xanthate groups for G1 dendron [12], 21% of the xanthate groups of the G2 dendron 
[13], and 12% of the xanthate groups of the G3 dendron [14]. Within experimental and 
expected NMR error
13
, these figures represent an average deprotection of 1 xanthate group 
per dendron for each generation. Incremental increases in the amount of n-butylamine added 
(up to a maximum of 2 equivalents for the G1 dendron, 4 equivalents for the G2 dendron and 
8 equivalents for the G3 dendron) resulted in a controlled and linear average number of 
xanthate groups deprotected for each dendron generation (calculated by 
1
H NMR), suggesting 
good synthetic control, Fig. 3.6. Disulphide formation was not seen under these conditions. 
 
Fig. 3.6 Partial deprotection of xanthate peripheral groups of G1-G3 xanthate functional dendrons ([12]-[14]) 
The degree to which the xanthate groups, i.e., the thiol protecting groups, are removed is 
preferably controllable for targeted sequential multifunctionalisation. Reaction of xanthate 
groups with n-butylamine is expected to be a statistical process and therefore, non-uniform; 
the 
1
H NMR-determined correlation shown in Fig. 3.6 represents the averaged value across 
all dendrons within each sample. Direct analysis of the partially deprotected materials using 
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mass spectroscopic techniques is hampered by the formation of disulphide bonds between the 
highly thiol-functional structures during sample preparation, as previously reported.
11
 
Therefore, partial modification of xanthate peripheral groups by reaction of deprotected thiols 
with a functional acrylate may assist the determination of the distribution of materials formed 
during statistical deprotection. 
3.2.1.2 Partial modification of xanthate functional dendrons 
It is possible to selectively deprotect desired numbers of xanthate peripheral groups of G1-G3 
dendrons [Xan2-G1-TSe];[12], [Xan4-G2-TSe];[13] and [Xan8-G3-TSe];[14], therefore, it 
may be possible to partially functionalise these materials by thiol-acrylate Michael addition 
with an excess of functional acrylate. Previous studies have revealed enhanced uptake of 
materials possessing secondary amine groups into monocyte-derived macrophages (ATHP-1) 
and epithelial cells (Caco-2)
14
, therefore, 2-(dimethylamino)ethyl acrylate (DMAEA, Am) 
was identified as a target functionality to incorporate into these materials. Benzyl acrylate 
(Bz) was chosen as opsonins attach more easily to hydrophobic surfaces than hydrophilic 
surfaces, thus increasing phagocytosis of nanoparticles with more hydrophobic surfaces.
15,16
 
The benzyl groups are also useful as they can be easily distinguished via 
1
H NMR 
spectroscopy as the chemical shifts of the aromatic protons are significantly different to 
others present in the target structures. These acrylates allow ready quantitative spectroscopic 
analysis and provide suitable mass differences for spectrometric assignment of products with 
varying distributions of functional groups. 
As outlined in literature
11
, full one-pot deprotection and thiol-acrylate Michael addition was 
carried out with an excess of n-butylamine and dimethylamino- and benzyl-functional 
acrylates, Am and Bz. The resulting materials, [Am8-G3-TSe];[44] and [Bz8-G3-TSe];[45] 
were analysed by 
1
H NMR, Fig. 3.7A and 3.7B, respectively, and 
13
C NMR, Fig. S3.1. 
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A) 
 
 
B) 
 
Fig. 3.7 
1
H NMR (400 MHz, CDCl3) spectra of A) [Am8-G3-TSe];[44] and B) [Bz8-G3-TSe];[45] 
For partially functionalised materials, G3 xanthate peripheral dendron [14] was deprotected 
with 1-8 equivalents of n-butylamine at ambient temperature for 1.5 hours, to generate thiols 
in situ. After this time, 1.5 equivalents of DMAEA (Am) per deprotected xanthate group was 
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added and the reaction left to stir overnight. The resulting materials were analysed by 
1
H 
NMR spectroscopy and MALDI-TOF mass spectrometry. Decreasing xanthate functionality 
and increasing Am functionality could be seen by 
1
H NMR analysis, Fig. 3.8. 
 
Fig. 3.8 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially DMAEA (Am) functionalised [Xan8-G3-
TSe];[14]: A) [Xan7-Am1-G3-TSe];[50]; B) [Xan6-Am2-G3-TSe];[51]; C) [Xan5-Am3-G3-TSe];[52]; D) 
[Xan4-Am4-G3-TSe];[53]; E) [Xan3-Am5-G3-TSe];[54]; F) [Xan2-Am6-G3-TSe];[55]; G) [Xan1-Am7-G3-
TSe];[56]; H) [Am8-G3-TSe];[44] 
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The gradual disappearance of characteristic xanthate resonances (CH2 quartet at δ ≈ 4.64 ppm 
and CH3 triplet at δ ≈ 1.42 ppm) and appearance of new resonances at δ ≈ 2.66 and 2.88 ppm 
in the 
1
H NMR spectra confirm partial deprotection and C-C bond formation via thiol-
Michael addition during the one-pot reaction. At high levels of Am functionalisation, an extra 
resonance at δ = 2.91-2.96 ppm appears in the 1H NMR spectra; this could be as a result of 
restricted rotation within the dendron structure, or the generation of different conformations 
with increasing Am incorporation. New resonances corresponding to Am at δ ≈ 2.28 ppm 
(terminal CH3 groups), δ ≈ 2.57 ppm (CH2 adjacent to amine) and δ ≈ 4.19 ppm (CH2 
adjacent to carbonyl) were also present in the 
1
H NMR spectra; their relative integrals relate 
to the number of xanthate groups deprotected in the first step.  
 
3.2.1.2.1 Analysis by mass spectrometry 
1
H NMR spectroscopy of the systematically varying xanthate (Xan) and DMAEA (Am) 
functional Michael adducts showed that it is possible to direct an overall molar average 
functionalisation, but gives little information about the structural variation within the sample. 
MALDI-TOF mass spectrometry was therefore applied to elucidate the distribution of 
structures formed during statistical partial functionalisation. As previously reported, sulphur 
has over 20 known isotopes of which 
32
S, 
33
S,
 34
S and 
36
S are stable with varying abundance. 
Sulphur is also prone to oxidation during mass spectrometric analysis, making definitive 
analysis difficult
12,17
; oxidation of thio-ethers will add multiples of 16 Da to the expected 
mass ion, which may be confused with the difference between sodium and potassium 
adducts. 
 
CHAPTER 3 
142 
 
The MALDI-TOF spectra of the targeted materials ([Xan7-Am1-G3-TSe];[50], [Xan6-Am2-
G3-TSe];[51], [Xan5-Am3-G3-TSe];[52], [Xan4-Am4-G3-TSe];[53], [Xan3-Am5-G3-
TSe];[54], [Xan2-Am6-G3-TSe];[55], [Xan1-Am7-G3-TSe];[56] and [Am8-G3-TSe];[44]) 
displayed a broad distribution of products, becoming more defined at higher Am 
incorporation ([Xanx-Amy-G3-TSe], x≤2, y≥6, x+y = 8), Fig. 3.9. 
 
Fig. 3.9 Stacked MALDI-TOF (DCTB) mass spectra of partially DMAEA (Am) functionalised [Xan8-G3-
TSe];[14] 
The MALDI-TOF spectrum of the partially functionalised G3 dendron with 6 Am units, 
nominally [Xan2-Am6-G3-TSe];[55] (Fig. 3.10, Table S3.1), was tentatively assigned 
assuming each observed species was either a protonated or potassium adduct; structures 
ranging from [Xan5-Am3-G3-TSe];[52] to [Am8-G3-TSe];[44] were clearly present. The 
repeating mass unit of 55 Da corresponds to the mass difference expected from removal of 
one xanthate and addition of one Am unit.  
[Xan7-Am1-G3-TSe];[50]
[M]+ = 2363.3 Da
2000 2100 2200 2300 2400 2500 2600 2700 2800 2900
m/z
[Xan6-Am2-G3-TSe];[51]
[M]+ = 2418.4 Da
[Xan5-Am3-G3-TSe];[52]
[M]+ = 2476.1 Da
[Xan4-Am4-G3-TSe];[53]
[M]+ = 2531.1 Da
[Xan3-Am5-G3-TSe];[54]
[M]+ = 2586.2 Da
[Xan2-Am6-G3-TSe];[55]
[M]+ = 2641.2 Da
[Xan1-Am7-G3-TSe];[56]
[M]+ = 2696.3 Da
[Am8-G3-TSe];[44]
[M]+ = 2751.3 Da
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Fig. 3.10 MALDI-TOF analysis (HABA) of the Michael adduct [Xan2-Am6-G3-TSe];[55].  
Double-headed arrows indicate mass differences of 55 Da  
(dotted arrows indicate missing peaks; solid arrows indicate identified peaks)
18 
As can be seen from Fig. 3.10, a considerable range of structures was present within the 
nominal [Xan2-Am6-G3-TSe];[55] product, spanning structures up to the complete 
deprotection and amine functionalisation, ie [Am8-G3-TSe];[44]. The technique can 
accurately determine the masses of individual structures, confirming MALDI-TOF is a useful 
tool for end-group analysis as well as product confirmation. Within the individual species 
identified, considerable isomeric variation is expected, Fig. 3.11, although no further analysis 
techniques (e.g. advanced NMR) were developed for this project to establish the presence of 
these structures. 
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Fig. 3.11 Probable isomeric distribution of [Xan4-Am4-G3-TSe];[53] formed as a result of statistical 
deprotection of four xanthate groups followed by Michael addition with an excess of DMAEA (Am) 
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3.2.1.3 Sequential multifunctionalisation 
The sequential deprotection/functionalisation strategy requires initial partial deprotection of 
available peripheral xanthate groups, followed by reaction with a slight molar excess  
(1.5 molar equiv. per thiol) of functional acrylate with respect to deprotected thiols; the 
remaining xanthate groups are subsequently deprotected, followed by addition of a second 
functional acrylate in excess, Fig. 3.3(A). 
A series of sequential reactions were conducted with xanthate peripheral G1-G3 dendrons 
[12]-[14], to target statistically multifunctionalised materials with benzyl (Bz) and 
dimethylamino (Am) functional groups, shown here for the 50/50 multifunctionalisation of 
G3 dendron [Xan8-G3-TSe];[14], Fig. 3.12. 
 
Fig. 3.12 Sequential multifunctionalisation of G3 dendron [Xan8-G3-TSe];[14], targeting an average 50/50 
functionalisation to obtain [Am4-Bz4-G3-TSe];[67] (representative structure) 
Targeting a 1:1 molar ratio of Am:Bz functionality with G1 dendron [12] involved initial 
deprotection of the available xanthate groups with 1 molar equivalent of n-butylamine at 
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ambient temperature, and subsequent addition of a slight excess (1.5 molar equivalents) of 
DMAEA with respect to the exposed thiol groups, followed by purification and 
1
H NMR 
spectroscopic analysis. The remaining xanthate groups were then deprotected and a 1.5 molar 
excess of benzyl acrylate per thiol was added. The resulting product was analysed by 
1
H 
NMR spectroscopy (Fig. S3.2) and MALDI-TOF MS following purification, confirming the 
expected average 50/50 functionalisation and the presence of targeted compound ([Am1-Bz1-
G1-TSe];[60], calculated [MH]
+
 = 770.96 Da). Signals were also observed in the mass 
spectrum corresponding to the symmetrical [Am2-G1-TSe];[40] (calculated [MH]
+
 =  
751.95 Da); signals indicating the presence of [Bz2-G1-TSe];[41] were not observed (Fig. 
S3.4), suggesting variable ionisation. The oxidised [Am1-Bz1-G1-TSe];[60] products were 
seen as a series of peaks separated by 16 Da. 
This sequential multifunctionalisation methodology was applied to G2 dendron [13] to 
generate, [Bz4-G2-TSe];[43], [Am1-Bz3-G2-TSe];[61], [Am2-Bz2-G2-TSe];[62], [Am3-Bz1-
G2-TSe];[63] and [Am4-G2-TSe];[42]. The MALDI-TOF mass spectra of these materials 
showed significant complexity, despite an excellent correlation between expected average 
structures and 
1
H NMR analysis in each case (Fig S3.5, S3.7-S3.9). The MALDI-TOF 
analysis for the targeted mixed functional dendron [Am3-Bz1-G2-TSe];[63], for example, 
exhibited species ranging from no benzyl functional groups present ([Am4-G2-TSe];[42]), 
through to species with 100% benzyl functionality ([Bz4-G2-TSe];[43]) (Fig. 3.13), 
confirming the statistical nature of the functionalisation strategy. 
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Fig. 3.13 Expansion of the MALDI-TOF (9-nitroanthracene) mass spectrum of targeted material [Am3-Bz1-G2-
TSe];[63] by sequential multifunctionalisation 
It should be noted that variation of relative peak intensities within each isotopic distribution 
was observed with each different matrix material used during optimisation of the analytical 
procedures (trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]malononitrile 
(DCTB), 9-nitroanthracene (9A), 2-(4'-hydroxybenzeneazo)benzoic acid (HABA), 2,5-
dihydroxybenzoic acid (DHB), dithranol), indicating differences in ionisation and therefore 
indicating that the relative abundance of each species should not be inferred from these 
analyses. 
A good agreement between 
1
H NMR analysis and expected average structures was seen for 
products resulting from the sequential multifunctionalisation of G3 dendron [14], targeting 
[Amx-Bzy-G3-TSe] (x = 0-8, y = 0-8; x+y = 8) (Fig. S3.10), shown here for [Am4-Bz4-G3-
TSe];[67], Fig. 3.14; although MALDI-TOF spectra of the resulting materials displayed three 
distinct populations, in many cases (Fig. S3.12-S3.19).  
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Fig. 3.14 
1
H NMR (400 MHz, CDCl3) of [Am4-Bz4-G3-TSe];[67] by sequential multifunctionalisation of 
[Xan8-G3-TSe];[14] 
For example, MALDI-TOF analysis of the targeted [Am4-Bz4-G3-TSe];[67] displayed a 
group of peaks that were readily assigned to chemical species as a direct result of the 
statistical nature of the sequential deprotection/functionalisation strategy, Fig. 3.15 and Table 
3.1, peaks 16-29. Two further populations of peaks at lower molecular weight can be 
assigned to materials containing either one (Fig. 3.15, Table 3.1 peaks 8-15) or two (Fig. 
3.15, Table 3.1 peaks 1-7) unreacted thiol functional groups. These thiols are thought to 
remain unreacted as a result of steric crowding and isolation during the sequential 
deprotection and thiol-acrylate Michael addition strategy. 
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Fig. 3.15 MALDI-TOF analysis (DCTB) of the product targeting [Am4-Bz4-G3-TSe];[67] via sequential 
multifunctionalisation 
The observation of species assigned as [Am6-(SH)2-G3-TSe];[81] and [Am7-(SH)1-G3-
TSe];[88], peaks 1 and 8 respectively (Fig. 3.15), supports thiol isolation as excess benzyl 
acrylate addition in the second reactive step would be expected to react all exposed thiols. 
Although more noticeable within the G3 dendron series (Fig. S3.12-S3.18), thiol isolation was 
also observed within several G2 dendron sequential multifunctionalisation reactions (Fig. 
S3.7-S3.9). Thiol trapping within higher generation dendrons may be as a result of 
backfolding
19,20
 or steric crowding around functional groups from the first step of sequential 
multifunctionalisation and may render this approach impractical for systems that require 
accurate statistical functionalisation. 
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Table 3.1 Peaks identified and assigned within the MALDI-TOF mass spectrum of the targeted [Am4-Bz4-G3-
TSe];[67] via sequential multifunctionalisation – see Fig. 3.15 
Peak Species assignment 
Theoretical 
m/z+1 (Da) 
Observed 
m/z (Da) 
1 [Am6-(SH)2-G3-TSe];[81] MH
+
 = 2463 2462.99 
2 [Am5-Bz1-(SH)2-G3-TSe];[82] MH
+
 = 2482 2481.97 
3 [Am4-Bz2-(SH)2-G3-TSe];[83] MH
+
 = 2501 2500.97 
4 [Am3-Bz3-(SH)2-G3-TSe];[84] MH
+
 = 2520 2519.97 
5 [Am2-Bz4-(SH)2-G3-TSe];[85] MH
+
 = 2539 2539.02 
6 [Am1-Bz5-(SH)2-G3-TSe];[86] MH
+
 = 2558 2558.06 
7 [Bz6-(SH)2-G3-TSe];[87] MH
+
 = 2577 2577.05 
8 [Am7-(SH)1-G3-TSe];[88] MH
+
 = 2606 2606.14 
9 [Am6-Bz1-(SH)1-G3-TSe];[89] MH
+
 = 2625 2625.12 
10 [Am5-Bz2-(SH)1-G3-TSe];[90] MH
+
 = 2644 2644.11 
11 [Am4-Bz3-(SH)1-G3-TSe];[91] MH
+
 = 2663 2663.12 
12 [Am3-Bz4-(SH)1-G3-TSe];[92] MH
+
 = 2682 2682.14 
13 [Am2-Bz5-(SH)1-G3-TSe];[93] MH
+
 = 2701 2701.14 
14 [Am1-Bz6-(SH)1-G3-TSe];[94] MH
+
 = 2720 2720.15 
15 [Bz7-(SH)1-G3-TSe];[95] MH
+
 = 2739 2739.19 
16 [Am8-G3-TSe];[44] MH
+
 = 2750 2750.21 
17 [Am7-Bz1-G3-TSe];[70] MH
+
 = 2768 2768.26 
18 [Am6-Bz2-G3-TSe];[69] MH
+
 = 2787 2787.21 
19 [Am5-Bz3-G3-TSe];[68] MH
+
 = 2806 2806.20 
20 [Am4-Bz4-G3-TSe];[67] MH
+
 = 2825 2825.26 
21 [Am3-Bz5-G3-TSe];[66] MH
+
 = 2844 2844.30 
22 [Am2-Bz6-G3-TSe];[65] MH
+
 = 2863 2863.29 
23 [Am1-Bz7-G3-TSe];[64] MH
+
 = 2882 2882.28 
24 [Bz8-G3-TSe];[45] MH
+
 = 2901 2901.32 
25 [Bz8-G3-TSe]H
+
 + 16 MH
+
 = 2901 2917.29 
26 [Bz8-G3-TSe]K
+
 MH
+
 = 2901 2939.32 
27 [Bz8-G3-TSe]K
+
 + 16 MH
+
 = 2901 2955.32 
28 [Bz8-G3-TSe]K
+
 + 32 MH
+
 = 2901 2971.32 
29 [Bz8-G3-TSe]K
+
 + 48 MH
+
 = 2901 2987.26 
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3.2.2 Simultaneous multifunctionalisation 
An alternative method of statistical multifunctionalisation to consider is the complete 
deprotection of xanthate functional groups and simultaneous reaction of exposed thiols with a 
stoichiometric mixture of functional acrylates, at the desired molar ratio, Fig. 3.3(B). A series 
of multifunctional materials were therefore targeted using G1-G3 dendrons [12]-[14], by full 
deprotection and reaction with a mixture of benzyl acrylate (Bz) and DMAEA (Am) to match 
the materials formed by sequential multifunctionalisation. As seen previously, 
1
H NMR 
analysis of the resulting products confirmed formation of the targeted materials, on average, 
shown here for [Am4-Bz4-G3-TSe];[67], Fig. 3.16 (see Fig. 3.14 for corresponding material 
formed via sequential modification). 
 
Fig. 3.16 
1
H NMR (400 MHz, CDCl3) of [Am4-Bz4-G3-TSe];[67] by simultaneous multifunctionalisation of 
[Xan8-G3-TSe];[14] 
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MALDI-TOF analysis, conducted under the same analytical conditions as for samples 
generated via the sequential multifunctionalisation strategy, showed a markedly different 
distribution of species when conducting the simultaneous mixed acrylate functionalisation. A 
single reaction with a mixture of acrylates yielded structures with far fewer isolated thiols in 
all studied reactions. In some cases, the formation of species with two unreacted thiols was 
almost undetectable. In comparison with previous results, MALDI-TOF analysis of [Am4-
Bz4-G3-TSe];[67], synthesised via the simultaneous multifunctionalisation strategy, exhibited 
almost the entire peak distribution listed in Table 3.1, but the relative intensities of the main 
distribution of ions (Fig. 3.15 and Table 3.1 peaks 16-29) was significantly higher in 
comparison to the peaks indicating the presence of isolated thiols (Fig. 3.15 and Table 3.1 
peaks 1-15), Fig. 3.17; in this case comparative concentrations are inferred between the same 
species in different samples as the materials are chemically highly related and the conditions 
of the MALDI-TOF analysis is identical. Almost no species containing isolated thiols were 
observed in some cases, such as targeting of [Am1-Bz7-G3-TSe];[64] and [Am2-Bz6-G3-
TSe];[65] (Fig. S3.12, S3.13), when using the simultaneous multifunctionalisation strategy. 
 
Fig. 3.17 MALDI-TOF analysis (DCTB) of the product targeting [Am4-Bz4-G3-TSe];[67] via: A) Sequential 
multifunctionalisation; and B) Simultaneous multifunctionalisation 
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3.2.3 SEC analysis of multifunctional dendrons 
Triple detection SEC analysis of the multifunctional materials shows an incremental decrease 
in retention time with increasing Bz functionality from [Am4-G2-TSe];[42] to [Bz4-G2-
TSe];[43] for the G2 dendron series, which may be correlated to an increase in molecular 
weight and molecular size in solution (Fig. 3.18). The observed size increase is surprising 
when just one Am functional group is replaced with a Bz group each time. 
 
Fig. 3.18 SEC chromatogram overlay of RI traces for  [Xan4-G2-TSe];[13] (dashed black line), [Am4-G2-
TSe];[42] (blue line), [Am3-Bz1-G2-TSe];[63] (red line), [Am2-Bz2-G2-TSe];[62] (green line), [Am1-Bz3-G2-
TSe];[61] (pink line) and [Bz4-G2-TSe];[43] (solid black line) 
The materials maintained a narrow dispersity (Ð) and a monomodal distribution (Table S3.2), 
despite the distribution of materials observed by MALDI-TOF analysis. 
 
Retention Volume (mL)
19.8 20.0 20.2 20.4 20.6 20.8 21.0 21.2 21.4
[Xan4-G2-TSe]
[Am4-G2-TSe]
[Am3-Bz1-G2-TSe]
[Am2-Bz2-G2-TSe]
[Am1-Bz4-G2-TSe]
[Bz4-G2-TSe]
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3.3 Statistical multifunctionalisation of xanthate functional dendrimers 
So far, the multifunctionalisation of increasingly complex model dendrons via sequential and 
simultaneous strategies has been explored. The overall aim of this research is the 
multifunctionalisation of HPDs, which possess large numbers of dendron chain ends, and 
hence, xanthate peripheral groups. Therefore, the sequential and simultaneous 
multifunctionalisation of a G2 model dendrimer, which presents a high concentration of 
xanthate functional groups in close proximity, would provide an insight into the 
multifunctionalisation of more complex polymers containing multiple xanthate functional 
dendrons, studied later, Fig. 3.19. 
 
Fig. 3.19 Schematic representation of the multifunctionalisation of a xanthate peripheral G2 dendrimer 
 
3.3.1 Sequential multifunctionalisation 
As outlined in section 3.2.1.3, the xanthate functional G2 dendrimer [Xan12-G2-THPE];[18] 
was subjected to varying molar equivalents of n-butylamine, targeting 25%, 50% and 75% of 
xanthate groups deprotected. Xanthate groups of the dendrimer were deprotected in a 
controlled manner, as seen previously for the model dendrons (Fig. S3.23). A slight molar 
excess of DMAEA was added with respect to the exposed thiols. Remaining xanthate groups 
were then deprotected and benzyl acrylate added in excess. The resulting materials were 
analysed by 
1
H NMR spectroscopy, Fig. 3.20.  
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Fig. 3.20 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of Am and Bz functionalised [Xan12-G2-THPE];[18] via 
the sequential strategy: A) [Am3-Bz9-G2-THPE];[96]; B) [Am6-Bz6-G2-THPE];[97]; C) [Am9-Bz3-G2-
THPE];[98] 
As an example, targeting [Am6-Bz6-G2-THPE];[97], 50% of xanthate groups were initially 
deprotected by addition of 6 equivalents of n-butylamine, followed by addition of 9 molar 
equivalents of Am acrylate. The product was purified, analysed by 
1
H NMR (Fig. S3.24), and 
the remaining xanthate groups deprotected and reacted with a 1.5 molar excess of Bz acrylate 
per exposed thiol. The resulting product was analysed by 
1
H NMR after purification, 
confirming the average 50/50 functionalisation targeted (Fig. S3.25). 
1
H NMR analysis of the 
targeted materials revealed ratios of 25:73, 50:46 and 85:15 of Am:Bz functionality 
incorporated (Fig. 3.20). Restricted rotation and slow molecular tumbling results in fairly 
broad resonances in the 
1
H NMR spectra of the functionalised dendrimer materials, despite 
their highly symmetric structures. 
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3.3.2 Simultaneous multifunctionalisation 
As described previously, in the simultaneous methodology, all xanthate groups are 
deprotected with an excess of n-butylamine and a stoichiometric mixture of functional 
acrylates added to simultaneously react with exposed thiols in a one-pot reaction. 
Multifunctionalisation with Am and Bz acrylates was targeted at 25:75, 50:50 and 75:25 
ratios by varying the molar equivalents of each acrylate added following deprotection. 
Materials analysed by 
1
H NMR spectroscopy showed good control over 
multifunctionalisation, with ratios of 26:73, 60:40 and 78:22 of Am:Bz functionality 
achieved, Fig. 3.21. 
 
Fig. 3.21 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of Am and Bz functionalised [Xan12-G2-THPE];[18] via 
the simultaneous strategy: A) [Am3-Bz9-G2-THPE];[96]; B) [Am6-Bz6-G2-THPE];[97]; C) [Am9- Bz3-G2-
THPE];[98] 
Simultaneous multifunctionalisation, targeting [Am6-Bz6-G2-THPE];[97], involved complete 
deprotection of all xanthate groups under mild basic conditions at ambient temperature, 
followed by addition of a 50/50 stoichiometric mixture of Am and Bz acrylates, and the 
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reaction left to stir overnight. The resulting mixture was purified by precipitation and 
analysed by 
1
H NMR spectroscopy, Fig. 3.22. 
 
Fig. 3.22 
1
H NMR (400 MHz, CDCl3) of [Am6-Bz6-G2-THPE];[97] by simultaneous multifunctionalisation 
According to 
1
H NMR analysis, both methods achieved a good degree of control over 
multifunctionalisation of the xanthate functional G2 dendrimer [18], however, mass 
spectrometry data obtained for the model dendrons (sections 3.2.1.3 and 3.2.2) suggests there 
is likely to be a broad distribution of materials obtained for each target structure. MALDI 
TOF mass spectrometry was not conducted on these functionalised dendrimer materials, but 
this served as proof of principal for later studies of complex polymers containing multiple 
dendrons that would not be able to be studied by mass spectrometry. 
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3.4 Post-polymerisation modification of xanthate functional polymeric 
materials with complex architectures 
Post-polymerisation modification of a single, well-defined macromolecular precursor allows 
the opportunity to control end group functionality without the potential for significant 
changes in chain length distribution that may result from multiple polymer sample syntheses. 
Due to the nature of polymerisation, HPDs are fundamentally polydisperse; the distribution 
can be maintained if post-polymerisation modification is applied. The synthesis of multiple 
samples with different molecular weight distributions and different functional group 
distributions would make it much more difficult to establish differences in behaviour and 
correlate surface group variation between samples. This method of functional material 
synthesis involves polymerisation of monomers or initiators with functional groups which are 
inert to polymerisation conditions, but allow quantitative conversion in a subsequent reaction 
step to incorporate a wide range of functionalities. Libraries of functional polymers with 
identical number average degrees of polymerisation (DPn) but with variable side chain 
functionality may be easily generated from a single sample of polymer.
21
 Detailed analysis of 
these materials is very difficult to achieve without lengthy separation of individual 
components of complex distributions and analysis using multiple techniques. The model 
studies of G1-G3 dendrons presented above (section 3.2) offers new insights into outcomes 
that would result from post-polymerisation modification of novel complex polymer 
architectures bearing dendron subunits, e.g. Janus-dendrimers, hyperbranched polymers, 
linear dendritic hybrids, dendron modified surfaces, dendron-bearing networks, dendronised 
polymers and hyperbranched polydendrons. 
The orthogonal nature of the dendron periphery and focal point protection chemistries used in 
these studies allows selective deprotection and introduction of ATRP initiating functional 
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groups at the focal point of the model dendrons. The syntheses of xanthate functional 
dendron macroinitiators (G0-G3) and subsequent polymerisations with nBMA and tBMA 
monomers is described in Chapter 2 (sections 2.7 and 2.8), to form linear dendritic hybrid 
(LDH) species, and corresponding hyperbranched polydendrons (HPDs) by inclusion of 
bifunctional monomer EGDMA. The potential of the sequential and simultaneous 
multifunctionalisation strategies are evaluated for the controlled introduction of mixed 
functionality to the dendron periphery of both LDH and HPD species, Fig. 3.23. 
 
Fig. 3.23 Synthesis and post-polymerisation modification of G2 LDH and corresponding HPD materials 
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3.4.1 Statistical multifunctionalisation of xanthate functional LDHs and HPDs 
3.4.1.1 tBMA 
Xanthate peripheral G1 and G2 dendron initiated tert-butylmethacrylate (tBMA) LDHs and 
HPDs ([25]-[28]), synthesised in Chapter 2 (sections 2.8.4.1 and 2.8.5.1, respectively), were 
investigated for their ability to undergo sequential and simultaneous multifunctionalisation 
with Bz and Am acrylate. The ability to access the chain-ends of these complex polymer 
architectures to controllably deprotect and functionalise peripheral groups has been 
investigated. The triple detection SEC-derived molecular weight distributions of the G1 and 
G2 dendron initiated LDH and HPD materials, and G2 materials following simultaneous 
multifunctionalisation are summarised in Table 3.2. 
Table 3.2 Triple detection SEC
a
 analysis of G1 and G2 dendron initiated polymer materials 
Polymer Type
b
 
Monomer 
conv. (%) 
SEC (THF)
a 
Mn  
(g mol
-1
) 
Mw 
(g mol
-1
) 
Ð 
p[(Xan2-G1)-tBMA50];[25] LDH >99 13 700 17 000 1.24 
p[(Xan2-G1)-tBMA50-co-
EGDMA0.8];[27] 
HPD >99 59 600 935 800 15.69 
      
p[(Xan4-G2)-tBMA50];[26] LDH >99 12 900 15 200 1.19 
p[(Am2-Bz2-G2)-tBMA50];[118] LDH - 16 300 19 100 1.18 
      
p[(Xan4-G2)-tBMA50-co-
EGDMA0.8];[28] 
HPD >99 46 500 340 700 7.29 
p[(Am2-Bz2-G2)-tBMA50-co-
EGDMA0.8];[121] 
HPD - 51 200 312 400 6.10 
aSEC values (Mn, Mw and Ð) determined using THF eluent containing 2% TEA (v/v), 1 ml min
-1 flow rate. bLDH = linear 
dendritic hybrid; HPD = hyperbranched polydendron 
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3.4.1.1.1 Sequential modification 
G1 and G2 LDHs; p[(Xan2-G1)-tBMA50];[25] and p[(Xan4-G2)-tBMA50];[26], and HPDs; 
p[(Xan2-G1)-tBMA50-co-EGDMA0.8];[27] and p[(Xan4-G2)-tBMA50-co-EGDMA0.8];[28], 
were subjected to the same sequential xanthate deprotection strategy as outlined for the 
model dendrons in section 3.2.1.1; increasing molar equivalents of n-butylamine were added 
to yield increasing numbers of exposed thiols. The polymer compositions are less well-
defined than the model dendrons, thus complicating the direct targeting of thiol-functionality, 
therefore, pseudo-calibration curves for xanthate deprotection were generated for each 
material. The pseudo-calibration curves relate the number of equivalents of n-butylamine 
used for deprotection with the percentage of thiols deprotected, as calculated by 
1
H NMR 
spectroscopy by integrating the characteristic xanthate resonance at δ = 4.64 ppm, relative to 
the polymer backbone (δ ≈ 0.8-1.1 ppm), which remains unchanged after deprotection. These 
curves are individually constructed for each polymer due to the distribution of species 
present; accurate calculation of molecular weight of primary polymer chains, and hence the 
number of xanthates per mole, is difficult and lengthy, particularly for branched polymer 
species which possess a broad dispersity of structures. The curves generated for the model 
dendrons (Fig. 3.6) are therefore inapplicable to polymeric species. The pseudo-calibration 
curves can be used to calculate the number of moles of n-butylamine required to target 
different degrees of deprotection during the first step of sequential multifunctionalisation 
when targeting different ratios of functional groups. The data can also be used to calculate the 
number of moles of each functional acrylate required to react with exposed thiols when 
targeting desired ratios of functionality during simultaneous multifunctionalisation.  
The pseudo-calibration curves were generated by: (1) estimation of number average degree of 
polymerisation (DPn) of the primary polymer chains using 
1
H NMR end-group analysis; (2) 
calculation of the average number of moles of xanthate groups in each sample; (3) addition of 
CHAPTER 3 
162 
 
varying equivalents of n-butylamine; and (4) determination of the average number of 
xanthates deprotected using 
1
H NMR analysis. It was evident from the resultant deprotection 
curves that the G1 dendron initiated LDH and HPD polymer materials required considerably 
more n-butylamine for deprotection than the model dendron ([Xan2-G1-TSe];[12]) to achieve 
the desired level of deprotection (Fig. 3.24A; LDH Fig. S3.26, HPD Fig. S3.29). Within 
experimental error, the G2 dendron initiated LDH and HPD closely resembled the behaviour 
of the model G2 dendron ([Xan4-G2-TSe];[13]), requiring approximately 1 molar equivalent 
of n-butylamine per xanthate to liberate the required number of thiols (Fig. 3.24B; LDH  Fig. 
S3.32, HPD Fig. S3.35).  
A) 
 
B) 
 
Fig. 3.24 Pseudo-calibration curves for xanthate deprotection of; A) structures derived from G1 dendrons, and 
B) structures derived from G2 dendrons. Model dendrons (open red circles), LDHs (open green triangles) and 
HPDs (open blue squares). All data was determined using 
1
H NMR spectroscopy and linear regression is shown. 
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To investigate this further, the deprotected materials were treated with Bz acrylate and the 
percentage of Michael adduct was determined by 
1
H NMR after purification (G1 LDH Fig. 
S3.27, HPD Fig. S3.30; G2 Fig. S3.33, HPD Fig. S3.36), shown here for p[(Xan2-Bz2-G2)-
tBMA50-co-EGDMA0.8];[113], Fig. 3.25; 5 equivalents of Bz acrylate per thiol were added 
to ensure full reaction. 
 
Fig. 3.25 
1
H NMR (400MHz, CDCl3) of p[(Xan2-Bz2-G2)-tBMA50-co-EGDMA0.8];[113] by sequential 
modification of p[(Xan4-G2)-tBMA50-co-EGDMA0.8];[28] 
The number of thiol-acrylate Michael adducts formed in each sequential deprotection-
functionalisation confirmed the observations seen within the pseudo-calibration curves; a 
significant molar excess of n-butylamine was required to efficiently deprotect the xanthates 
within both G1 dendron initiated LDH and HPD polymer samples. In all cases the ability to 
target the deprotection of a bespoke number of thiols, and a near-linear relationship with 
subsequent thiol-acrylate Michael addition, was seen, Fig. 3.26. 
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A) 
 
B) 
 
Fig. 3.26 Relationship between moles of n-butylamine required for sequential xanthate deprotection and 
subsequent benzyl acrylate Michael adducts. A) Structures derived from G1 dendrons, and B) structures derived 
from G2 dendrons. Model dendrons (open red circles), LDHs (open green triangles) and HPDs (open blue 
squares). All data was determined using 
1
H NMR spectroscopy and linear regression is shown. 
The difference in behaviour between the model G1 dendron and the polymers derived from 
the G1 dendron initiator may suggest a difficulty in accessing peripheral xanthates for 
deprotection and subsequent thiol-acrylate Michael addition. The G2 dendron initiated 
samples appear, conversely, to be accessible; suggesting that even at relatively low dendron 
generation, a different coiling of chains in solution may be present. 
Further functionalisation was achieved by deprotection of the remaining xanthate groups in 
the partially Bz functional materials with a 5-fold molar excess of n-butylamine and 
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subsequent addition of an excess of Am acrylate. Resulting materials were analysed by 
1
H 
NMR following purification, confirming the formation of mixed Bz and Am functional 
p[(Amx-Bzy-G2)-tBMA50-co-EGDMA0.8] (x = 0-4, y = 0-4, x+y = 4) (G1 LDH Fig. S3.28, 
HPD Fig. S3.31; G2 LDH Fig. S3.34, HPD Fig. S3.37). 
 
3.4.1.1.2 Simultaneous modification 
Simultaneous statistical multifunctionalisation was investigated using the G2 dendron 
initiated LDH p[(Xan4-G2)-tBMA50];[26] and HPD p[(Xan4-G2)-tBMA50-co-
EGDMA0.8];[28]. The complete deprotection of chain-end xanthate functionality (1.2 molar 
equivalents of n-butylamine per xanthate) and addition of a 1:1 molar ratio of Bz and Am 
acrylates (1 molar equivalent per thiol) resulted in the functionalised LDH p[(Am2-Bz2-G2)-
tBMA50];[118] and HPD p[(Am2-Bz2-G2)-tBMA50-co-EGDMA0.8];[121] as confirmed by 
1
H NMR spectroscopy (Fig. S3.38 and Fig. 3.27, respectively) and SEC (Fig. 3.28; Table 
3.2).  
 
Fig. 3.27 
1
H NMR (400MHz, CDCl3) of p[(Am2-Bz2-G2)-tBMA50-co-EGDMA0.8];[121] by simultaneous 
multifunctionalisation of p[(Xan4-G2)-tBMA50-co-EGDMA0.8];[28] 
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1
H NMR analysis confirmed a 1:1 ratio of Bz and Am functionality within both products, 
however, integrals for the methylene resonances (δ ≈ 2.68 and 2.89 ppm; Fig. 3.27 peak 3) of 
the targeted Michael adduct p[(Am2-Bz2-G2)-tBMA50-co-EGDMA0.8];[121] were lower than 
expected when compared to the polymer backbone CH3 resonance at δ ≈ 1.32–1.55 ppm; this 
is thought to be due to restricted movement of protons within the structure.  
SEC analysis of the linear-dendritic hybrid before and after the full deprotection and 
subsequent thiol-acrylate Michael addition showed a slight shift to lower retention times (Fig. 
3.28A) and subsequent increase in the determined values for Mn and Mw (Table 3.2). 
Interestingly, the shape of the molecular weight distributions of the LDHs, and subsequent Đ 
values, were nearly identical with no obvious broadening or bimodality. This would suggest 
an absence of intermolecular coupling after deprotection and exposure of a large number of 
thiol functional groups. To establish the storage stability of the xanthate-protected p[(Xan4-
G2)-tBMA50];[26], a sample was stored for approximately 2 years and showed no meaningful 
change in the molecular weight distribution (Fig. 3.28A). The same simultaneous 
deprotection/thiol-Michael addition strategy also formed the mixed-functionality HPD 
p[(Am2-Bz2-G2)-tBMA50-co-EGDMA0.8];[121] without obvious intermolecular coupling, as 
confirmed by SEC analysis (Fig. 3.28B); additionally, xanthate-functional HPD storage 
stability was confirmed by analysis of a sample approximately two years after initial 
synthesis (Fig. 3.28B). 
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A) 
 
B) 
 
Fig. 3.28 SEC chromatogram overlays of RI of (A) LDH materials and (B) HPD materials. Molecular weight 
distributions for xanthate-functional materials as prepared (blue lines), stored for 2 years (red lines) and after 
full xanthate deprotection and subsequent simultaneous Michael addition reaction with 1:1 molar ratio of Bz and 
Am (black lines). 
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3.4.1.2 nBMA 
The polymer was changed from tBMA (Tg = 118°C) to nBMA (Tg = 20°C)
22
 for this study as 
the aim of this research is to generate multifunctional nanoparticles for drug delivery; a lower 
Tg material would present cells with a more pliable particle, rather than a hard sphere, which 
may influence uptake.
3-6
 Xanthate peripheral G0-G3 dendron initiated n-butylmethacrylate 
(nBMA) HPDs ([36]-[39]) were investigated for their ability to undergo sequential and 
simultaneous statistical post-polymerisation modification, shown here for G3 initiated HPD, 
Fig. 3.29. 
 
Fig. 3.29 Statistical multifunctionalisation of xanthate functional G3 dendron initiated HPD 
G0-G3 nBMA HPDs; p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], p[(Xan2-G1)-nBMA100-
co-EGDMA0.8];[37], p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] and p[(Xan8-G3)-
nBMA100-co-EGDMA0.8];[39], were subjected to sequential deprotection to construct 
pseudo-calibration curves for each material. Increasing molar equivalents of n-butylamine 
resulted in increasing deprotection of peripheral xanthate groups, giving rise to a near-linear 
correlation, independent of the dendron generation of the HPD structures, Fig. 3.30. 
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A) 
 
B) 
 
C) 
 
D) 
 
Fig. 3.30 Pseudo-calibration curves for the sequential deprotection of xanthate groups of branched n-
butylmethacrylate HPDs; A) p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], B) p[(Xan2-G1)-nBMA100-co-
EGDMA0.8];[37], C) p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] and D) p[(Xan8-G3)-nBMA100-co-
EGDMA0.8];[39] 
The G2 dendron initiated HPD required more molar equivalents of n-butylamine for xanthate 
deprotection than expected. This is likely to be due to a population of very high molecular 
weight species in the polymer distribution, which can be easily seen in the SEC RALS trace 
for the G2 dendron initiated HPD material (Fig. 2.24C). This is thought to have led to a poor 
estimation of primary polymer chain length, and hence, the number of xanthates per mole of 
polymer. It may also be a diffusion control effect of the very high molecular weight 
polymers, restricting penetration of n-butylamine into the dense polymer structures. This 
further highlights the need to generate pseudo-calibration curves for each polymer sample for 
targeted statistical multifunctionalisation of these complex architectures. 
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Overall, the nBMA HPDs required much more equivalents of n-butylamine for xanthate 
deprotection than the equivalent tBMA HPDs. This may suggest differences in amine 
penetration, or coiling of polymer chains in solution between the polymers. 
 
3.4.1.2.1 Simultaneous modification 
Simultaneous multifunctionalisation was carried out by deprotection of all xanthate 
peripheral groups with an excess of n-butylamine and reaction with a stoichiometric mixture 
of the chosen acrylates at various ratios (Am:Bz 25:75, 50:50 and 75:25), as calculated using 
the pseudo-calibration curves (Fig. 3.30) (
1
H NMRs G0-G3 Fig. S3.42-S3.45). 
A) 
 
B) 
 
C) 
 
D) 
 
Fig. 3.31 Results of simultaneous multifunctionalisation of HPDs targeting Am:Bz ratios of 25:75, 50:50 and 
75:25 for: A) p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36]; B) p[(Xan2-G1)-nBMA100-co-EGDMA0.8];[37]; C) 
p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38]; and D) p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39]. Bz (red 
closed circles) and Am (blue closed triangles), pseudo-calibration curves for G0-G3 dendrons shown (green 
dashed line) 
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There is a good agreement between targeted % functionalisation for G0-G2 dendron initiated 
HPDs, showing good control when applying the simultaneous strategy to these highly 
complex structures, despite the structural complexity and variation between the samples 
(Table S3.3). However, there is a disparity between theoretical and experimental values of % 
acrylate incorporated (analysed via 
1
H NMR) for the G3 dendron initiated HPDs, suggesting 
less control. This inconsistency in multifunctionalisation at higher dendron generations could 
be as a result of a steric effect; access to thiols may be difficult for acrylates in highly 
hydrophobic polymers. The problems seen with steric “trapping” of thiols in G3 dendrons is 
magnified in these much larger, branched polymer systems. Statistical multifunctionalisation 
of HPDs appears to be more successful for lower generation dendrons. 
 
3.5 Conclusion 
Although significant progress has been made in recent years, the precise control over the 
distribution of surface functional groups on large, multifunctional materials, and their 
characterisation, remains a challenge. Many analytical techniques that are commonly used in 
multifunctional material characterisation (NMR spectroscopy, elemental analysis, UV-Vis 
spectrophotometry) can only be used to identify the mean functional group ratio. Results 
generated from these types of analytical techniques are clearly not sufficient to ensure clinical 
translation of multifunctional materials.  
A rigorous model study of two strategies (sequential and simultaneous) to introduce mixed 
functionality onto masked-thiol dendrons has been conducted. These model studies allow 
detailed evaluation and comparison of the strategies, which would not be possible through 
analysis of the linear-dendritic hybrid (LDH) and hyperbranched polydendron (HPD) 
architectures alone, due to their inherent distribution of molecular weights. A distribution of 
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outcomes from statistical multifunctionalisation was expected (Fig. 3.32); however, the 
dendron studies shown here provide an insight into the complexity of the diverse structures 
and isolation of unreacted groups. NMR spectroscopy was the primary characterisation 
technique used to analyse the multifunctional dendritic materials within this study, however, 
MALDI-TOF mass spectrometry was required to resolve structure distributions within the 
sample. Interestingly, the simultaneous reaction of the chosen acrylates with thiol-functional 
dendrons generally led to fewer isolated thiols in the final materials. Coupling of exposed 
thiols during reactions was not observed. 
 
Fig. 3.32 Schematic representation of the distribution of possible outcomes from statistical 
multifunctionalisation of G3 dendron [Xan8-G3-TSe];[14] 
Although it is apparent that LDH materials, and their more complex HPD analogues, can be 
successfully manipulated through both functionalisation approaches, it is also clear that 
neither statistical functionalisation approach would lead to outcomes substantially resembling 
the nominal chosen product, and a large range of structures including full functionalisation 
with a single functional group will be formed on individual dendrons. The statistical 
introduction of two functional groups will potentially generate a considerable chemical 
diversity within the final sample leading to incorrect conclusions being drawn from the study 
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of molecular behaviour that is interpreted through an ill-informed view of the composition of 
the material under investigation.  
The implications for partial or mixed post-synthesis surface group modification of any 
material are clear. These are more substantial when attempting to modify the functional 
groups of dendron-bearing materials. For example, LDHs bear a single dendron at the end of 
each chain and when subjected to partial or mixed-functionalisation, would be expected to 
generate end-groups representing the full spectrum of chemical compositions and very little 
of the targeted chemistry. In the example studied here, compositions ranging from 100% 
amine-containing through to 100% benzyl-terminated species would be present, leading to 
significant impact on the physical behaviour of the product. Although this was not studied 
here, highly heterogeneous and non-uniform behaviour to environmental conditions of 
varying pH
23
 or temperature would be expected, as shown previously for subtle changes in 
the single functionality at the chain-ends of linear polymers.
24,25
 Through the formation of 
HPDs, however, the distribution of outcomes is widely averaged across the large number of 
conjoined chain-ends, allowing the inclusion of the intended ratio of functional groups to be 
more closely achieved within individual highly branched molecules (Fig. 3.33) rather than at 
the single chain-end of LDHs. Such a result would also be expected for materials such as 
dendronised polymers, but the distribution of diverse compositions, even in LDHs and linear 
polymers, does potentially lead to other implications such as the formation of concentrated 
areas of specific functional groups which may influence the behaviour of the materials under 
specific conditions (e.g. biological interactions).
26-28
 It would be incorrect to assume that 
localised domains of grouped functionality are not present within statistically modified mixed 
functionality materials (Fig. 3.33), therefore we are not confident that this is the most 
appropriate strategy to undertake the detailed studies of patchy vs. statistical functionality 
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detailed in Chapter 1 and highlighted again at the beginning of this chapter. Another strategy 
(see Chapter 4) to allow such studies was therefore adopted. 
 
Fig. 3.33 Schematic representation of the outcome of statistical chain-end modification of LDHs and HPDs 
These multifunctionalisation strategies provide an opportunity to build systematically varying 
complex architectures which may overcome many of the limitations of analogous 
macromolecules with more iterative and lengthy syntheses. These materials have tremendous 
potential in applications involving multifunctional nanoparticulate systems combining 
targeting, imaging, diagnostics and therapy. 
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3.7 Appendix 
 
Fig. S3.1 
13
C NMR (100 MHz, CDCl3) of [Bz8-G3-TSe];[45] 
 
 
Fig. S3.2 
1
H NMR (400 MHz, CDCl3) of Sequential [Am1-Bz1-G1-TSe];[60] 
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Fig. S3.3 
1
H NMR (400 MHz, CDCl3) of Simultaneous [Am1-Bz1-G1-TSe];[60] 
 
 
Fig. S3.4 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am1-Bz1-G1-TSe];[60] 
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Fig. S3.5 
1
H NMR (400 MHz, CDCl3) of Sequential [Am1-4-Bz1-4-G2-TSe]: (A) [Am1-Bz3-G2-TSe];[61]; (B) 
[Am2-Bz2-G2-TSe];[62]; (C) [Am3-Bz1-G2-TSe];[63]. 
 
 
Fig. S3.6 
1
H NMR (400 MHz, CDCl3) of Simultaneous [Am1-4-Bz1-4-G2-TSe]: (A) [Am1-Bz3-G2-TSe];[61]; (B) 
[Am2-Bz2-G2-TSe];[62]; (C) [Am3-Bz1-G2-TSe];[63]. 
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Fig. S3.7 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am1-Bz3-G2-TSe];[61] 
 
 
Fig. S3.8 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am2-Bz2-G2-TSe];[62] 
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Fig. S3.9 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am3-Bz1-G2-TSe];[63] 
 
 
Fig. S3.10 
1
H NMR (400 MHz, CDCl3) of Sequential [Am1-8-Bz1-8-G3-TSe]: (A) [Am1-Bz7-G3-TSe];[64]; (B) 
[Am2-Bz6-G3-TSe];[65]; (C) [Am3-Bz5-G3-TSe];[66]; (D) [Am4-Bz4-G3-TSe];[67]; (E) [Am5-Bz3-G3-
TSe];[68]; (F) [Am6- Bz2-G3-TSe];[69]; (G) [Am7- Bz1-G3-TSe];[70] 
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Fig. S3.11 
1
H NMR (400 MHz, CDCl3) of Simultaneous [Am1-8-Bz1-8-G3-TSe]: (A) [Am1-Bz7-G3-TSe];[64]; 
(B) [Am2-Bz6-G3-TSe];[65]; (C) [Am3-Bz5-G3-TSe];[66]; (D) [Am4-Bz4-G3-TSe];[67]; (E) [Am5-Bz3-G3-
TSe];[68]; (F) [Am6- Bz2-G3-TSe];[69]; (G) [Am7- Bz1-G3-TSe];[70] 
 
 
Fig. S3.12 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am1-Bz7-G3-TSe];[64] 
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Fig. S3.13 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am2-Bz6-G3-TSe];[65] 
 
 
 
Fig. S3.14 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am3-Bz5-G3-TSe];[66] 
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Fig. S3.15 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am4-Bz4-G3-TSe];[67] 
 
 
Fig. S3.16 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am5-Bz3-G3-TSe];[68] 
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Fig. S3.17 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am6-Bz2-G3-TSe];[69] 
 
 
Fig. S3.18 MALDI-TOF MS (Dith, THF) comparison of Sequential vs. Simultaneous [Am7-Bz1-G3-TSe];[70] 
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Table S3.1. Peaks identified and assigned within the MALDI-TOF spectrum of [Xan2-Am6-G3-TSe];[55] – see 
Fig. 3.10 
Peak 
Species 
assignment 
Theoretical 
Exact mass 
m/z+1 (Da) 
Peak identified 
m/z (Da) 
1 [Xan5-Am3-G3-TSe]H
+
 + 48 2525 
2526.9 
 
2 
[Xan5-Am3-G3-TSe]K
+
 + 32 
 
2547 2546.9 
3 
[Xan5-Am3-G3-TSe]K
+
 + 48 
 
2563 2561.0 
4 
[Xan4-Am4-G3-TSe]K
+
 + 16 
 
2586 2582.0 
5 
[Xan4-Am4-G3-TSe]H
+
 + 64 
 
2596 2596.0 
6 
[Xan4-Am4-G3-TSe]K
+
 + 48 
 
2618 2618.9 
7 
[Xan3-Am5-G3-TSe]H
+
 + 48 
 
2635 2635.6 
8 
[Xan3-Am5-G3-TSe]K
+
 + 16 
 
2641 2641.1 
9 
[Xan3-Am5-G3-TSe]K
+
 + 32 
 
2657 2656.1 
10 
[Xan2-Am6-G3-TSe]K
+
 + 16 
 
2696 2694.6 
11 
[Xan2-Am6-G3-TSe]H
+
 + 64 
 
2706 2708.6 
12 
[Xan1-Am7-G3-TSe]K
+
 + 16 
 
2751 2750.0 
13 
[Xan1-Am7-G3-TSe]K
+
 + 32 
 
2767 2764.1 
14 
[Xan1-Am7-G3-TSe]K
+
 + 48 
 
2783 2781.2 
15 
[Am8-G3-TSe]H
+
 + 48 
 
2800 2800.1 
16 
[Am8-G3-TSe]K
+
 + 16 
 
2806 2805.9 
17 
[Am8-G3-TSe]H
+
 + 64 
 
2816 2817.1 
18 
[Am8-G3-TSe]K
+
 + 32 
 
2822 2822.1 
19 
[Am8-G3-TSe]K
+
 + 48 
 
2838 2836.2 
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Fig. S3.19 MALDI-TOF MS (Dith, THF) comparison of Sequential [Am1-8-Bz1-8-G3-TSe];[64]-[70] 
 
 
Fig. S3.20 MALDI-TOF MS (Dith, THF) comparison of Simultaneous [Am1-8-Bz1-8-G3-TSe];[64]-[70] 
CHAPTER 3 
188 
 
 
Fig. S3.21 Experimental vs. theoretical % acrylate for Sequentially multifunctionalised G1-G3 dendrons [12]-
[14] 
 
 
Fig. S3.22 Experimental vs. theoretical % acrylate for Simultaneously multifunctionalised G1-G3 dendrons [12]-
[14] 
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Table S3.2 Triple detection SEC analysis of simultaneously multifunctionalised G2 dendron [Xan4-G2-
TSe];[13]; [Am4-G2-TSe];[42], [Am3-Bz1-G2-TSe];[63], [Am2-Bz2-G2-TSe];[62], [Am1-Bz3-G2-TSe];[61] and 
[Bz4-G2-TSe];[43] 
  MS [MNa]
+ 
SEC (THF)
a 
Dendron MCalc (Da) MObs (Da) Mn Mw Ð 
[Xan4-G2-TSe];[13] 1196.1 1219.1 1193 1413 1.19 
      
[Am4-G2-TSe];[42] 1416.5 - 1432 1704 1.19 
[Am3-Bz1-G2-TSe];[63] 1435.5 - 1450 1726 1.19 
[Am2-Bz2-G2-TSe];[62] 1454.5 - 1449 1666 1.15 
[Am1-Bz3-G2-TSe];[61] 1473.4 - 1470 1735 1.18 
[Bz4-G2-TSe];[43] 1492.4 - 1493 1747 1.17 
a
THF containing 2% TEA (v/v) at 35°C, 1mL min
-1
 flow rate. 
Mn – number average molecular weight; Mw – weight average molecular weight 
 
 
 
Fig. S3.23 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially deprotected xanthate peripheral G2 
dendrimer [18]. Equivalents of n-butylamine added: A) 3, B) 6 and C) 9 
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Fig. S3.24 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially Am functionalised G2 dendrimer [18];  
A) [Am3-Xan9-G2-THPE];[57], B) [Am6-Xan6-G2-THPE];[58]  and C) [Am9-Xan3-G2-THPE];[59]. 
 
Fig. S3.25 
1
H NMR (400 MHz, CDCl3) of [Am6-Bz6-G2-THPE];[97] by sequential multifunctionalisation 
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Fig. S3.26 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially deprotected p[(Xan2-G1)-tBMA50];[25]. 
Equivalents of n-butylamine added: A) 0, B) 1.5, C) 3, D) 4.5. 
 
 
Fig. S3.27 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially Bz functionalised p[(Xan2-G1)-
tBMA50];[25]. Equivalents of n-butylamine added: A) 1.5, B) 3, C) 4.5. 
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Fig. S3.28 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of sequentially multifunctionalised p[(Xan2-G1)-
tBMA50];[25]. Equivalents of n-butylamine added for deprotection in first step: A) 1.5, B) 3. 
 
 
Fig. S3.29 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially deprotected p[(Xan2-G1)-tBMA50-co-
EGDMA0.8];[27]. Equivalents of n-butylamine added: A) 1.5, B) 3, C) 4.5. 
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Fig. S3.30 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially Bz functionalised p[(Xan2-G1)-tBMA50-co-
EGDMA0.8];[27]. Equivalents of n-butylamine added: A) 1.5, B) 3, C) 4.5. 
 
 
Fig. S3.31 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of sequentially multifunctionalised p[(Xan2-G1)-
tBMA50-co-EGDMA0.8];[27]. Equivalents of n-butylamine added for deprotection in first step: A) 1.5, B) 3. 
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Fig. S3.32 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially deprotected p[(Xan4-G2)-tBMA50];[26]. 
Equivalents of n-butylamine added: A) 1.5, B) 3, C) 4.5. 
 
 
Fig. S3.33 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially Bz functionalised p[(Xan4-G2)-
tBMA50];[26]. Equivalents of n-butylamine added: A) 1.5, B) 3, C) 4.5. 
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Fig. S3.34 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of sequentially multifunctionalised p[(Xan4-G2)-
tBMA50];[26]. Equivalents of n-butylamine added for deprotection in first step: A) 1.5, B) 3. 
 
 
Fig. S3.35 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially deprotected p[(Xan4-G2)-tBMA50-co-
EGDMA0.8];[28]. Equivalents of n-butylamine added: A) 1.5, B) 3, C) 4.5. 
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Fig. S3.36 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of partially Bz functionalised p[(Xan4-G2)-tBMA50-co-
EGDMA0.8];[28]. Equivalents of n-butylamine added: A) 1.5, B) 3, C) 4.5. 
 
 
Fig. S3.37 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of sequentially multifunctionalised p[(Xan4-G2)-
tBMA50-co-EGDMA0.8];[28]. Equivalents of n-butylamine added for deprotection in first step: A) 1.5, B) 2, C) 
3, D) 4. 
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Fig. S3.38 
1
H NMR (400 MHz, CDCl3) of p[(Am2-Bz2-G2)-tBMA50];[118]: (A) Simultaneous (B) Sequential 
 
 
Fig. S3.39 
1
H NMR (400 MHz, CDCl3) of p[(Am2-Bz2-G2)-tBMA50-co-EGDMA0.8];[121]: (A) Simultaneous 
(B) Sequential 
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Fig. S3.40 
1
H NMR (400 MHz, CDCl3) of Simultaneous p[(Am2-Bz2-G2)-tBMA50];[118] 
 
 
Fig. S3.41 
1
H NMR (400 MHz, CDCl3) of Simultaneous p[(Am2-Bz2-G2)-tBMA50-co-EGDMA0.8];[121] 
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Fig. S3.42 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of simultaneously multifunctionalised p[(Xan1-G0)-
nBMA100-co-EGDMA0.7];[36], p[(Amx-Bzy-G0)-nBMA100-co-EGDMA0.7];[127] (x = 0-1, y = 0-1, x+y = 1) 
targeting; A) 75:25, B) 50:50 and C) 25:75 Am:Bz functionality. 
 
 
Fig. S3.43 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of simultaneously multifunctionalised p[(Xan2-G1)-
nBMA100-co-EGDMA0.8];[37], p[(Amx-Bzy-G1)-nBMA100-co-EGDMA0.8];[128] (x = 0-2, y = 0-2, x+y = 2) 
targeting; A) 75:25, B) 50:50 and C) 25:75 Am:Bz functionality. 
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Fig. S3.44 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of simultaneously multifunctionalised p[(Xan4-G2)-
nBMA100-co-EGDMA0.8];[38], p[(Amx-Bzy-G2)-nBMA100-co-EGDMA0.8];[129] (x = 0-4, y = 0-4, x+y = 4) 
targeting; A) 75:25, B) 50:50 and C) 25:75 Am:Bz functionality. 
 
Fig. S3.45 Stacked 
1
H NMR (400 MHz, CDCl3) spectra of simultaneously multifunctionalised p[(Xan8-G3)-
nBMA100-co-EGDMA0.8];[39], p[(Amx-Bzy-G3)-nBMA100-co-EGDMA0.8];[130] (x = 0-8, y = 0-8, x+y = 8) 
targeting; A) 75:25, B) 50:50 and C) 25:75 Am:Bz functionality. 
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Table S3.3 % Am and Bz functional group incorporation following simultaneous multifunctionalisation of G0-
G3 nBMA HPDs [36]-[39]. 
Polymer 
Targeted (%) Experimental (%)
a
 
Am Bz Am Bz 
p[(Xan1-G0)-nBMA100-co-
EGDMA0.7];[36] 
25 75 31.8 67.3 
50 50 48.5 51.9 
75 25 68.9 26.6 
     
p[(Xan2-G1)-nBMA100-co-
EGDMA0.8];[37] 
25 75 25.0 73.1 
50 50 50.7 47.3 
75 25 70.8 25.6 
     
p[(Xan4-G2)-nBMA100-co-
EGDMA0.8];[38] 
25 75 21.7 77.8 
50 50 52.4 43.7 
75 25 65.1 33.8 
     
p[(Xan8-G3)-nBMA100-co-
EGDMA0.8];[39] 
25 75 17.9 77.9 
50 50 37.4 60.9 
75 25 50.3 48.1 
a
Determined by 
1
H NMR in CDCl3 
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Controlling the distribution of surface functional 
groups of dendritic polymer nanoparticles 
 
 
 
 
Publication arising from this Chapter: 
 “Co-initiated hyperbranched-polydendron building blocks for the direct nanoprecipitation of dendron-directed 
patchy particles with heterogeneous surface functionality.” 
F. Y. Hern, A. Hill, A. Owen and S. P. Rannard (Chem. Commun., 2018, manuscript under review). 
Individual contributions: A. Hill – GNP synthesis; A. Owen and S. P. Rannard – supervisors. 
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4.1 Introduction 
Performing multiple reactions on a single substrate or inducing multiple interactions in 
complex biological environments presents a significant challenge for chemistry and materials 
science. Naturally occurring multivalent interactions provide inspiration as biological systems 
are able to perform multiple simultaneous reactions with excellent regio/stereospecificity in 
complex environments under mild conditions, and dramatically enhance substrate-substrate 
interactions and recognition.
1
 Surface heterogeneity (denoted as “patchiness”) may induce a 
multivalency effect, reminiscent of interactions widely occurring in biological systems. 
Patchy particles have an anisotropic distribution of surface functional groups which may be 
useful in the medical field due to their ability to simultaneously present multiple different 
surface chemistries on the same construct (see section 1.6).
2
 
Building on the previous chapter, we aim to synthesise nanoparticles with statistical and 
patchy distributions of surface functional groups. The initial aim of generating statistically 
distributed functional groups through one-pot deprotection/thiol-mixed acrylate reactions led 
to measureable thiol isolation within model xanthate functional G3 dendron studies and 
considerably reduced confidence in this approach to accurately generate hyperbranched 
polydendrons (HPDs) with comparable statistical and patchy chemistry. The G0 initiator 
[Xan1-G0-BiB];[20] provides an opportunity to deliver spatially distributed individual 
functional groups that are considerably different to the arrangement of functionality within 
the modified G3 dendrons; subsequent post-polymerisation modification of the G0-xanthate 
functional HPD utilising a mixed acrylate feedstock for the synthesis of statistically 
multifunctionalised materials is expected to significantly overcome or minimise thiol 
isolation in the resulting structures, Fig. 4.1A. The formation of patches of functionality is 
hypothesised from co-initiation of HPDs using two mono-functional G3 dendron 
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macroinitiators, resulting in the formation of “zones” of functionality on the resulting 
anisotropic polymeric particle periphery after nanoprecipitation (a single-step process that 
does not require the use of surfactants and yields nanoparticles with narrow size distributions 
(see section 1.6.2)), Fig. 4.1B. Tailoring of initiator feeds is also hypothesised to nominally 
maintain the same molar ratio of the different functional groups in both statistical and patchy 
materials, allowing for direct comparison of nanoprecipitate behaviour. 
A) 
 
B) 
 
Fig. 4.1 Overall target materials; A) statistically and B) patchy multifunctionalised nanomaterials 
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In the late 1970s, Abuchowski et al. pioneered the covalent attachment of poly(ethylene 
glycol) (PEG) to proteins (commonly known as “PEGylation”) to form polymer-protein 
bioconjugates; resulting in enhanced solubility, electrophoretic mobility, reduced 
immunogenicity and prolonged residence time.
3,4
 Since then, PEGylation has been applied to 
a range of bioconjugate systems to improve biocompatibility and can be found in a range of 
FDA-approved drug formulations.
5-13
 In order to sustain nanoparticle stability in aqueous 
environments for the envisioned nanoprecipitates and to mediate, but not eliminate, 
interactions between these materials and components of the mononuclear phagocyte system 
(MPS) in future applications, the incorporation of PEG chains into branched polymer 
structures by either post-polymerisation modification of the xanthate groups via Michael 
addition with a PEG acrylate, or co/ter-initiation of dendron macroinitiators and a PEG-
derived macroinitiator will be studied; this has previously been shown to be an effective 
approach and an advantage of the HPD platform.
14
 Patchiness may benefit from varying the 
PEG:dendron initiator ratio in co/ter-initiated HPD synthesis, leading to isolation of dendron 
peripheral groups. Different generations of dendron initiators could also potentially lead to 
patches of different numbers of functional groups, which may alter interaction with biological 
systems. 
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4.1.1 Confirmation of patchy and statistical particle formation 
The aim of this chapter is, therefore, to synthesise materials and nanoparticles with different 
spatial arrangements of functional groups at the periphery of primary chains, and ultimately, 
spherical nanoparticles. A key factor within the formation of patchy nanoparticles is the 
generation of clear indications that patchiness has actually been achieved. Analytical 
techniques for measuring the distribution of different functional groups at the atomic scale 
are not available to the project; therefore a direct imaging approach was hypothesised and 
studied to establish whether evidence of patchy nanoparticle surfaces could be determined. 
As stated above, xanthate functional G0 and G3 initiators will be used in the copolymerisation 
of branched nBMA with the bifunctional monomer EGDMA. Co-initiation of a PEG-derived 
macroinitiator with either xanthate functional G0 or G3 dendron macroinitiators is expected to 
result in branched polymers with mixed end groups that will nanoprecipitate to form particles 
with a statistical distribution (Fig. 4.2A) or  patches (Fig. 4.2B) of xanthate groups at the 
periphery. A large proportion of PEG groups are required at the surface in order to induce 
functional group isolation in materials with both grouped and statistically distributed 
functionality. The incorporation of PEG groups at the periphery may also enable 
nanoprecipitation of the polymers, without the need of a surfactant. Molar equivalents of 
peripheral xanthate groups will be maintained between the patchy and statistical structures, as 
outlined in Fig. 4.2.  
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A) 
 
B) 
 
Fig. 4.2 Probing the distribution of; A) statistical and B) patchy distributions of surface functional groups 
As demonstrated in Chapter 3, thiols can be readily generated from xanthate groups under 
mild basic conditions. It is hypothesised that visualisation of the distribution of accessible 
functional groups at the surface of the nanoprecipitates may be achieved by deprotection of 
the xanthate functional HPDs to expose thiols, followed by nanoprecipitation and 
coordination of small gold nanoparticles (GNPs). Due to the binding affinity of gold for 
thiols, the GNPs should bind with accessible thiols on the surface of the nanomaterials. The 
electron density of gold would enable the application of transmission electron microscopy 
(TEM) to visualise the distribution of coordinated GNPs and provide a clear indication of 
either isolated GNPs or grouped GNPs which will be interpreted as providing evidence for 
differing distributions of functional groups at the nanoparticle surface as either patchy or 
statistical; see Fig. 4.2. 
 
 
 
Cu(I)Cl, bpy
MeOH, 60°C
1) deprotect
2) nanoprecipitate
3)0.9
0.1
Cu(I)Cl, bpy
MeOH, 60°C
1) deprotect
2) nanoprecipitate
3)
Br=
0.986
0.014
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4.2 Nanoparticle formation 
4.2.1 Aqueous nanoprecipitation of xanthate functional LDHs and HPDs 
Initial studies of the nanoprecipitation of xanthate-functional linear and branched polymers 
were carried out to ascertain ideal conditions for nanoparticle formation and establish 
differences between simple and complex architectures. G0-G3 xanthate functional LDHs 
(p[(Xan1-G0)-nBMA100];[32], p[(Xan2-G1)-nBMA100];[33], p[(Xan4-G2)-nBMA100];[34] 
and p[(Xan8-G3)-nBMA100];[35]) and HPDs (p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], 
p[(Xan2-G1)-nBMA100-co-EGDMA0.8];[37], p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] 
and p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39]) were dissolved in acetone (“good” solvent) 
at an initial concentration of 5 mg/mL, then rapidly added to water (miscible anti-solvent) 
with stirring. The acetone was allowed to evaporate overnight resulting in nanoparticle 
dispersions with a final concentration of 1 mg/mL of polymer in water, Fig. 4.3.  
 
Fig. 4.3 Aqueous nanoprecipitation of xanthate functional HPDs 
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The nanoparticles were analysed primarily by dynamic light scattering (DLS), as summarised 
in Table 4.1 below, with size by intensity distributions shown in Fig. 4.4. The hydrodynamic 
diameter, also known as the Z-average diameter (Dz), of the HPD nanoprecipitates decreases 
with increasing dendron generation number, and hence number of peripheral xanthate groups. 
A narrow polydispersity index (PdI) (< 0.2) indicates size consistency across each sample.  
Table 4.1 DLS measurement data for G0-G3 xanthate functional DP100 LDH and HPD polymers 
Polymer 
acetone 
Dz (nm) PdI ζ (mV) 
p[(Xan1-G0)-nBMA100];[32] 161 0.052 -19.1 
p[(Xan2-G1)-nBMA100];[33] 123 0.037 -19.6 
p[(Xan4-G2)-nBMA100];[34] 102 0.040 -20.8 
p[(Xan8-G3)-nBMA100];[35] 60 0.094 -28.3 
p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] 125 0.028 -18.4 
p[(Xan2-G1)-nBMA100-co-EGDMA0.8];[37] 104 0.066 -20.6 
p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] 78 0.039 -20.1 
p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39] 53 0.107 -26.8 
 
The nanoprecipitates formed from the equivalent LDH materials to the previously discussed 
HPDs were generally larger in size. For example, linear polymer p[(Xan1-G0)-
nBMA100];[32] nanoprecipitates had a Dz of 161 nm, whilst branched polymer p[(Xan1-G0)-
nBMA100-co-EGDMA0.7];[36] nanoparticles were 125 nm in diameter. The trend follows 
with increasing dendron generation producing smaller nanoparticles: p[(Xan2-G1)-
nBMA100];[33] produces 123 nm diameter nanoparticles, whilst p[(Xan2-G1)-nBMA100-co-
EGDMA0.8];[37] generates 104 nm particles; p[(Xan4-G2)-nBMA100];[34] nanoparticles 
were 102 nm in diameter, whilst p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] nanoparticles 
were 78 nm in diameter; and p[(Xan8-G3)-nBMA100];[35] produces 60 nm diameter 
nanoparticles, whilst p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39] nanoprecipitates were 53 
nm in diameter. 
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A) 
 
B) 
 
Fig. 4.4 DLS size distribution by intensity traces of aqueous nanoparticle dispersions of; A) LDHs p[(Xan1-G0)-
nBMA100];[32], p[(Xan2-G1)-nBMA100];[33], p[(Xan4-G2)-nBMA100];[34] and p[(Xan8-G3)-nBMA100];[35], 
and B) HPDs p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], p[(Xan2-G1)-nBMA100-co-EGDMA0.8];[37], 
p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] and p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39] (correlograms 
Fig. S4.4) 
The nanoprecipitates were not expected to be stable when dispersed in water due to the 
hydrophobic nature of the polymers. The zeta potential (ζ) measured for each sample was 
slightly negative (approx. -20 mV), indicating that there may be an inherent charge stability. 
The negative ζ value is consistent with previous reports of hydrophobic nanoparticles formed 
by nanoprecipitation
14-16
 and other hydrophobic polymer surfaces
17
. Although the origin of 
the negative charge in such systems is somewhat disputed, localised concentrations of 
negative charge are thought to originate from adsorbed hydroxide ions at the polymer/water 
interface as a result of water auto-dissociation and hydrogen bonding with surface functional 
groups.
18
 Here, the polarity within the xanthate functional groups appears to provide 
sufficient hydrogen bonding capability to interact with multiple hydroxide ions; the 
increasing density of xanthates within the increasing dendron generations results in both 
smaller nanoprecipitates (due to the more rapid establishment of colloidal stability during 
nanoparticle growth) and higher negative ζ values. 
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The negative charge on the nanoparticle surface indicates a degree of electrostatic repulsion 
between similarly charged particles in the dispersion, which when high enough (≥ ±40 mV), 
may prevent aggregation or flocculation, which can lead to sedimentation and precipitation. 
Charge stabilised colloids can be easily destabilised by screening of surface charges via the 
addition of electrolytes.
19
 The screening of surface charge blocks the repulsion between 
particles in suspension, which may aggregate and ultimately precipitate. The desire is 
therefore to produce sterically stabilised nanoparticles for use in biological systems due to the 
presence of various salts within the body; a PEG will therefore be used in later syntheses. 
 
4.2.2 Probing accessible xanthate groups of HPD nanoprecipitates 
The formation of nanoprecipitates will result in the full encapsulation of some polymer 
chains within the final nanoparticle and the “burying” of dendron end-groups, as shown in 
earlier reports of similar systems.
14
 It is therefore possible that the formation of 
nanoprecipitates only allows the displaying of a small fraction of the available dendrons at 
the particle surface. The variation in negative ζ clearly suggests that some xanthate functional 
groups are present at the particle periphery, but in order to probe the number of accessible 
groups at the periphery of xanthate functional HPD nanoprecipitates, an excess of  
n-butylamine (50 equiv.) was added to each nanoparticle dispersion (G0-G3) and the resultant 
mixtures were left to stir overnight. Nanoparticles formed from HPDs containing higher 
generation dendrons (G2 and G3) were destabilised soon after addition of excess  
n-butylamine, strongly suggesting larger numbers of xanthate groups are accessible at the 
periphery of these nanoparticles as the amine removes the proposed hydrogen bonding site 
(xanthate carbonyl) for the adsorbed hydroxide ions, reducing the possibility of charge 
stabilisation and causing the particles to destabilise and precipitate.  
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The nanoparticle suspensions were rapidly frozen in liquid nitrogen and lyophilised for 72 
hours to remove the water and excess n-butylamine. The resulting polymer monolith was 
dissolved in deuterated chloroform (CDCl3) and analysed by 
1
H NMR spectroscopy. The 
percentage of remaining xanthate groups was calculated using the characteristic CH2 
resonance at δ = 4.64 ppm, calibrated against the polymer signal at δ ≈ 0.8-1.1 ppm, which 
remains unchanged after deprotection of the xanthate groups. The percentage of xanthate 
groups deprotected in the aqueous nanoparticle suspensions were as follows: G0 = 42.5%;  
G1 = 71.5%; G2 = 84.7%; and G3 = 89.7% (
1
H NMRs Fig. 4.5 and S4.1-4.3).  
 
Fig. 4.5 
1
H NMR (400MHz, CDCl3) of p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38] lyophilised deprotected 
nanoparticle dispersion 
This correlates well with the variation in ζ measured for the nanoparticles, Fig. 4.6, although 
it is unclear whether some hydroxide binding would be expected in the absence of xanthate 
functional groups and whether some penetration of the n-butylamine into the nanoparticle 
occurred prior to freeze-drying. 
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Fig. 4.6 Correlation between % of xanthate groups deprotected and zeta potential of nanoprecipitate suspensions 
 
4.3 Post-polymerisation modification of p[(Xan1-G0)-nBMA100-co-EGDMA0.7] with 
PEG(2K) acrylate 
In order to increase the steric stability of nanoparticles in water following deprotection of the 
xanthate peripheral groups, a PEG functional group may be added at the periphery of the 
polymer samples. PEG groups sterically stabilise nanoparticles in water when formed by 
rapid nanoprecipitation. In order to investigate the impact of PEG chains at the nanoparticle 
surface, branched G0 initiated HPD p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] was 
subjected to partial post-polymerisation modification with PEG(2K) acrylate, applying 1 
equivalent of n-butylamine per xanthate group for deprotection, as calculated in Chapter 3 
from the pseudo-calibration curve (Fig. 3.30A), followed by addition of a slight excess of 
PEG(2K) acrylate (1.5 equiv.) per deprotected xanthate, Scheme 4.1. A PEG(2K) content of 
25%, 50%, 75% and 100% was targeted during the post-polymerisation modification of G0 
xanthate functional HPD [36]. 
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Scheme 4.1 Post-polymerisation modification of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36]  
with PEG(2K) acrylate 
The resulting polymers contained 22%, 49%, 70% and >99% of PEG(2K) groups at the 
periphery respectively, as calculated via 
1
H NMR end group analysis using the characteristic 
CH3 end group resonance at δ = 3.38 ppm and the backbone resonance at δ = 3.63-3.66 ppm 
of the PEG(2K) groups, calibrated against the nBMA polymer signal at δ ≈ 0.8-1.1 ppm, 
which remains unchanged after post-polymerisation modification (Fig. 4.7 and Fig. S4.5-
S4.7). 
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Fig. 4.7 
1
H NMR (400MHz, CDCl3) of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] following partial 
modification with 49% of PEG(2K) groups 
 
4.3.1 Aqueous nanoprecipitation studies of branched polymers with varying PEG 
functionality 
A nanoprecipitation approach was utilised to assess the ability of these PEG(2K) post-
polymerisation functionalised HPDs to form stable nanoparticles in water. The polymers 
were dissolved in acetone or THF at an initial concentration of 5 mg/mL, then rapidly added 
to water, with stirring. The solvent was allowed to evaporate overnight resulting in 
nanoparticle dispersions with a final concentration of 1 mg/mL of polymer in water. The 
nanoparticles were analysed primarily by DLS, as summarised in Table 4.2, below. 
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Table 4.2 DLS measurement data for partially PEG(2K) functionalised G0 HPD polymers 
PEG(2K) end groups (mol%) 
Solvent 
acetone THF 
Dz (nm) PdI Dz (nm) PdI 
22 135 0.058 184 0.023 
49 108 0.042 145 0.042 
70 86 0.054 114 0.056 
>99 66 0.077 89 0.085 
The data in Table 4.2 shows that increasing the molar percentage of PEG end-groups results 
in an overall decrease in Dz of the resulting nanoparticles. This effect can be clearly seen 
when comparing the size distribution by intensity traces of each sample, Fig. 4.8 and results 
from the rapid attainment of steric stability during the growth of the nanoprecipitates. When 
steric stability is achieved, the growth of the individual nanoparticles ceases; the higher the 
density of PEG chains, the earlier in the growth stage this is achieved. Additionally, a 
difference in the final nanoparticle size was observed when using the different solvents; an 
observation which has been reported previously.
20
 This is not widely understood but it is 
believed to result from the different rates of diffusion and mixing of the water-miscible 
solvents, and the ability of the solvent/water mixture to swell the particles and modify the 
particle formation process. 
A) 
 
B) 
 
Fig. 4.8 DLS size distribution by intensity traces of aqueous nanoparticle dispersions of p[(Xan1-G0)-nBMA100-
co-EGDMA0.7];[36] post-functionalised with PEG(2K) acrylate, containing 22%, 49%, 70% and >99% of 
PEG(2K) groups, nanoprecipitated from; A) acetone and B) THF (correlograms Fig. S4.8) 
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4.3.2 Probing accessible xanthate groups of PEG-functionalised HPDs 
The PEG stabilised xanthate functional HPDs, synthesised by post-polymerisation 
modification of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] with varying degrees of 
PEG(2K) acrylate, were nanoprecipitated into water from acetone and the solvent left to 
evaporate with stirring overnight at ambient temperature. After this time, an excess of  
n-butylamine (50 mol. equiv.) was added to the nanoparticle dispersions, and then left to stir 
for 24 hours. The nanoparticle suspensions were rapidly frozen in liquid nitrogen and 
lyophilised for 72 hours to remove the water and excess n-butylamine. The resulting polymer 
monoliths were dissolved in deuterated chloroform (CDCl3) and analysed by 
1
H NMR 
spectroscopy. The percentage of remaining xanthate groups was calculated using the 
characteristic CH2 resonance at 4.64 ppm, calibrated against the polymer signal at δ ≈ 0.8-1.1 
ppm, which remains unchanged after deprotection of the xanthate groups, Fig. 4.9 (Fig. S4.9 
and S4.10). 
 
Fig. 4.9 
1
H NMR (400MHz, CDCl3) of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], partially post-modified 
with 49% of PEG(2K) groups, lyophilised deprotected nanoparticle dispersion 
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The data for the number of xanthate groups (mol%) deprotected in the aqueous nanoparticle 
suspensions are summarised in Table 4.3, below. 
Table 4.3 Xanthate groups deprotected in aqueous suspension
a 
PEG(2K) end groups 
(mol%) 
Initial xanthate end 
groups (mol%) 
Final xanthate end 
groups (mol%) 
Xanthate groups 
deprotected (% of initial) 
22 78 49 38 
49 51 42 18 
70 30 28 8 
aDetermined by 1H NMR spectroscopy (400 MHz) in CDCl3 
 
Increasing numbers of PEG(2K) end groups results in decreasing numbers of xanthate groups 
accessible to deprotection by excess n-butylamine in aqueous nanoparticle suspension. This 
could be due to the interior of the particles being less permeable to n-butylamine as the 
internal PEG concentration increases.
14
 It may also be due to less xanthate groups being 
expressed on the surface of the particles, and are therefore inaccessible to deprotection. There 
may also be a decrease in reaction rates between n-butylamine and surface xanthates in the 
presence of increasing numbers of PEG groups.  
Although nanoparticles containing the least amount (22 mol%) of PEG(2K) end groups 
remained stable, a higher percentage of PEG groups are expected to be required at the surface 
for functional group isolation to obtain the desired “patchy” and “statistical” distributions of 
surface groups.  
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4.4 Utilisation of co-initiation to generate mixed functionality polymers 
The co-initiation of dendron and PEG-derived macroinitiators to form highly branched 
macromolecular architectures with tuneable surface chemistry has recently been reported by 
Hatton et al.
14
 Varying the ratio of the initiator feeds results in polymers which form highly 
uniform nanoparticles by nanoprecipitation, with varying surface and internal chemistry. 
These early studies highlight the potential for moderating permeation of nanoparticles 
through a model human gut epithelium. Understanding the mechanisms involved in 
multifunctional material synthesis and subsequent nanoparticle formation allows us to have 
better control over physicochemical properties and interaction behaviour with biological 
targets within the body. 
We hypothesise that co-initiation of PEG and dendron macroinitiators of varying generations 
may also result in functional group isolation or the formation of “patches” of functionality 
within nanoprecipitates and may offer a simpler route to control the chain end composition of 
HPDs. In order to induce functional group isolation, and hence, patchiness on the surface of 
resulting nanomaterials, a large proportion of PEG groups is expected to be required at the 
periphery. This may be achieved by tailoring the initiator feed during co-initiated HPD 
synthesis, with a large mole percentage of chain ends as PEG chains. 
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4.4.1 PEG(2K) macroinitiator synthesis 
Monomethoxy PEG (Mn ~ 2000 g mol
-1
) was converted into an ATRP macroinitiator via 
esterification with α-bromoisobutyryl bromide, Scheme 4.2.21 The use of monomethoxy PEG 
circumvents crosslinking and allows selective activation and reaction of one end of the PEG 
chain. 
 
Scheme 4.2 PEG(2K) macroinitiator synthesis 
Initiator formation was confirmed by 
1
H NMR spectroscopy, with integrals of the terminal 
methyl environment (δ ≈ 3.33 ppm) and the two symmetrical methyl environments of the 
bromoisobutyrate moiety (δ ≈ 1.91 ppm) in a 3:6 ratio, as expected, Fig. 4.10 (13C NMR 
analysis Fig. S4.11). 
 
Fig. 4.10 
1
H NMR (400 MHz, D2O) of [PEG(2K)-BiB];[131] 
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4.4.2 Linear polymer synthesis 
 
Scheme 4.3 Linear polymerisation with [PEG(2K)-BiB];[131] macroinitiator 
The [PEG(2K)-BiB];[131] initiator was used to polymerise nBMA in a linear polymerisation 
to establish confidence in the conditions used for HPD co-initiated polymerisations, initially 
targeting a DPn of 100 monomer units, p[(PEG(2K))-nBMA100];[132]. The polymerisation 
was carried out at 60°C in methanol with a CuCl:bpy (1:2) catalyst system and a monomer 
concentration of 50 v/v% with respect to solvent. Polymerisation kinetics studies were carried 
out by sampling the reaction (approx. 0.2 mL) at regular intervals and diluting in CDCl3 for 
1
H NMR studies and DMF for SEC analysis.  
The semi-logarithmic plot (ln([M0]/[M])) for p[(PEG(2K))-nBMA100];[132] reveals a slight 
deviation from the expected linear time dependency, indicating a variation in radical 
concentration during the polymerisation, Fig. 4.11A. This is indicative of the persistent 
radical effect (PRE); the radical initiation rate of another species, e.g. the monomer itself, is 
much lower than the dissociation rate of the transition metal catalyst, and the polymerisation 
is therefore self-regulating.
22
 Termination early in the polymerisation leads to a build-up of 
deactivated species. The polymerisation equilibrium is therefore shifted towards the dormant 
species and the radical concentration is lowered. Despite this, high conversion (>80%) was 
achieved within 7 hours, and the polymerisation was terminated at 28 hours (94% 
conversion).  
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A) B) 
  
Fig. 4.11 Kinetic studies of the ATRP of nBMA p[(PEG(2K))-nBMA100];[132]: A) Conversion vs. time (open 
triangles) with corresponding semi-logarithmic plots (closed black circles); dashed line represents linear 
regression of semi-logarithmic plot; B) Mn vs. conversion (closed black squares) with theoretical Mn vs. 
conversion (solid line) and Ð (open circles). 
The refractive index increment (dn/dc) quantifies the change in refractive index of a solution 
with concentration of the analyte. Due to the difference in dn/dc values of PEG and 
p(nBMA), the evolution of dn/dc of the block copolymer was studied as the polymerisation 
progressed. The fraction of each monomer in a copolymer system can be estimated if the 
dn/dc values of the two monomers vary significantly; above a certain molecular weight, the 
effect of end groups is negligible and the dn/dc of the homopolymer is constant. 
(
𝑑𝑛
𝑑𝑐
)
𝑐𝑜𝑝𝑜𝑙𝑦𝑚𝑒𝑟
=  (𝑊𝑃𝐸𝐺 × (
𝑑𝑛
𝑑𝑐
)
𝑃𝐸𝐺
) + ((1 − 𝑊𝑃𝐸𝐺) × (
𝑑𝑛
𝑑𝑐
)
𝑝(𝑛𝐵𝑀𝐴)
)    (Eq. 4.1) 
For each kinetic time point, the weight fraction of PEG, WPEG, was calculated using the 
theoretical Mn by 
1
H NMR analysis. A theoretical (dn/dc)copolymer was then calculated using 
Eq 4.1 for each kinetic time point (average (dn/dc)PEG and (dn/dc)p(nBMA) obtained from 
published literature
23
). The value of dn/dc is expected to vary systematically as the p(nBMA) 
portion of the copolymer chain increases throughout the polymerisation. The calculated 
(dn/dc)copolymer value for each time point was then input into the SEC analysis software by 
editing the method to obtain more accurate values for Mn and Mw, and the corrected values of 
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Mn plotted against conversion, Fig. 4.11B, to produce a corrected kinetic plot for molecular 
weight evolution.
24
 Molecular weight (Mn) evolves linearly with conversion, as expected, and 
Ð remains low (<1.23) throughout the polymerisation, despite a non-linear semi-logarithmic 
plot, suggesting very little impact on the control of the polymerisation from the varying 
radical concentration indicated. 
A linear polymerisation combining both PEG(2K) and xanthate functional G3 macroinitiators, 
at a xanthate:PEG functional group molar ratio of 1:1 (initiator molar ratio G3 dendron:PEG 
of 0.125:0.875) was studied to ascertain whether the mixed initiator functionality would 
affect the polymerisation adversely. The resulting mixed polymer sample contained linear 
polymers bearing either PEG(2K) or G3 dendron functionalities at one chain-end. During 
branched ATRP, the different chain-end functionalities are expected to be statistically 
incorporated into the growing branched macromolecules at the nominal molar ratio of 
initiators used. A difference in initiation or polymerisation during ATRP in the presence of 
both initiators would be evidenced by two distinct populations in the SEC chromatogram of 
the resulting polymer or a marked broadening of the molecular weight distribution. Data 
obtained from polymerisations containing 100:0, 12.5:87.5 and 0:100 G3 dendron:PEG(2K) 
initiators are summarised in Table 4.4 and the RI traces shown in Fig. 4.12. 
Table 4.4 Triple detection SEC data for linear polymers with [Xan8-G3-BiB];[23] and [PEG(2K)-BiB];[131] 
macroinitiators 
Sample name 
Initiator (mol%) 
Conv. 
(%)
a
 
SEC 
G3 
dendron 
PEG(2K) 
Mn 
(g mol
-1
) 
Mw 
(g mol
-1
) 
Ð 
p[(Xan8-G3)-nBMA100];[35] 100 0 84 26 600
b
 31 800
b
 1.19
b
 
p[(PEG(2K))0.875-(Xan8-G3)0.125-
nBMA100];[133] 
12.5 87.5 95 17 600
c 
22 600
c 
1.28
c 
p[(PEG(2K))-nBMA100];[132] 0 100 94 13 400
b
 14 500
b
 1.08
b
 
a Determined by 1H NMR analysis in CDCl3 
bSample analysed in DMF containing 0.01 M LiBr at 60°C, 1mL min-1 flow rate. 
cSample analysed in THF containing 2% TEA (v/v) at 35°C, 1 mL min-1 flow rate. 
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The molecular weights of these linear polymers appear to increase with increasing G3 
initiator content. This would suggest that [PEG(2K)-BiB];[131] has a much better initiator 
efficiency than [Xan8-G3-BiB];[23], thus decreasing the number average molecular weight of 
the resulting polymer sample. Decreased initiator efficiency, conversely, results in less 
polymer chains in the sample, with a higher number average molecular weight. The linear 
polymerisation conducted with mixed initiators has a molecular weight between the two 
single initiator polymerisations, which can be easily seen in the SEC chromatogram overlay 
in Fig. 4.12. Additionally, indications of a residual dendron initiator are also present in the 
SEC chromatogram of p[(Xan8-G3)-nBMA100];[35], also supporting the possibility of 
reduced initiator efficiency in this case. 
 
Fig. 4.12 SEC chromatogram overlay (refractive index) of p[(Xan8-G3)-nBMA100];[35] (blue), p[(PEG(2K))-
nBMA100];[132] (red) and p[(PEG(2K))0.875-(Xan8-G3)0.125-nBMA100];[133] (green) 
The 
1
H NMR spectrum of p[(Xan8-G3)-nBMA100];[35] LDH is shown in Chapter 2, Fig. 
S2.58, with major peaks assigned. The 
1
H NMR spectrum of p[(PEG(2K))0.875-(Xan8-
G3)0.125-nBMA100];[133] co-initiated linear polymers is shown in Fig. 4.13. Integrals 
corresponding to the xanthate functional group (CH2 δ ≈ 4.64 ppm, peak 7 Fig. 4.13) and the 
PEG chain end (terminal methyl δ ≈ 3.33 ppm, peak 8 Fig. 4.13) confirm a nominal chain-
end functional group molar ratio of 0.125:0.875 of G3 dendron:PEG(2K), as targeted. 
Retention volume (mL)
17 18 19 20
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Fig. 4.13 
1
H NMR (400 MHz, CDCl3) of p[(PEG(2K))0.875-(Xan8-G3)0.125-nBMA100];[133] 
 
4.4.3 Branched polymer synthesis 
The co-initiated branched copolymerisation of nBMA and EGDMA with xanthate functional 
G0 or G3 dendron initiators ([Xan1-G0-BiB];[20] and [Xan8-G3-BiB];[23]) and PEG(2K) 
macroinitiator ([PEG(2K)-BiB];[131]) was carried out, targeting a range of functional chain-
end molar ratios. The targeted DPn of the primary polymer chains was maintained at 100 
monomer units, with an initiator:brancher ratio of 1:0.8. 
 
4.4.3.1 G0 dendron and PEG(2K) co-initiated HPDs 
G0 and PEG macroinitiator ratios of 1:99, 7.5:92.5 and 10:90 were targeted for the co-
initiated copolymerisation of nBMA and EGDMA. Methanolic ATRP was carried out as 
previously described (see section 2.8.5.2) with a CuCl:bpy (1:2) catalyst system, at a 
concentration of 50 v/v% relative to the monomer. The targeted DPn of nBMA was kept 
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constant (DPn = 100 monomer units), as was the initiator:brancher ratio (1:0.8). The 
molecular weights of the resulting polymers are summarised in Table 4.5. Inclusion of 
bifunctional monomer EGDMA resulted in branched polymers with high molecular weights 
and a broad Ð, as previously reported in the published literature
14,15,20,25
 and in Chapter 2. 
Due to the incorporation of a long chain PEG initiator, the resulting polymers were analysed 
by SEC in a dimethylformamide (DMF) eluent system at 60°C with 0.01 M LiBr (to 
minimise any polyelectrolyte effects), utilising triple detection. 
Table 4.5 Triple detection SEC data of G0/PEG co-initiated HPDs, with corresponding linear polymers 
Entry 
no. 
Initiator (mol%) 
Target polymer 
composition 
Conv. 
(%)
a 
SEC (DMF)
b 
G0 dendron PEG(2K) 
Mn 
(g mol
-1
) 
Mw 
(g mol
-1
) 
Ð 
1 100 0 p(nBMA)100 95 21 700 26 400 1.21 
2 0 100 p(nBMA)100 94 13 400 14 500 1.08 
        
3 1 99 p(nBMA)100-co-EGDMA0.8 99 43 100 283 000 6.56 
4 7.5 92.5 p(nBMA)100-co-EGDMA0.8 94 36 400 216 200 5.94 
5 10 90 p(nBMA)100-co-EGDMA0.8 98 41 600
c
 149 600
c 
3.60
c
 
aDetermined by 1H NMR analysis in CDCl3
 bDMF containing 0.01 M LiBr at 60°C, 1mL min-1 flow rate. cSample analysed 
in THF containing 2% TEA (v/v) at 35°C, 1mL min-1 flow rate. 
 
Despite the differing chain-end molar ratios, the G0/PEG(2K) co-initiated HPDs had 
relatively similar molecular weights, presumably as the polymerisation is dominated by the 
PEG(2K) initiator, [131]; the major component in the co-initiation mixture in all cases. An 
approximation of the average number of conjoined chains was determined by utilising the 
PEG(2K) initiated linear polymers and dividing the Mn and Mw values into the values 
determined for the branched polymer materials. As the mole percentage of G0 dendrons 
increases, the number average number of conjoined chains remains approximately 3-3.5 
primary chains, whilst the weight average number of chains varies progressively from 19.5 
primary chains to 15 primary chains and finally 10.5 chains. 
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4.4.3.2 G3 dendron and PEG(2K) co-initiated HPDs 
A series of branched p(nBMA) polymers with G3 dendron and PEG(2K) initiator molar ratios 
of 1:99, 1.4:98.6 and 5:95 (with relative xanthate:PEG functional group molar ratios of 
approximately 7.5:92.5, 10:90 and 30:70) were synthesised. A targeted DP100 for the 
p(nBMA) primary chains was maintained, as was the initiator:brancher ratio (1:0.8). The 
molecular weights of the resulting polymers are summarised in Table 4.6. 
Table 4.6 Triple detection SEC data of G3/PEG co-initiated HPDs, with corresponding linear polymers 
Entry 
no. 
Initiator (%) 
Target polymer 
composition 
Conv. 
(%)
a SEC (DMF)
b
 
G3 dendron PEG(2K)  
Mn 
(g mol
-1
) 
Mw 
(g mol
-1
) 
Ð 
1 100 0 p(nBMA)100 84 26 600
 
31 800 1.19 
2 12.5 87.5 p(nBMA)100 95 17 600
c 
22 600
c 
1.28
c 
3 0 100 p(nBMA)100 94 13 400 14 500 1.08 
        
4 1 99 p(nBMA)100-co-EGDMA0.8 97 39 200 235 700 6.01 
5 1.4 98.6 p(nBMA)100-co-EGDMA0.8 99 39 900
c
 185 700
c
 4.66
c
 
6 5 95 p(nBMA)100-co-EGDMA0.8 98 37 200 190 400 5.12 
aDetermined by 1H NMR analysis in CDCl3
 bDMF containing 0.01 M LiBr at 60°C, 1mL min-1 flow rate. cSample analysed 
in THF containing 2% TEA (v/v) at 35°C, 1mL min-1 flow rate. 
 
As seen previously, the G3/PEG(2K) co-initiated polymerisations appear to be dominated by 
the PEG(2K) initiator, resulting in similar molecular weights in all cases, and closely 
resembled the molecular weights achieved for the G0 co-initiated materials (Table 4.5). The 
resulting branched polymers, although tailored to maintain the same xanthate functional 
group molar ratios as the G0 initiated polymers (xanthate:PEG 7.5:92.5 and 10:90, section 
4.4.3.1), contain a larger molar proportion of PEG chain-ends; this is due to each G3 dendron 
initiator possessing eight xanthate functional groups at the periphery. In this case, the number 
average number of conjoined primary chains was again maintained at approximately 3 
chains, but due to the lower mole percentage of the G3 dendron macroinitiator used, the 
weight average number of conjoined chains only varied from 16 to 13 over these materials. 
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4.5 Probing the distribution of functional groups at the surface 
Taking advantage of the ability to easily generate thiols on the surface of co-initiated HPDs 
by deprotection of xanthate groups, it may be possible to coordinate GNPs on the surface of 
thiol-functional nanoprecipitates due to their high binding affinity. Altered distributions of 
GNPs would indicate the patchy nature of the surface functional groups. In order to probe the 
distribution of thiols, small GNPs are required to diffuse through the peripheral PEG chains 
and bind with free thiols at the surface of the nanoparticles. The size range of the GNPs also 
needs to be on a scale to allow multiple GNPs to group around a single G3 dendron site to 
allow visualisation of the patches of multiple thiol functional groups. 
 
4.5.1 Modelling of dendron initiators 
Computational estimates were used to determine the optimum size of GNPs required to 
diffuse through peripheral PEG chains of the polymer nanoparticle, and bind with free thiols 
at the surface. The surface area of a thiol functional G3 dendron at the chain-end of a short 
p(nBMA) chain (DP9) was calculated using Avogadro v1.2.0 molecular modelling software, 
Fig. 4.14.
26
 
 
Fig. 4.14 Molecular modelling of p(nBMA9) with thiol-functional G3 dendron chain-end 
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It was found that the span of the thiol-functional G3 dendron site in vacuum measured 23 Å in 
total, Fig. 4.15. This is may be an over-estimation of the G3 dendron site span in the  
co-initiated HPD structures, which present a high density of functional groups at the surface; 
this is likely to result in a contraction of the dendron sites located between large, hydrated 
PEG chain-ends in aqueous nanoprecipitates. 
 
Fig. 4.15 Molecular modelling of G3 dendron site on p(nBMA9), marking the maximum distance between thiol 
functional groups at the periphery (23 Å) 
The distance between neighbouring branches in the G3 dendron chain-end was measured at 
13 Å, Fig. 4.16. 
 
Fig. 4.16 Molecular modelling of G3 dendron site on p(nBMA9), marking the distance between thiol functional 
groups on adjacent branches at the periphery (13 Å) 
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From the measurements obtained from the molecular modelling projections, it was decided 
that GNPs on the scale of <5 nm were required to penetrate the PEG corona of the 
nanoprecipitates and bind with free thiols on the surface. The relative size of 3 nm GNPs, the 
total span of the modelled G3 dendron site, and distance between adjacent branches were 
compared to see whether binding of multiple GNPs was possible, Fig. 4.17. 
 
Fig. 4.17 Relative size of 3 nm GNPs (gold) and G3 dendron site of p(nBMA); maximum span (blue) of 2.3 nm 
and adjacent branches (green) of 1.3 nm 
The relative size of 3 nm GNPs, overlaid with the molecular modelling projection of the G3 
dendron site (oriented end-on), gives an idea of how many thiols may simultaneously bind 
with the individual GNPs, Fig. 4.18. 
 
Fig. 4.18 Molecular modelling of G3 dendron site of p(nBMA), overlaid with relative size of 3 nm GNPs 
3nm
2.3nm
1.3nm
3nm
2.3nm
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From the molecular modelling projections, it appears that it may be possible to cluster up to 
three GNPs on a single thiol-functional G3 dendron site. We would expect to see only one 
GNP bound per thiol-functional G0 dendron site, however, due to the statistical distribution of 
G0 chain-ends on the surface of resulting nanoprecipitates, groups of two or even three GNPs 
may be possible. For a G3 dendron, we could see one GNP bound as the nanoparticle could 
dominate the dendron; two bound particles would be possible, and even up to three from a 
single dendron; four and above bound GNPs may be possible for G3 dendrons in statistically 
close proximity on the surface. Higher than four or five bound GNPs would be unlikely, 
however. 
Molecular modelling has been applied to study the packing of small GNPs around a G3 
dendron site; the relative size of an average polymer nanoparticle (65 nm), a G3 dendron site 
(2.3 nm) and a 3 nm GNP has been represented here to assess the ability to visualise the 
different arrangements of GNPs on the polymer nanoparticle surfaces with differing spatial 
arrangements of functional groups by TEM, Fig. 4.19. 
 
Fig. 4.19 Relative size of 65 nm polymer nanoparticle (purple), 2.3 nm G3 dendron site (red)  
and 3 nm GNP (gold) 
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4.5.2 Coordination of GNPs to thiol-functional co-initiated HPDs 
Small GNPs (approximately 3 nm) were coordinated to the surface of thiol-functional 
nanoprecipitated HPDs by stirring in solution for 24 hrs. The electron density of the GNPs 
allowed the application of TEM to image the resulting nanomaterials. 
 
4.5.2.1 3 nm GNP synthesis 
Combined citrate and tannic acid stabilised GNPs, approximately 3 nm in diameter, were 
synthesised via the Inverse Turkevich method
27
, as outlined in literature
28
 by Mr Alex Hill of 
the Brust research group at the University of Liverpool. The resulting particles were analysed 
by UV-Vis spectroscopy and TEM to determine their size. A summary of the GNP 
characterisation is included in the appendix (Fig. S4.12 and S4.13). 
 
4.5.2.2 Confirming availability of thiols at the surface 
In order to confirm thiol groups are available on the surface, the co-nanoprecipitation of 
100% thiol-functional and 99:1 PEG:thiol functional branched polymers was carried out. 
Xanthate functional polymers p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] and 
p[(PEG(2K))0.99-(Xan1-G0)0.01-nBMA100-co-EGDMA0.8];[134] were deprotected with 
excess n-butylamine (20 equiv.) at room temperature for 1.5 hours, to generate thiols in situ. 
The thiol-functional polymers were then co-nanoprecipitated from acetone at a combined 
initial concentration of 5 mg/mL (1:1 ratio of [36]:[134]) into water at ambient temperature 
with stirring. The acetone was allowed to evaporate overnight and the resulting nanoparticle 
suspension (1 mg/mL) analysed initially by DLS (Entry 2 Table 4.7). 3 nm GNPs were added 
to the polymer nanoparticle suspension at a 1:9 ratio (v/v) of polymer:GNP, and left to stir for 
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24 hours. The resulting nanomaterials were analysed by DLS, summarised in Table 4.7 and 
TEM, Fig. 4.20, below. 
Table 4.7 DLS measurement data for co-nanoprecipitated 100% thiol- and 99:1 PEG:thiol-functional polymers 
Entry Polymer Dz (nm) PdI 
1 
p[(Xan1-G0)-nBMA100-co-EGDMA0.7]/ 
p[(PEG(2K))0.99-(Xan1-G0)0.01-nBMA100-co-EGDMA0.8] 
95 0.072 
    
2 
p[((SH)1-G0)-nBMA100-co-EGDMA0.7]/ 
p[(PEG(2K))0.99-((SH)1-G0)0.01-nBMA100-co-EGDMA0.8] 
75 0.073 
    
3 
p[((SH)1-G0)-nBMA100-co-EGDMA0.7]/ 
p[(PEG(2K))0.99-((SH)1-G0)0.01-nBMA100-co-EGDMA0.8] + 3 nm GNPs 
79 0.094 
 
  
Fig. 4.20 TEM images (3 mm Cu(holey carbon) grids) of co-nanoprecipitated thiol-functional polymers p[((SH)1-G0)-
nBMA100-co-EGDMA0.7] and p[(PEG(2K))0.99-((SH)1-G0)0.01-nBMA100-co-EGDMA0.8], with coordinated 3 nm GNPs 
It is evident from the TEM images (Fig. 4.20) that thiols of the co-nanoprecipitated polymers 
are available at the surface to bind with GNPs in aqueous suspension. This can be seen from 
clusters of GNPs (dark spots in images) across the surface of what is assumed to be the 
polymer nanoparticles. The sizes of polymer nanoparticles in the images correspond well 
with the nanoparticle diameter obtained via DLS, providing more confidence that these 
slightly darker regions on the TEM grids are polymer nanoparticles. Staining was not used to 
image the polymer nanoparticles as the resolution of the individual gold nanoparticles was 
the aim of this study. 
100 nm 100 nm
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4.5.2.3 Probing nanoprecipitates formed from co-initiated HPDs with a statistical 
distribution of xanthate functional groups 
Co-initiated HPDs with a statistical distribution of xanthate functional groups, 
p[(PEG(2K))0.99-(Xan1-G0)0.01-nBMA100-co-EGDMA0.8];[134], p[(PEG(2K))0.925-(Xan1-
G0)0.075-nBMA100-co-EGDMA0.8];[135] and p[(PEG(2K))0.9-(Xan1-G0)0.1-nBMA100-co-
EGDMA0.8];[136], were deprotected with excess n-butylamine, and nanoprecipitated from 
acetone into water to give nanoparticles with a final concentration of 1 mg/mL. The resulting 
nanoparticles were analysed by DLS, summarised in Table 4.8. 3 nm GNPs were added at a 
1:9 ratio (v/v) of polymer:GNP suspensions, and the mixture left to stir for 24 hrs. The 
nanoparticles were analysed by DLS, Table 4.8, and TEM, Fig 4.21. 
Table 4.8 DLS measurement data for nanoprecipitated deprotected statistical polymers [134], [135] and [136],  
+ with coordinated 3 nm GNPs 
Polymer Dz (nm) PdI 
p[(PEG(2K))0.99-((SH)1-G0)0.01-nBMA100-co-EGDMA0.8] 53 0.128 
p[(PEG(2K))0.925-((SH)1-G0)0.075-nBMA100-co-EGDMA0.8] 52 0.083 
p[(PEG(2K))0.9-((SH)1-G0)0.1-nBMA100-co-EGDMA0.8] 65 0.097 
   
p[(PEG(2K))0.99-((SH)1-G0)0.01-nBMA100-co-EGDMA0.8] + 3 nm GNPs 60 0.230 
p[(PEG(2K))0.925-((SH)1-G0)0.075-nBMA100-co-EGDMA0.8] + 3 nm GNPs 64 0.224 
p[(PEG(2K))0.9-((SH)1-G0)0.1-nBMA100-co-EGDMA0.8] + 3 nm GNPs 74 0.235 
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A) 
  
B) 
  
C) 
  
Fig. 4.21 TEM images of HPD nanomaterials with a statistical distribution of thiols, with coordinated 3 nm 
GNPs, with thiol:PEG functional group molar ratios of; A) 1:99, B) 7.5:92.5 and C) 10:90. 
The GNPs appear to be generally evenly distributed across the surface of the polymer 
nanoparticles, with some cases of grouping seen where it is assumed that G0 sites are located 
in close proximity due to their statistical distribution (Fig. 4.21). This is seen more 
prominently for nanoparticles with a higher thiol content (10:90 thiol:PEG, Fig. 4.21C), as 
there is greater probability of G0 sites being located close together. The GNPs may also have 
bound on the “top” or “bottom” of the particle, relative to the TEM grid, and appear close 
together due to the transmission of the electron beam through the sample.  
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4.5.2.4 Probing nanoprecipitates formed from co-initiated HPDs with a patchy 
distribution of xanthate functional groups 
Co-initiated HPDs with a patchy distribution of xanthate functional groups, p[(PEG(2K))0.99-
(Xan8-G3)0.01-nBMA100-co-EGDMA0.8];[137], p[(PEG(2K))0.986-(Xan8-G3)0.014-nBMA100-
co-EGDMA0.8];[138] and p[(PEG(2K))0.95-(Xan8-G3)0.05-nBMA100-co-EGDMA0.8];[139], 
were deprotected with excess n-butylamine, and nanoprecipitated from acetone into water to 
give nanoparticles with a final concentration of 1 mg/mL. The resulting nanoparticles were 
analysed by DLS, summarised in Table 4.9. 3 nm GNPs were added at a 1:9 ratio (v/v) of 
polymer:GNP suspensions, and the mixture left to stir for 24 hrs. The nanoparticles were 
analysed by DLS, Table 4.9, and TEM, Fig 4.22. 
Table 4.9 DLS measurement data for nanoprecipitated deprotected patchy polymers [137], [138] and [139],  
+ with coordinated 3 nm GNPs 
Polymer Dz (nm) PdI 
p[(PEG(2K))0.99-((SH)8-G3)0.01-nBMA100-co-EGDMA0.8] 51 0.105 
p[(PEG(2K))0.986-((SH)8-G3)0.014-nBMA100-co-EGDMA0.8] 61 0.141 
p[(PEG(2K))0.95-((SH)8-G3)0.05-nBMA100-co-EGDMA0.8] 52 0.101 
   
p[(PEG(2K))0.99-((SH)8-G3)0.01-nBMA100-co-EGDMA0.8] + 3 nm GNPs 54 0.124 
p[(PEG(2K))0.986-((SH)8-G3)0.014-nBMA100-co-EGDMA0.8] + 3 nm GNPs 66 0.190 
p[(PEG(2K))0.95-((SH)8-G3)0.05-nBMA100-co-EGDMA0.8] + 3 nm GNPs 56 0.101 
 
 
 
CHAPTER 4 
237 
 
A) 
  
B) 
  
C) 
  
Fig. 4.22 TEM images of HPD nanomaterials with a patchy distribution of thiols, with coordinated 3 nm GNPs, 
with thiol:PEG functional group molar ratios of; A) 7.5:92.5, B) 10:90 and C) 30:70. 
In the case of particles possessing a thiol:PEG ratio of 7.5:92.5 and 10:90 (Fig. 4.22A and 
4.22B), the GNPs appear to be clustered on the surface of the polymer nanoparticles. This 
effect is less prominent for particles with a higher thiol:PEG ratio of 30:70 (Fig. 4.22C), 
where GNPs appear to be statistically distributed across the surface, with some evidence of 
clustering. The clusters of GNPs suggest multiple particles binding to an area with a higher 
concentration of thiol functional groups, likely to be originating from G3 dendron sites. 
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TEM studies of GNP binding on HPD nanoprecipitates with statistical (G0 chain-ends,  
Fig. 4.21) and patchy (G3 chain-ends, Fig. 4.22) distributions of thiol groups demonstrated 
observable differences in the spatial arrangement of surface functional groups. Comparing the 
clustering of GNPs on the surface of particles derived from p[(PEG(2K))0.9-((SH)1-G0)0.1-
nBMA100-co-EGDMA0.8] and p[(PEG(2K))0.986-((SH)8-G3)0.014-nBMA100-co-EGDMA0.8] 
comprising a nominal 10 mole % thiol functionality relative to total chain-ends (Fig. 4.21C 
and 4.22B, respectively) allowed quantification of the different sized clusters; GNPs were 
considered clustered when ≥two particles were visibly touching. In all samples, isolated 
single GNPs were the most common species, however higher order clusters (≥two GNPs) 
were frequently seen. Quantification of the number of clusters, containing one to ≥four GNPs 
showed a considerable bias towards clusters of ≥two GNPs within G3-initiated materials  
(Fig. 4.23 and 4.24). 
For the G0-initiated samples, 1193 individual GNPs were observed as either single isolated 
GNPs (820; 68.7%) or clusters containing two (258 total; 21.6%), three (99 total; 8.3%) or 
≥four (16 total; 1.3%) GNPs, Fig. 4.23. Similar observation of 572 individual GNPs within 
the G3-initiated samples shows a markedly different distribution, observed as single isolated 
GNPs (231; 40.4%), or clusters containing two (220 total; 38.5%), three (93 total; 16.3%) and 
≥four (28 total; 4.9%) GNPs, Fig. 4.23. This strongly suggests that GNPs were nearly equally 
likely to be part of a clustered pair on G3-containing nanoprecipitates as they were to be 
isolated as single GNPs; in comparison, GNPs on G0-containing nanoprecipitates are less 
than a third as likely to be in clustered pairs than isolated on the surface. GNPs were nearly 
twice as likely to be present in clusters of three, and >3.5 times as likely to be in clusters of 
≥four GNPs within the G3-containing samples than the comparative G0-containing 
nanoprecipitates. 
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Fig. 4.23 GNP clustering on co-initiated HPD nanoprecipitates containing statistical (G0, blue) and patchy  
(G3, orange) distributions of surface functional groups; GNPs per cluster as a % of total GNPs observed 
An alternative quantification approach treats each cluster as a single entity, normalising the 
percentage of single GNPs and cluster type in each sample, Fig. 4.24. Using this approach, a 
total of 986 GNP-derived entities were observed in the G0 materials, and 379 entities in the 
G3 materials. G0-containing samples showed isolated single GNPs (820; 83.2%), and clusters 
containing two (129; 13.1%), three (33, 3.3%) and ≥four (4; 0.4%) GNPs; corresponding  
G3-containing samples showed isolated single GNPs (231; 60.9%), and clusters containing 
two (110; 29%), three (31; 8.2%) and ≥four (7; 1.8%) GNPs, Fig. 4.24.  
 
Fig. 4.24 GNP clustering on co-initiated HPD nanoprecipitates containing statistical (G0, blue) and patchy  
(G3, orange) distributions of surface functional groups; GNPs per cluster as a % of total entities observed 
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The patchy and statistical materials contain the same molar ratio of thiol and PEG chain-ends 
(10:90), therefore, despite larger numbers of thiol-bearing chain-ends in the G0-initiated HPD 
nanoprecipitates, the G3 dendrons appear to significantly impact GNP clustering; this is 
thought to be due to the additional dendron-directed anisotropic spatial distribution of thiol 
functionality. These observations provide compelling evidence to suggest that it is possible to 
design and synthesise stable nanomaterials with predetermined spatial arrangements of 
functional groups by simple nanoprecipitation. 
The nanoprecipitates and corresponding GNP-coordinated nanoparticle suspensions were re-
analysed by DLS after 1 year storage under ambient conditions, Table 4.10. There were no 
significant changes in Dz or PdI of the nanoparticle suspensions, indicating that they remain 
remarkably stable. The GNPs bound on the surface of the polymer nanoparticles appeared to 
remain stable much longer than the GNP suspension alone; retaining a characteristic red 
colour long after the citrate/tannic acid GNP suspension had aggregated and turned grey, as 
can be seen from the images in the final column of Table 4.10, next to the deprotected G0/G3 
and PEG(2K) co-initiated HPD nanoprecipitates ([134]-[139]). This is, again, remarkable as 
the GNPs are coordinated onto the HPD nanoprecipitate surface which prevents further 
aggregation due to their immobilisation as long as the nanoprecipitates maintain stability. 
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Table 4.10 DLS data for: p[(PEG(2K))x-(Xan1-G0)y-nBMA100-co-EGDMA0.8];[134] (x = 0.99, y = 0.01);[135] 
(x = 0.925, y = 0.075);[136] (x = 0.9, y = 0.1); and p[(PEG(2K))x-(Xan8-G3)y-nBMA100-co-EGDMA0.8];[137] 
(x = 0.99, y = 0.01);[138] (x = 0.986, y = 0.014);[139] (x = 0.95, y = 0.05) nanoprecipitates 1 year stability 
studies at ambient temperature with coordinated 3 nm GNPs 
Material 
Initiator (%) 
GNPs 
Original 1 year 
G0 G3 PEG(2K) Dz PdI Dz PdI 
polymer 
nanoparticle 
suspension 
polymer 
nanoparticle 
suspension 
+ 3 nm GNPs 
[134] 1 0 99 - 53 0.128 56 0.101 
 
[134] 1 0 99  60 0.230 55 0.078 
[135] 7.5 0 92.5 - 52 0.083 56 0.063 
 
[135] 7.5 0 92.5  64 0.224 54 0.082 
[136] 10 0 90 - 65 0.097 65 0.100 
 
[136] 10 0 90  74 0.235 61 0.134 
[137] 0 1 99 - 51 0.105 53 0.094 
 
[137] 0 1 99  54 0.124 60 0.102 
[138] 0 1.4 98.6 - 61 0.141 62 0.107 
 
[138] 0 1.4 98.6  66 0.190 78 0.167 
[139] 0 5 95 - 52 0.101 55 0.065 
 
[139] 0 5 95  56 0.101 56 0.083 
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4.6 Conclusion 
In this chapter, we aimed to synthesise and visualise stable nanoparticulates with differing 
spatial arrangements of functional groups on the surface; patchy and statistical. Compelling 
evidence for achieving these predeterminate and different structures was obtained via 
coordination of small GNPs to thiol functional groups, readily liberated by deprotection of 
xanthate groups under mild basic conditions, and subsequent TEM imaging. Clustering of 
GNPs was seen for nanoparticles possessing a patchy distribution of surface functional 
groups, whereas materials with a statistical distribution of thiols on the surface appeared to 
coordinate 3 nm GNPs statistically across the surface. 
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4.8 Appendix 
 
Fig. S4.1 
1
H NMR (400MHz, CDCl3) of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] lyophilised deprotected 
nanoparticle dispersion 
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Fig. S4.2 
1
H NMR (400MHz, CDCl3) of p[(Xan2-G1)-nBMA100-co-EGDMA0.8];[37] lyophilised deprotected 
nanoparticle dispersion 
 
 
Fig. S4.3 
1
H NMR (400MHz, CDCl3) of p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39] lyophilised deprotected 
nanoparticle dispersion 
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A) 
 
B) 
 
Fig. S4.4 DLS correlograms of aqueous nanoparticle dispersions of; A) LDHs p[(Xan1-G0)-nBMA100];[32], 
p[(Xan2-G1)-nBMA100];[33], p[(Xan4-G2)-nBMA100];[34] and p[(Xan8-G3)-nBMA100];[35], and B) HPDs 
p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], p[(Xan2-G1)-nBMA100-co-EGDMA0.8];[37], p[(Xan4-G2)-
nBMA100-co-EGDMA0.8];[38] and p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39]. 
 
Fig. S4.5 
1
H NMR (400MHz, CDCl3) of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] following partial 
modification with 22% of PEG(2K) groups 
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Fig. S4.6 
1
H NMR (400MHz, CDCl3) of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] following partial 
modification with 70% of PEG(2K) groups 
 
Fig. S4.7 
1
H NMR (400MHz, CDCl3) of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] following partial 
modification with >99% of PEG(2K) groups 
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A) 
 
B) 
 
Fig. S4.8 DLS correlograms of aqueous nanoparticle dispersions of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36] 
post-functionalised with PEG(2K) acrylate, containing 22%, 49%, 70% and >99% of PEG(2K) groups, 
nanoprecipitated from; A) acetone and B) THF 
 
Fig. S4.9 
1
H NMR (400MHz, CDCl3) of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], partially post-modified 
with 22% of PEG(2K) groups, lyophilised deprotected nanoparticle dispersion 
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Fig. S4.10 
1
H NMR (400MHz, CDCl3) of p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], partially post-modified 
with 70% of PEG(2K) groups, lyophilised deprotected nanoparticle dispersion 
 
 
Fig. S4.11 
13
C NMR (100 MHz, CDCl3) of [PEG(2K)-BiB];[131] 
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Fig. S4.12 TEM images of 3 nm GNPs synthesised by the Inverse Turkevich method 
 
 
 
Fig. S4.13 Size determination of GNPs by UV-Vis spectroscopy
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Nanoparticle design, radiolabelling and 
pharmacology 
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5.1 Introduction 
When a freely dissolved drug is administered, various metabolic processes leading to non-
specific distribution and renal clearance occur, resulting in reduced efficacy and undesirable 
side-effects. These problems can be limited by designing drug carriers that perform multiple 
tasks such as encapsulation, controlled release, minimising immune clearance, penetration of 
biological barriers and site-specific targeting.
1
 Surface properties of drug carriers such as 
hydrophobicity, charge and chemical composition play an important role in determining the 
nature of particle-cell interaction, and hence their fate in vivo, in vitro and in the 
environment.
2
 Tailoring nanoparticle surface properties to mediate non-specific protein 
deposition will facilitate the design of new delivery systems with desirable macrophage 
uptake whilst avoiding adverse toxicological effects.
3
 
The application of co-initiated HPD synthesis to generate materials with patchy and statistical 
distributions of functional groups was demonstrated in Chapter 4. In this chapter, we aim to 
synthesise multifunctional nanomaterials containing dimethylamino (Am) and benzyl (Bz) 
functionality, varying only in the spatial arrangement of functional groups at the periphery. 
Post-polymerisation modification of xanthate-functional co-initiated HPDs will be applied to 
generate statistically multifunctionalised materials in a simultaneous, one-pot strategy; whilst 
co-initiation of two different functional G3 dendron macroinitiators with a PEG(2K) 
macroinitiator is hypothesised to generate materials with patches of the two different 
functionalities, Fig. 5.1. 
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A) 
 
B) 
 
Fig. 5.1 Overall target materials; A) statistically multifunctionalised nanomaterials via post-polymerisation 
modification and B) patchy multifunctionalised nanomaterials by co-initiated HPD synthesis 
 
5.2 Statistical and Patchy material synthesis 
As demonstrated in Chapter 4, the formation of materials with differing spatial arrangements 
of functional groups at the periphery is possible by varying the dendron generation (G0 and 
G3), and hence the number of functional groups per “patch”, during co-initiated HPD 
synthesis with a PEG(2K) macroinitiator. The availability and distribution of functional 
groups at the surface was probed by deprotection of the xanthate groups and coordination of 
3 nm GNPs. For the study of biological interactions, a functional group ratio of 10:90 
xanthate:PEG groups was chosen, as these structures (p[(PEG(2K))0.9-(Xan1-G0)0.1-
nBMA100-co-EGDMA0.8];[136] and p[(PEG(2K))0.986-(Xan8-G3)0.014-nBMA100-co-
EGDMA0.8];[138]) displayed clear differences in functional group distribution when probed 
with GNPs and imaged using TEM. 
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5.2.1 Statistical multifunctional polymer synthesis 
Synthesis of the G0 dendron and PEG(2K) coinitiated HPD p[(PEG(2K))0.9-(Xan1-G0)0.1-
nBMA100-co-EGDMA0.8];[136] is outlined in Chapter 4 (section 4.4.3.1), Fig. 5.2. 
 
Fig. 5.2 Synthesis of G0 and PEG(2K) co-initiated HPD 
A pseudo-calibration curve for sequential xanthate deprotection was generated for this co-
initiated HPD, based on the estimated DPn of the primary chains by 
1
H NMR end-group 
analysis (see section 3.4.1.1.1), Fig. 5.3. 
 
Fig. 5.3 Calibration curve for partial deprotection of xanthate peripheral groups of  
p[(PEG(2K))0.9-(Xan1-G0)0.1-nBMA100-co-EGDMA0.8];[136] 
From the calibration curve, it was found that 1.1 molar equivalents of n-butylamine were 
required for deprotection of 50% of the xanthate peripheral groups, therefore, 1.1 molar 
equivalents of each functional acrylate (Am and Bz) was applied for the simultaneous 50:50 
functionalisation of the G0 and PEG co-initiated HPD [136], following full deprotection, Fig. 
5.4. 
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Fig. 5.4 Simultaneous thiol-acrylate Michael addition for statistical multifunctionalisation of  
G0 and PEG(2K) co-initiated HPD 
The complete deprotection of xanthate chain-end functionality (4.5 molar equivalents of  
n-butylamine per xanthate) and addition of a 1:1 molar ratio of Bz and Am acrylates (1.1 
molar equivalents per thiol) resulted in the multifunctionalised co-initiated HPD 
p[(PEG(2K))0.9-(Am0.5-Bz0.5-G0)0.1-nBMA100-co-EGDMA0.8];[140], as confirmed by 
1
H 
NMR spectroscopy (Fig. 5.5). 
 
Fig. 5.5 
1
H NMR (400 MHz, CDCl3) of p[(Am0.5-Bz0.5-G0)0.1-(PEG(2K))0.9-nBMA100-co-EGDMA0.8];[140] by 
simultaneous multifunctionalisation of p[(Xan1-G0)0.1-(PEG(2K))0.9-nBMA100-co-EGDMA0.8];[136] 
Peaks corresponding to Bz (peaks 1 and 2, Fig. 5.5) and Am (peak 4, Fig. 5.5) functionalities 
are present in the resulting 
1
H NMR spectrum, at a 1:1 ratio, relative to the polymer backbone 
Thiol-acrylate 
Michael 
addition
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resonance at δ ≈ 0.8-1.1 ppm, which remains unchanged following multifunctionalisation. At 
these very low levels of functional group incorporation the confirmatory signals within the 
NMR spectra are very small and expansion of the baseline was required to establish their 
presence and carry out integration. Peaks in the 
1
H NMR spectrum corresponding to the Bz 
functionality at δ = 7.17 ppm (aromatic, ∫7.17 ppm = 0.2502/5 = 5%) and δ = 5.15 ppm  
(CH2, ∫5.15 ppm = 0.0958/2 = 5%) confirm an incorporation of 5% benzyl functionality; a peak 
corresponding to the Am functionality at δ = 2.30 ppm (2CH3, ∫2.30 ppm = 0.3015/6 = 5%) 
confirms incorporation of 5% dimethylamino functionality, relative to the polymer backbone.  
 
5.2.2 Patchy multifunctional polymer synthesis 
Specific, directed cell binding interactions may be triggered by materials with spatially-
directed functionalisation at the nanoparticle periphery.
4
 It was shown in Chapter 4 that 
patchy particles can be generated by aqueous nanoprecipitation of co-initiated hyperbranched 
polydendrons possessing G3 dendrons at the periphery. Here, it was hypothesised that co-
initiation of a PEG(2K) macroinitiator and two different mono-functional G3 dendron 
macroinitiators may generate co-initiated HPDs with patches of different functional groups to 
generate multifunctional patchy particles, Fig. 5.6. 
 
Fig. 5.6 Synthesis of benzyl- and dimethylamino-functional G3 dendron and PEG(2K) co-initiated HPD 
Cu(I)Cl, bpy
MeOH, 60°C
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The synthesis of mono-functional G3 macroinitiators was targeted by full one-pot 
deprotection and thiol-acrylate Michael addition of xanthate functional G3 dendron [Xan8-
G3-TSe];[14] with Bz and Am acrylate, followed by focal point manipulation to incorporate 
the tertiary alkyl bromide ATRP initiation site. Modification of the xanthate functional G3 
dendron macroinitiator [Xan8-G3-BiB];[23] was not attempted as previous studies have seen 
complications thought to be due to the in situ generation of thiols leading to competing thiol-
bromo click reactions.
5,6
 Tailoring the initiator feed ratio of the G3 dendron and PEG 
macroinitiators is hypothesised to nominally maintain the same molar ratio of functional 
groups as targeted for the statistically multifunctional materials (5:5:90 Am:Bz:PEG, section 
5.2.1). 
 
5.2.2.1 Benzyl functional G3 dendron initiator synthesis 
As outlined in literature
7
, and as described in Chapter 3 (section 3.2.1.2), full one-pot 
deprotection of xanthate functional G3 dendron [Xan8-G3-TSe];[14], and subsequent thiol-
acrylate Michael addition, was carried out with an excess of n-butylamine and Bz acrylate to 
generate [Bz8-G3-TSe];[45].  The resulting Bz functional G3 dendron was analysed by 
1
H and 
13
C NMR (Fig. 3.7B and S3.1, respectively). 
 
Scheme 5.1 Synthesis of benzyl functional G3 macroinitiator, [Bz8-G3-BiB];[142] 
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Complete removal of focal point protecting group p-toluenesulfonyl ethyl (TSe) was carried 
out as described in Chapter 2 (section 2.5), with an excess (1.3 molar equivalents) of  
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and stirring at ambient temperature for 16 hours, 
Scheme 5.1. 
1
H NMR analysis of the resulting focal point acid functional material [Bz8-G3-
COOH];[141] confirmed the loss of CH2 resonances at δ = 4.46 ppm and 3.45 ppm and 
aromatic resonance at δ = 7.79 ppm, corresponding to the loss of the TSe protecting group, 
Fig. 5.7. Some evidence of the vinyl sulfone by-product generated during deprotection was 
indicated at δ = 7.53 ppm and 7.15 ppm (aromatic resonances) and δ = 6.45, 6.18 and 5.86 
ppm (vinyl resonances), although no further purification was carried out as the by-products 
would not lead to side reactions and would be removed by liquid chromatography in the next 
step. Confirmation by 
13C NMR revealed a characteristic carbonyl resonance at δ = 172 ppm, 
corresponding to the newly formed acid functionality, Fig. S5.1. 
 
Fig. 5.7 
1
H NMR (400 MHz, CDCl3) of [Bz8-G3-COOH];[141] 
CHAPTER 5 
259 
 
[HEBiB];[19] was used to react with focal point acid functional dendron [Bz8-G3-
COOH];[141] using DCC/DPTS chemistry to generate benzyl functional G3 macroinitiator 
[Bz8-G3-BiB];[142] in 74% yield. 
1
H NMR analysis revealed the formation of a broad singlet 
at δ ≈ 1.92 ppm corresponding to the two symmetrical methyl environments on the 
bromoisobutyrate moiety, Fig. 5.8. A broad resonance is also observed at δ ≈ 4.36 ppm, 
overlapping with backbone CH2 resonances, corresponding to the two OCH2 environments 
from the HEBiB unit (peaks 11 and 12, Fig. 5.8). 
 
Fig. 5.8 
1
H NMR (400 MHz, CDCl3) of [Bz8-G3-BiB];[142] 
13C NMR analysis indicated the presence of new resonances at δ = 21.7, 30.7 and 49.2 ppm 
corresponding to the HEBiB unit, the loss of acid carbonyl resonance at approximately  
δ = 172 ppm and the subsequent formation of a new ester carbonyl at δ = 171 ppm; 
confirming incorporation of the bromoinitiator functionality, Fig. S5.2. 
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5.2.2.2 LDH synthesis with benzyl functional initiator, Bz8-G3-BiB 
The polymerisation of nBMA with a targeted DPn of 100 monomer units was carried out with 
benzyl functional G3 dendron macroinitiator [Bz8-G3-BiB];[142] at 60°C in methanol with a 
CuCl:bpy (1:2) catalyst system, Scheme 5.2, to establish the efficiency of the initiator within 
the proposed polymerisations. 
 
Scheme 5.2 Synthesis of LDH using benzyl functional G3 initiator [Bz8-G3-BiB];[142] 
The polymerisation was terminated by exposure to oxygen when conversion reached >95%, 
as calculated by 
1
H NMR spectroscopy. The SEC and 
1
H NMR analysis is summarised in 
Table 5.1. 
Table 5.1 
1
H NMR and SEC data for p[(Bz8-G3)-nBMA100];[143] 
Polymer 
Monomer 
conv. (%) 
SEC (THF)
a
 
1
H NMR
b
 
Mn  
(g mol
-1
) 
Mw
  
(g mol
-1
) 
Ð DPn DPn 
P[(Bz8-G3)-nBMA100] 95 28,100 34,700 1.24 177 174 
aTHF containing 2% TEA (v/v) at 35°C, 1 mL min-1 flow rate. bDetermined by 1H NMR analysis in CDCl3 
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The benzyl-functional LDH eluted at lower retention volumes than seen previously for 
xanthate functional dendron initiated LDHs (section 2.8.4.2), Fig. 5.9, indicating higher than 
expected chain lengths being formed. This could be due to <100% initiator efficiency as a 
result of poor solubility in methanol and steric hindrance around the initiating site due to the 
bulky, hydrophobic benzyl peripheral groups. This generates fewer initiated chains, and 
hence, higher than expected molecular weight of the resulting polymer; some evidence of 
residual initiator is indicated by a small peak in the RI detector trace at an elution volume of 
~19-20 mL. A slight shoulder is also seen at lower retention volumes, which could be due to 
coupling of chains at high conversion.
8
 
 
Fig. 5.9 SEC RI chromatogram trace of p[(Bz8-G3)-nBMA100];[143] 
The polymerisation did, however, achieve high conversion and relatively low dispersity 
(<1.3), and it was clear that the incorporation of benzyl-functional G3 chain ends via 
methanolic ATRP of nBMA was successful. 
 
 
 
 
Retention Volume (mL)
8 10 12 14 16 18 20 22 24 26
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5.2.2.3 Patchy co-initiated HPD synthesis 
Synthesis of the Am-functional G3 dendron macroinitiator was not successful as focal point 
protecting group removal of [Am8-G3-TSe];[44] (synthesised by full one-pot 
deprotection/thiol-acrylate Michael addition of [Xan8-G3-TSe];[14] with Am acrylate, see 
section 3.2.1.2) with DBU cleaved the Am functionality at the periphery. The strategy was 
therefore modified to allow co-initiation with xanthate-functional G3 macroinitiator, [Xan8-
G3-BiB];[23], and subsequent post-polymerisation modification with Am acrylate, Fig. 5.10. 
 
Fig. 5.10 Synthesis of benzyl- and xanthate-functional G3 dendron and PEG(2K) co-initiated HPD 
The co-initiated branched copolymerisation of nBMA and EGDMA with benzyl- and 
xanthate-functional G3 dendron macroinitiators ([Bz8-G3-BiB];[142] and [Xan8-G3-
BiB];[23]) and PEG(2K) macroinitiator ([PEG(2K)-BiB];[131]) was carried out, targeting a 
5:5:90 molar ratio of xanthate:benzyl:PEG chain-ends. The DPn of primary polymer chains 
was targeted at 100 monomer units, with an initiator:brancher ratio of 1:0.8. Triple detection 
SEC analysis of the co-initiated HPD and corresponding linear polymers are summarised in 
Table 5.2. 
 
 
 
Cu(I)Cl, bpy
MeOH, 60°C
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Table 5.2 Triple detection SEC data of benzyl- and xanthate-functional G3 dendron/PEG(2K) co-initiated 
HPDs, with corresponding linear polymers 
Entry 
no. 
Initiator (mol%) 
Target polymer 
composition 
Conv. 
(%)
a 
SEC 
xanthate 
G3 dendron 
benzyl  
G3 dendron 
PEG(2K) 
Mn  
(g mol
-1
) 
Mw  
(g mol
-1
) 
Ð 
1 100 0 0 p(nBMA)100 84 26 600
b 
31 800
b
 1.19
b
 
2 0 100 0 p(nBMA)100 95 28,100
c 
34,700
c
 1.24
c
 
3 0 0 100 p(nBMA)100 94 13 400
b
 14 500
b
 1.08
b
 
         
4 0.7 0.7 98.6 
p(nBMA)100-co-
EGDMA0.8 
99 37,700
c
 148,300
c
 3.94
c
 
aDetermined by 1H NMR analysis in CDCl3
 bDMF containing 0.01 M LiBr at 60°C, 1mL min-1 flow rate. cSample analysed in 
THF containing 2% TEA (v/v) at 35°C, 1mL min-1 flow rate. 
 
As seen previously, the benzyl- and xanthate-functional G3 dendron/PEG(2K) co-initiated 
polymerisation appears to be dominated by the PEG(2K) initiator, the major component in 
the initiator mixture, resulting in molecular weights that closely resembled those previously 
achieved for the xanthate-functional G0/G3 dendron and PEG(2K) co-initiated materials 
(sections 4.4.3.1 and 4.4.3.2), Fig. 5.11.  
 
Fig. 5.11 SEC RI chromatogram trace of p[(PEG(2K))0.986-(Xan8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-
EGDMA0.8];[144] 
During singly-initiated linear polymerisations, the xanthate- and benzyl-functional G3 
dendron macroinitiators seem to have very similar initiator efficiency (see sections 2.8.4.2 
and 5.2.2.2), and should therefore be incorporated equally during co-initiated polymerisation. 
Retention Volume (mL)
12 14 16 18 20 22
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Complete deprotection of the incorporated xanthate functional G3 dendrons of co-initiated 
HPD p[(PEG(2K))0.986-(Xan8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8];[144], 
followed by functionalisation with Am acrylate was applied to achieve 50:50 
functionalisation, following chemical procedures described and optimised in Chapter 3, Fig. 
5.12. 
 
Fig. 5.12 Schematic representation of the complete deprotection and thiol-acrylate Michael addition for patchy 
multifunctionalisation of G3 and PEG(2K) co-initiated HPD 
The complete deprotection of xanthate chain-end functionality with an excess of  
n-butylamine (10 molar equivalents), followed by thiol-Michael addition with Am acrylate 
(15 molar equivalents), resulted in the multifunctionalised co-initiated HPD 
p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8];[145], as confirmed 
by 
1
H NMR spectroscopy (Fig. 5.13). 
 
Thiol-acrylate 
Michael addition
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Fig. 5.13 
1
H NMR (400 MHz, CDCl3) of p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-
EGDMA0.8];[145], by post-polymerisation modification of p[(PEG(2K))0.986-(Xan8-G3)0.007-(Bz8-G3)0.007-
nBMA100-co-EGDMA0.8];[144] 
Peaks corresponding to Bz (peaks 1 and 2, Fig. 5.13) and Am (peak 4, Fig. 5.13) 
functionalities are present in the resulting 
1
H NMR spectrum, in an approximately 1:1 ratio, 
relative to the polymer backbone resonance at δ ≈ 0.8-1.1 ppm, which remains unchanged 
following functionalisation. Again, the very low incorporation of the dimethylamino and 
benzyl functionality resulted in restricted analysis by NMR and the resonances relating to 
these functional groups were only identified after considerable expansion of the baseline. 
Peaks in the 
1H NMR spectrum corresponding to the Bz functionality at δ = 7.34 ppm 
(aromatic, ∫7.34 ppm = 0.2269/40 = 0.6%) and δ = 5.12 ppm (CH2, ∫5.12 ppm = 0.0931/16 = 0.6%) 
confirm an incorporation of 0.6% benzyl functional G3 dendrons, which equates to 4.5% 
benzyl functionality overall (0.6*8 peripheral groups per G3 dendron), relative to the polymer 
backbone; a peak corresponding to the Am functionality at δ = 2.28 ppm (2CH3, ∫2.28 ppm = 
0.3315/48 = 0.7%) confirms incorporation of 0.7% dimethylamino functional G3 dendrons, 
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which equates to 5.5% dimethylamino functionality overall (0.7*8 peripheral groups per G3 
dendron), relative to the polymer backbone. 
 
5.2.3 Aqueous nanoprecipitation studies of branched polymers with patchy and 
statistical functional group distributions 
Aqueous nanoprecipitation of multifunctionalised co-initiated HPDs, with statistical and 
patchy distributions of functional groups (statistical p[(PEG(2K))0.9-(Am0.5-Bz0.5-G0)0.1-
nBMA100-co-EGDMA0.8];[140], Fig. 5.14A; patchy p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-
G3)0.007-nBMA100-co-EGDMA0.8];[145], Fig. 5.14B) was carried out from an initial 
concentration of 5 mg/mL in acetone.  
A) 
 
B) 
 
Fig. 5.14 Graphical representation of nanoparticles with; A) statistical and B) patchy distributions of surface 
functional groups, formed by nanoprecipitation 
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The dissolved polymer was rapidly added to water with stirring at ambient temperature. The 
solvent was allowed to evaporate overnight in a high velocity fume cupboard, and the 
resulting nanoparticle suspension (1 mg/mL) analysed by DLS, as summarised in Table 5.3 
below, with average size by intensity distributions shown in Fig. 5.15.  
Table 5.3 DLS measurement data for multifunctional co-initiated HPDs with statistical ([140]) and patchy 
([145]) functional group distributions 
Polymer Dz (nm) PdI 
pH7 ζ 
(mV) 
pH5 ζ 
(mV) 
p[(PEG(2K))0.9-(Am0.5-Bz0.5-G0)0.1-nBMA100-co-EGDMA0.8];[140] 66 0.203 -23.0 -7.5 
      
p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-
EGDMA0.8];[145] 
68 0.189 -8.4 -7.7 
 
A) 
 
B) 
 
Fig. 5.15 Average DLS size distribution by intensity traces of aqueous nanoparticle dispersions of; A) statistical 
p[(PEG(2K))0.9-(Am0.5-Bz0.5-G0)0.1-nBMA100-co-EGDMA0.8];[140] and B) patchy p[(PEG(2K))0.986-(Am8-
G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8];[145] nanoprecipitates (correlograms Fig. S5.4) 
The Z-average diameter (Dz) and PdI of the nanoprecipitates were approximately the same 
for both materials with differing spatial arrangements of functional groups, despite the 
different molar ratio of PEG:dendron chain-ends. A clearer representation of the relative 
molar ratio of macroinitiators required to maintain the same Am/Bz:PEG functional group 
ratio between the materials is shown in Fig. 5.16. 
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A) 
 
B) 
 
Fig. 5.16 A graphical representation of the chain-end distribution in; A) statistical and B) patchy 
multifunctionalised co-initiated HPDs to maintain a 5:5:90 Am:Bz:PEG ratio (green = polymer backbone; blue 
= PEG chain-ends; red = Am functional G3 dendron chain-ends; purple = Bz functional G3 dendron chain-ends) 
A much lower concentration of G3 dendron chain-ends are required to maintain a 5:5:90 
Am:Bz:PEG functional group ratio than co-initiated HPDs containing G0 dendrons, as G3 
dendrons have 8 peripheral groups whereas G0 dendrons have 1; this clearly adds 
considerable spatial inhomogeneity and ensures the isolation of the functional groups within 
defined zones of the branched polymer. 
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Materials with a statistical distribution of Am groups are expected to charge differently to 
those co-localised on a G3 dendron in the patchy materials. Neighbouring protonated Am 
groups on the G3 dendron periphery are expected to repel each other, meaning multiple 
charges on the same dendron are less likely, leading to a lower average charge on the 
structure. It is hypothesised that protonation of Am groups which are statistically distributed 
lead to somewhat isolated charges across the polymer periphery, increasing the average 
positive charge on the particle. Evidence for this was obtained when the pH of the 
nanoparticle suspensions was lowered from neutral (pH7) to slightly acidic (pH5) via the 
addition of HCl. Zeta potential (ζ) values of statistical materials increased from -23.0 mV to  
-7.5 mV, indicating amine protonation, whereas ζ values obtained for the patchy material  
(ζ = -8.4 mV at pH7, increased to ζ = -7.7 mV at pH5) suggest the average charge remains 
approximately constant after addition of acid. 
 
5.3 Radiolabelling 
For the statistically multifunctionalised materials, isotropy in the surface functional group 
distribution and hence interaction behaviour with biological systems is an idealisation; even 
on the molecular scale anisotropy is encountered, leading to theories of molecular liquids
9
 
and anisotropic fluids
10
. This was seen in Chapter 4 where multiple GNP binding was seen 
for materials with functional groups in statistically close proximity (Fig. 4.21). Therefore, it 
is important to monitor these nanoparticulate delivery systems with differing spatial 
arrangements of functional groups on the surface (patchy and statistical) by non-invasive 
means, such as radiolabelling. Radiolabelling of the synthesised polymers with 
3
[H] ensures a 
high degree of radioactivity due to rapid exchange of labile protons throughout the structure. 
This allows direct monitoring of the delivery vehicle in cell studies, rather than encapsulation 
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of a radiolabelled compound which may leach out. Also, the simple exchange of labile 
protons with tritium prevents additional manipulation of the polymers and the unnecessary 
introduction of functional groups that would perturb the target chemistry. It is possible to 
induce specific behaviour by other labelling techniques such as methylation using 
14
CH3I, 
which would generate permanent positive charge, or fluorescent labelling, which would 
create large areas of considerable hydrophobicity. 
 
5.3.1 Radio analysis 
The radiolabelled polymer sample was generated with >3 mCi of activity by treatment with 
tritium gas by a contract research organisation (RC Trictec AG, Teufen, Switzerland) on a 
scale too small to fully analyse the distribution of radioactivity throughout the sample (patchy 
= 20.68 μg, statistical = 22.38 μg), however, it has previously been reported that the broad 
distribution of polymers formed via statistical branching during ATRP (linear to highly 
branched species) nanoprecipitate to give rise to uniform nanoprecipitates.
11
 The addition of a 
small quantity of the radiolabelled polymer to the conventional sample is not expected to 
modify any behaviour of the branched material. Therefore, the radiolabelled polymers are 
still likely to be incorporated into resulting nanoprecipitates when mixed with the “cold” 
(unlabelled) sample, leading to nanoprecipitates that may be studied quantitatively. 
 
5.3.2 Aqueous nanoprecipitation of radiolabelled materials 
In a 5 mL scale nanoprecipitation with a targeted final concentration of 1 mg/mL, the total 
activity of the statistical material used was 53.71 μCi, meaning a specific activity of  
10.74 μCi/mg; and for the patchy material, the total activity used was 64.09 μCi, meaning a 
specific activity of 12.82 μCi/mg. The radiolabelled polymers were nanoprecipitated from 
acetone, as described previously (section 5.2.3), and the solvent left to evaporate overnight in 
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a high velocity fume cupboard. It was found that the volume of water in the resulting 
nanoprecipitates was lower than expected, and hence the concentration of the sample had 
increased. The nanoprecipitates were diluted with water back to the initially targeted 
concentration of 1 mg/mL of polymer in water and analysed by DLS, as summarised in Table 
5.4 below, with average size by number (Dn) distributions shown in Fig. 5.17. 
Table 5.4 DLS measurement data for nanoprecipitated cold (Entry 1 and 2) and radiolabelled (Entry 3 and 4) 
statistical and patchy co-initiated HPDs 
Entry Polymer Dn (nm) 
1 p[(PEG(2K))0.9-(Am0.5-Bz0.5-G0)0.1-nBMA100-co-EGDMA0.8] 33 
2 p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8] 36 
   
3 p[(PEG(2K))0.9-(Am0.5-Bz0.5-G0)0.1-nBMA100-co-EGDMA0.8] +
3
[H] 51 
4 p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8] +
3
[H] 38 
 
A) 
 
B) 
 
Fig. 5.17 Average DLS size distribution by number traces of aqueous nanoparticle dispersions of radiolabelled; 
A) statistical p[(PEG(2K))0.9-(Am0.5-Bz0.5-G0)0.1-nBMA100-co-EGDMA0.8];[140] and B) patchy 
p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8];[145] nanoprecipitates 
Although some aggregates could be seen in the radiolabelled nanoprecipitates due to 
excessive water evaporation, the Dn values obtained by DLS were comparable with the 
corresponding cold samples (section 5.2.3, Table 5.3). The samples were therefore taken 
forward to be used in pharmacological studies. 
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5.4 Pharmacology 
Studies on cellular accumulation of the radiolabelled multifunctional nanoprecipitates were 
carried out in the Department of Molecular and Clinical Pharmacology at the University of 
Liverpool by Dr Lee Tatham under the supervision of Prof. Andrew Owen. 
 
5.4.1 Cellular accumulation studies 
We hypothesised that the binding of opsonins on hydrophobic regions of patchy materials 
may introduce a distinct biological “handle” that components of the MPS can recognise; this 
may lead to enhanced uptake compared to the statistically multifunctionalised materials 
where a more even adsorption of opsonins, or possibly a reduced strength of adsorption, 
would be expected. Directed interactions may occur between patches of surface functional 
groups and receptor clusters on the macrophage. Enhanced uptake has been seen previously 
for non-spherical, flexible particles.
12
 
 
5.4.1.1 ATHP-1 cells 
The cellular accumulation ratio (CAR) of the radiolabelled statistical ([140]) and patchy 
([145]) co-initiated HPD nanoprecipitates was investigated in ATHP-1 cells. ATHP-1 cells 
are in vitro-differentiated monocyte-derived macrophages used as a model to monitor 
accumulation in macrophages, and can be used to evaluate mechanisms of phagocytosis. 
Accumulation in macrophages is advantageous for the treatment of HIV as they behave as 
cellular sanctuary sites in systemic circulation for the virus.
13
 The CAR of the 
nanoprecipitates with different spatial arrangements of surface functional groups in ATHP-1 
cells was compared directly at 1 and 6 hours incubation time, Fig. 5.18. 
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A) 
 
B) 
 
***, P <0.001 (paired test, two tailed) n=4 
Fig. 5.18 Cellular accumulation ratios (CAR) for patchy (black bar) and statistically (white bar) multifunctional 
nanoprecipitates at; A) 1 hour incubation, and B) 6 hours incubation with ATHP-1 cells 
Enhanced cellular accumulation is seen for materials with a patchy distribution of surface 
functional groups, compared to statistically multifunctionalised materials, as postulated in 
Chapter 1 (1.8.3, Fig. 1.18). The patchy material appears to accumulate 3.2-fold more in 
ATHP-1 cells following 1 hour exposure and 3.4-fold more following 6 hours of exposure 
compared to the statistically multifunctional material. The enhanced CAR of materials with a 
patchy distribution of surface functional groups may be because the structure contains 
inhomogeneous surface characteristics which trigger an enhanced response within the 
macrophages. Surface charge anisotropy originating from the patches of Am functional 
groups may affect uptake, as has been seen previously for protein-protein interactions.
14
 
Anisotropic interactions dominate if entropic penalties are overcome, which cannot occur if 
patches are too small, as in the case of statistically multifunctional nanoparticles.
15
 
 
 
0
20
40
60
80
1 h incubation
Treatment
C
A
R ***
0
20
40
60
80
6 h incubation
C
A
R
***
Treatment
CHAPTER 5 
274 
 
5.4.1.2 THP-1 cells 
Undifferentiated THP-1 cells (human monocytic cells) were incubated with the patchy and 
statistical materials and their CAR assessed, Fig. 5.19. 
A) 
 
B) 
 
**, P <0.01 (paired test, two tailed) n=4 
Fig. 5.19 Cellular accumulation ratios (CAR) for patchy (black bar) and statistically (white bar) multifunctional 
nanoprecipitates at; A) 1 hour incubation, and B) 6 hours incubation with undifferentiated THP-1 cells 
Reduced accumulation of nanomaterials was observed for THP-1 cells compared to ATHP-1 
cells at 1 hour and 6 hours incubation; however, similar trends were seen with patchy 
nanoprecipitates appearing to accumulate more than statistically multifunctionalised 
materials, although the difference between the materials is reduced compared to ATHP-1 
cells. 
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5.4.1.3 Cell-free particle adhesion 
ATHP-1 and THP-1 are not adherent cell lines, therefore, the previous studies were 
conducted using collagen-coated plastic well plates to promote adhesion of cells and facilitate 
the washing steps required to aid the cell accumulation quantification. In order to rule out the 
impact of spatially-derived adhesion to collagen and/or the plastic plates as the cause of the 
observed differences in CAR, cell-free experiments were carried out to monitor particle 
adhesion to collagen and plastic, in the same way as detailed for the cell-based experiments, 
Fig. 5.20. 
A) 
 
B) 
 
C) 
 
D) 
 
Fig. 5.20 % of treatment recovered for cell-free studies with patchy and statistically multifunctional 
nanoprecipitates at; A) 1 hour incubation, and B) 6 hours incubation with collagen; and C) 1 hour incubation, 
and D) 6 hours incubation with and without collagen 
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Modified nanoparticle adhesion was again seen in the presence of collagen for both 
radiolabelled patchy and statistical nanoparticles, although a lower overall % recovery was 
achieved for both materials, essentially removing this potential error as the cause of the 
differences seen in CAR experiments in the presence of cells. Interestingly, the patchy 
particles appear to have a greater rate of adsorption to collagen than the statistically 
multifunctional nanoparticles but overall there were no statistical differences between the 
materials after 6 hours incubation in the presence or absence of collagen. 
 
5.5 Conclusion 
The formation of patchy and statistically multifunctionalised nanomaterials was achieved by 
co-initiation of dendron and PEG(2K) macroinitiators, followed by one-pot thiol-acrylate 
Michael addition to introduce multifunctionality at the periphery, and nanoprecipitation to 
form stable nanoparticles in water. The polymers were radiolabelled by tritiation and the 
accumulation of the resulting nanoprecipitates in ATHP-1 cells assessed. It was found that 
nanomaterials with a patchy distribution of functional groups at the periphery favourably 
accumulate in ATHP-1 cells; 3.2-fold more than statistically multifunctional materials after 1 
hour incubation, and 3.4-fold more after 6 hours. The results were confirmed by repeating the 
cell studies with undifferentiated THP-1 cells and investigating cell-free particle adhesion. 
The THP-1 cell studies suggest this difference isn’t simply due to enhanced phagocytosis and 
the cell-free control suggests that there may be adhesion differences, but these are not driving 
the results seen.  
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5.7 Appendix 
 
Fig. S5.1 
13
C NMR (100 MHz, CDCl3) of [Bz8-G3-COOH];[141] 
 
Fig. S5.2 
13
C NMR (100 MHz, CDCl3) of [Bz8-G3-BiB];[142] 
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Fig. S5.3 
1
H NMR (400 MHz, CDCl3) of p[(PEG(2K))0.986-(Xan8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-
EGDMA0.8];[144] 
 
A) 
  
B) 
 
Fig. S5.4 DLS correlograms of aqueous nanoparticle dispersions of; A) statistical p[(PEG(2K))0.9-(Am0.5-Bz0.5-
G0)0.1-nBMA100-co-EGDMA0.8];[140] and B) patchy p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-G3)0.007-nBMA100-
co-EGDMA0.8];[145] nanoprecipitates 
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6.1 Synthesis 
The chosen strategy for the direct synthesis of patterned nanoparticles for tailored biological 
interactions required the formation of dendrons to allow the spatial control of functionality 
within complex polymer architectures, and the formation of nanoparticles with patchy surface 
distributions. The divergent synthesis of polyester dendrons up to the third generation was 
achieved by anhydride coupling of acetonide-protected bis-MPA. Although this highly 
efficient dendron synthesis route has been widely explored and applied
1-5
, this strategy is 
limited by tedious purification steps and toxic reagents, and is highly mass inefficient as each 
functionalisation/growth step only uses half of the symmetrical anhydride. Recovery of the 
unreacted portion of the anhydride may be possible in optimised syntheses. A recently 
developed alternative involves the use of 1,1’-carbonyldiimidazole (CDI) as a coupling 
reagent and caesium fluoride (CsF) as a catalyst.
6,7
 Dendritic scaffolds based on bis-MPA 
were reportedly synthesised by fluoride-promoted esterification (FPE) on a multigram scale 
in high yields (>90%) using simple purification, under sustainable conditions. This synthetic 
strategy may alleviate problems associated with poor mass efficiency of the anhydride route, 
and overcome scaling issues. Focal point manipulation allowed the formation of ATRP 
bromoinitiators which were used in the methanolic copolymerisation of nBMA and 
bifunctional monomer EGDMA to generate hyperbranched polydendrons (HPDs), bearing 
the dendron functionality at every primary chain-end. Carefully controlling the 
brancher:initiator ratio to avoid cross-linking of the polymer core, and to compensate for 
varying initiator efficiency of the dendron macroinitiators, yielded high molecular weight, 
soluble branched polymers (up to Mw = 3.7 x 10
6
 g mol
-1
). ATRP was applied for polymer 
synthesis due to its versatility towards monomers and its tolerance to various functional 
groups and solvents. Cytotoxicity assays of polymers made via ATRP previously within the 
research group
8
 have not revealed any toxicity with Caco-2 cells (human epithelial colorectal 
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adenocarcinoma cell line) across a range of nanoparticle concentrations and hence it is not 
believed that the residual copper catalyst renders the materials unusable for biological 
studies, as reported in many publications. However, scale-up of ATRP procedures may be 
difficult; therefore, more conventional chemistries would facilitate the application of 
materials demonstrated in this study. 
 
6.2 Post-polymerisation modification 
With the successful formation of a range of materials that were targeted to address the chosen 
strategy for controlling the placement of surface functionality, post-polymerisation 
modification was utilised through the xanthate chemistry. Manipulation of peripheral 
xanthate groups of G0-G3 dendrons avoided the direct handling of thiols, which were shown 
to be controllably generated in situ under mild basic conditions. Thiol-acrylate Michael 
addition allows the incorporation of a wide range of functional groups at the periphery of 
dendritic materials in a simple, one-pot reaction. Statistical modification of xanthate 
functional materials, via either the sequential or simultaneous strategy, allowed control over 
the molar average of functional groups introduced. Sequential and simultaneous Michael 
addition offer respective advantages; sequential thiol Michael addition allows incorporation 
of sensitive or highly reactive functionality at a late stage in the synthesis, whereas 
simultaneous Michael addition reduces thiol isolation seen for sequential 
multifunctionalisation of higher generation dendrons, and reduces the number of reaction and 
purification steps. The functional acrylates used in this research were chosen as hydrophobic 
benzyl (Bz) groups may induce opsonin adsorption, which may promote immune recognition 
and uptake by macrophages; whereas dimethyl amino (Am) groups have been previously 
shown
9
 to lead to enhanced uptake in ATHP-1 and Caco-2 cell studies. Detailed analysis of 
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the resulting multifunctional dendrons showed that statistical modification of HPDs has the 
potential to lead to materials with significant homogeneity, not unlike the targeted patchy 
materials. This is not completely unexpected, but the level of homogeneity formed was 
surprising and shown very clearly by MALDI-TOF analysis of the model dendron studies; 
this may actually provide an easier route to patchy materials with benefits not unlike those 
seen from our more detailed and precise proof-of-concept. Other approaches to generate truly 
statistically multifunctionalised materials may be available, but xanthates were maintained 
and a new approach was taken to create the more clear segregation of chemistry required for 
the proof-of-concept demonstration. 
 
6.3 Particle formation and patchiness 
Co-initiated HPD synthesis with G0 and G3 dendron initiators and a PEG(2K) macroinitiator 
was chosen as the route to achieve statistical and patchy distributions of surface functional 
groups on resulting nanomaterials. Nanoprecipitation for the formation of nanoparticles was 
successfully applied to these systems and long-term stability (>1 year) was also seen. The 
formation of patchy particles is somewhat controversial; imaging of the patchiness was 
shown via electron microscopy of thiol-functional polymer nanoparticles with coordinated 
gold nanoparticles (GNPs). However, even this approach showed that despite the statistics of 
patchiness being biased towards the G3-containing materials, significant patchiness was also 
presented on the structures possessing G0 dendrons. The imaging of thiol-containing 
materials was highly successful and directly extrapolated to the Am/Bz-containing materials, 
however the author is aware that direct imaging of patchiness in these materials was not 
achieved and is postulated without direct evidence. G0 and G3 individually co-initiated HPDs 
with PEG-initiators allowed the direct biological comparison of materials with statistical and 
CHAPTER 6 
284 
 
patchy multifunctionality at the surface, however, other materials would be required to allow 
a full and fair demonstration of the effects of functional group distribution on cellular 
accumulation; for example G3-(Am/Bz)/PEG, G3-Bz/PEG, G3-Am/PEG, G0-Bz/PEG and G0-
Am/PEG, Fig. 6.1. 
A) 
 
B) 
 
C) 
 
D) 
 
 E) 
 
Fig. 6.1 Examples of other materials required to demonstrate the effects of functional group distribution on 
cellular accumulation; A) G3-(Am/Bz)/PEG, B) G3-Bz/PEG, C) G3-Am/PEG, D) G0-Bz/PEG  
and E) G0-Am/PEG (blue = Bz, orange = Am) 
The extremes of G0-(Am/Bz)/PEG and G3-(Am/Bz)/PEG were selected to establish a proof-
of-concept and a clear difference was seen. 
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6.4 Biological interactions and outlook 
Clear differences between nanoparticles formed from co-initiated HPDs with patchy (G3) and 
statistical (G0) distributions of peripheral functional groups were seen in each of the cellular 
accumulation studies (ATHP-1, THP-1, +/- collagen). The cellular accumulation ratio (CAR) 
of patchy and statistically multifunctionalised nanoparticles was monitored using 
3
[H] 
radiolabelling and displayed a 3.4-fold increase in CAR for materials with a patchy 
distribution of surface functional groups, thus demonstrating that functional group 
distribution affects cellular interaction, which can be tailored using the co-initiated HPD 
platform. Further cell studies to establish the mechanisms of uptake could involve monitoring 
CAR of nanoparticles in serum-free experiments to determine whether non-specific protein 
binding (opsonin adsorption) influences phagocytosis. Another study could draw a 
comparison between HIV-infected and non-infected macrophage uptake of the nanoparticles; 
increased phagocytosis is expected for infected macrophages, however, this effect may be 
enhanced for particles with a patchy distribution of surface functional groups. 
There is potential for this research to direct therapeutic nanoparticle design in the future, with 
this chemistry providing a significant simplification to other reported approaches to 
patchiness. However, the chemistry presented here is not trivial and even simpler strategies 
would be required to build towards commercial or clinical applications. Drug encapsulation 
into these systems was not carried out during this research, and would need to be 
demonstrated for therapeutic applications. A clear outcome of this research is the detailed 
study of statistical functionalisation of dendritic macromolecules, which brings many reports 
of low level modification of dendrimer and dendrimer-like systems into some question.  
Overall, this thesis has taken clear steps towards demonstrating the value of patchiness on 
particles and the modification of biological interactions. Future exploitation will need even 
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simpler chemistry that can be readily scaled, or the application of this approach will be 
considerably limited to very rare clinical conditions where no other approach exists to aid 
therapy. The thesis has shown there is value in following these approaches. 
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7.1 Materials and Methods 
7.1.1 Materials 
All compounds were purchased from Sigma Aldrich unless otherwise stated and used without 
further purification. Potassium ethyl xanthogenate, 2-bromoacetic acid, pyridine, 4-
dimethylaminopyridine (DMAP), 2,2-dimethoxypropane, N,N’-dicyclohexylcarbodiimide 
(DCC), benzyl acrylate and 2-(dimethylamino)ethyl acrylate (DMAEA) were purchased from 
Alfa Aesar and used without further purification. Para-toluene sulfonyl ethanol (p-TSe) was 
purchased from Fluorochem and used without further purification. Dichloromethane, hexane 
and ethyl acetate were HPLC grade and supplied by Fisher Scientific. Analytical TLC was 
performed on commercial Merck plates coated with silica gel. Flash chromatography was 
performed using a Grace Reveleris Flash System with Silica gel Flash Cartridges. 
 
7.1.2 Analysis 
Nuclear magnetic resonance (NMR): Spectra were recorded using a Bruker Avance 400 
spectrometer, operating at 400 MHz for 
1
H NMR and 100 MHz for 
13
C NMR, in CDCl3, 
CD3OD or D2O purchased from Goss Scientific. Chemical shifts (δ) are reported in parts per 
million (ppm) and TMS was used as an internal standard for both 
1
H and 
13
C spectra.  
Mass Spectrometry (MS): Chemical ionisation (CI) mass spectra were obtained using an 
Agilent GC/Q-TOF 7200 instrument, using methane CI gas; whilst electrospray ionisation 
(ESI) mass spectra was obtained using a MicroMass LCT mass spectrometer using electron 
ionisation and direct infusion syringe pump sampling. All samples were diluted with 
methanol. Matrix-assisted laser desorption/ionisation - time of flight mass spectrometry 
(MALDI-TOF MS) sample solutions were prepared with a 2 mg/mL concentration in THF. 
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Matrix solution was prepared at a concentration of 10 mg/mL in THF and 1 mg/mL Na 
counter ion solution was prepared. 5 μL of sample solution, 20 μL of matrix solution and 1.5 
μL of counter ion was added to an Eppendorf sample tube and homogenised. Solution was 
deposited on a stainless steel sample plate and the solvent allowed to evaporate. Spectrum 
acquisitions were conducted on a Bruker UltraFlex MALDI-TOF MS with SCOUT-MTP Ion 
source (Bruker Daltonics, Bremen) equipped with a N2-laser (337 nm), a gridless ion source 
and a reflector. All spectra were acquired using a reflector-positive method with an 
acceleration voltage of 25 kV and a reflector voltage of 26.3 kV. The detector mass range 
was set to exclude everything under 1000 Da in order to exclude high intensity peaks from 
the lower mass range. A total of 1000 shots were performed per sample and the laser intensity 
was set to the lowest possible value for acquisition of high resolution spectra. The instrument 
was calibrated using SpheriCal
TM
 calibrants purchased from Polymer Factory Sweden AB. 
The obtained spectra were analysed with FlexAnalysis Bruker Daltonics, Bremen, version 
2.2.  
Elemental microanalysis: Recorded on a Thermo FlashEA 1112 series CHNSO elemental 
analyser.  
Size Exclusion Chromatography (SEC): Carried out using a Malvern Viscotek SEC Max 
equipped with a GPCmax VE2001 autosampler, two Viscotek T6000 columns (and a guard 
column), a refractive index detector VE3580 and a 270 Dual Detector (light scattering and 
viscometer) A mobile phase of THF containing 2% triethylamine (v/v) at 35 °C, or DMF 
containing 0.01 M LiBr at 60 °C, was used as the eluent, with a flow rate of 1mL min
-1
. 
Dynamic light scattering (DLS): Measurements were carried out using a Malvern Zetasizer 
Nano ZS (4 mW He-Ne laser; wavelength 633 nm), at 25 °C using plastic disposable cuvettes 
for aqueous dispersions.  
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Transmission electron microscopy (TEM): Images were recorded using a Hitachi S-4800 FE-
SEM at 20 kV. 10 μL of aqueous nanoparticle suspension was pipetted directly onto a Cu 
(holey carbon) 400 mesh 3 mm TEM grid (Agar Scientific) and blotted with filter paper. 
  
7.2 Chapter 2 compounds 
Isopropylidene-2,2-bis(methoxy)propionic Acid [Acet1-G1-COOH];[1]. 2,2-
Bis(hydroxymethyl)-propionic acid (bis-MPA) (100 g, 0.746 mol, 1 equiv.), 2,2-
dimethoxypropane (116.7 g, 137.24 mL, 1.12 mol, 1.5 equiv.), and p-toluenesulfonic acid 
monohydrate (7.09 g, 37.0 mmol, 0.05 equiv.) were added to 500 mL of acetone. The 
reaction mixture was stirred for 2 hours at ambient temperature (clear, colourless). After this 
time, the catalyst was neutralised by addition of 10 mL NH4OH:EtOH (1:1 mixture), 
resulting in salt precipitation. The product was obtained by removal of acetone in vacuo, 
dissolving the crude solid in CH2Cl2 (750 mL), washing the organic layer twice with distilled 
water (2 x 300 mL), drying over MgSO4 and evaporating to dryness. Yield: 100.86 g, white 
solid, (78%). 
1
H NMR (400 MHz, CDCl3): δ = 1.22 (s, 3H), 1.42 (s, 3H), 1.45 (s, 3H), 3.68 
(d, J = 12.1 Hz, 2H), 4.20 (d, J = 12.1 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ = 18.47, 
21.92, 25.18, 41.86, 65.86, 98.43, 180.31. This compound was prepared by the procedure 
reported by Ihre et al.
1
 Spectroscopic data agreed with those reported.  
 
Isopropylidene-2,2-bis(methoxy)propionic Anhydride [Acet2-G1-Anhy];[2]. [Acet1-G1-
COOH];[1] (88.94 g, 0.511 mol, 1 equiv.) and N,N’-Dicyclohexylcarbodiimide (DCC) (52.68 
g, 0.255 mol, 0.50 equiv.) were added to 500 mL of CH2Cl2. The reaction mixture was stirred 
at ambient temperature for 48 hours. The precipitated N,N’-dicyclohexylurea (DCU) 
byproduct was removed by filtration and washed with a small volume of CH2Cl2. The crude 
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product was purified by precipitating the filtrate into 2.5 L of cold hexane (cooled with dry 
ice bath) with vigorous stirring. Yield: 84.18 g, white viscous oil, (99%). 
1
H NMR (400 
MHz, CDCl3): δ = 1.24 (s, 3H), 1.40 (s, 3H), 1.44 (s, 3H), 3.69 (d, J = 12.1 Hz, 4H), 4.21 (d, 
J = 12.1 Hz, 4H). 
13
C NMR (100 MHz, CDCl3): δ = 17.70, 21.73, 25.56, 43.59, 65.64, 98.42, 
169.57. This compound was prepared from [1] according to the procedure reported by 
Malkoch et al.
2
 Spectroscopic data agreed with those reported. 
 
General esterification procedure for divergent dendron growth, [Acet1-G1-TSe];[3]. 
[Acet1-G1-Anhy];[2] (41.88 g, 127 mmol, 1.3 equiv.), para-toluene sulfonyl ethanol (p-TSe) 
(19.53 g, 98 mmol, 1 equiv.) and 4-dimethylaminopyridine (DMAP) (2.38 g, 20 mmol, 0.2 
equiv.) were dissolved in anhydrous pyridine (40 mL, 5 equiv. per OH-group) and anhydrous 
CH2Cl2 (120 mL 1:3 ratio of pyridine:CH2Cl2 (v/v)) under a nitrogen atmosphere. The 
reaction was left to stir at ambient temperature for 16 hours, monitoring the reaction using 
TLC to confirm the loss of the starting alcohol. Following this, approximately 40 mL of 
distilled water was added and stirred vigorously at ambient temperature for an additional 2 
hours to quench the excess anhydride. The product was isolated by diluting the mixture with 
CH2Cl2 (1 L) and washing with 1 M NaHSO4 (3 x 400 mL), 1M NaHCO3 (3 x 400 mL), and 
brine (1 x 400 mL). The organic layer was dried over MgSO4 and evaporated to dryness. 
Residual solvent was removed under high vacuum overnight. Purification by liquid 
chromatography on silica was not required for the isolation of [3]. Yield: 33.69 g, colourless 
viscous oil, (97%). 
1
H NMR (400 MHz, CDCl3): δ = 1.07 (s, 3H), 1.35 (s, 3H), 1.41 (s, 3H), 
2.46 (s, 3H), 3.45 (t, 2H, J = 6.2 Hz), 3.56 (d, 2H, J = 11.9 Hz), 4.06 (d, 2H, J = 11.9 Hz), 
4.45 (t, 2H, J = 6.2 Hz), 7.38 (d, 1H, J = 7.9 Hz), 7.81 (d, 1H, J = 7.9 Hz). 
13
C NMR (100 
MHz, CDCl3): δ = 18.26, 21.62, 22.12, 25.09, 41.69, 55.06, 58.03, 65.75, 98.05, 128.17, 
130.11, 136.14, 145.28, 173.72. Calcd: [MH]
+
 (C17H25O6S) = 357.13 Da. Found: CI-MS: 
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[MH]
+
 = 357.14 Da. Anal. Calcd for C17H24O6S: C, 57.28; H, 6.79; S, 9.00. Found: C, 57.30; 
H, 6.81; S, 8.89. 
 
General deprotection procedure for removal of acetonide protecting groups, [(OH)2-G1-
TSe];[4]. DOWEX 50W-X2 (approx. 6 g) was added to a solution of [Acet1-G1-TSe];[3] 
(34.73 g, 97 mmol, 1 equiv.) in methanol (350 mL) and allowed to stir at 50 °C for 3 hours. 
The deprotection was monitored by TLC until total disappearance of the starting material 
resulted. Once complete, the resin was filtered off and the solution evaporated to dryness. 
Residual solvent was removed under high vacuum overnight. Yield: 30.49 g, white crystals, 
(99%). 
1
H NMR (400 MHz, CD3OD): δ = 1.05 (s, 3H), 2.47 (s, 3H), 3.15 (s, br, 1H), 3.44 (t, 
2H, J = 5.8 Hz), 3.73-3.85 (dd, 4H, J = 11.6 Hz), 4.53 (t, 2H, J = 5.8 Hz), 7.39 (d, 2H, J = 8.0 
Hz), 7.80 (d, 2H, J = 8.0 Hz). 
13
C NMR (100 MHz, CD3OD): δ = 17.06, 21.74, 49.65, 55.14, 
57.42, 67.96, 128.07, 130.22, 135.55, 145.57, 175.22. Calcd: [M+Na]
+
 (C14H20NaO6S) = 
339.10 Da. Found: ESI-MS: [M+Na]
+
 = 339.10 Da. Anal. Calcd for C14H20O6S: C, 53.15; H, 
6.37; S, 10.14. Found: C, 53.29; H, 6.44; S, 10.01. 
 
[Acet2-G2-TSe];[5]. [(OH)2-G1-TSe];[4] (14.73 g, 46.56 mmol, 1 equiv.), DMAP (2.56 g, 
20.95 mmol, 0.45 equiv.), [2] (46.15 g, 139.68 mmol, 3 equiv.), 38 mL pyridine and 114 mL 
CH2Cl2 were reacted according to the general esterification procedure, resulting in a viscous 
colourless oil that was purified by liquid chromatography on silica, eluted from 
EtOAc:hexane (10:90) increasing the polarity to EtOAc:hexane (50:50). Yield: 26.35 g, 
colourless viscous oil, (90%). 
1
H NMR (400 MHz, CDCl3): δ = 1.11 (s, 6H), 1.17 (s, 3H), 
1.34 (s, 6H), 1.41 (s, 6H), 2.46 (s, 3H), 3.45 (t, 2H, J = 6.2 Hz), 3.61 (d, 4H, J = 11.9 Hz), 
4.13 (d, 4H, J = 11.9 Hz), 4.19 (dd, 4H, J = 11.1 Hz), 4.45 (t, 2H, J = 6.2 Hz), 7.38 (d, 2H, J 
= 8.1 Hz), 7.80 (d, 2H, J = 8.1 Hz).
13
C NMR (100 MHz, CDCl3): δ = 17.37, 18.42, 21.65, 
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25.68, 42.09, 46.64, 54.83, 58.32, 65.06, 65.98, 65.98, 98.09, 128.05, 130.20, 136.24, 145.24, 
171.98, 173.46. Calcd: [M+Na]
+
 (C30H44NaO12S) = 651.73 Da. Found: ESI-MS: [M+Na]
+
 = 
651.20 Da. Anal. Calcd for C30H44O12S: C, 57.31; H, 7.05; S, 5.10. Found: C, 58.10; H, 7.16; 
S, 4.72. 
 
[(OH)4-G2-TSe];[6]. DOWEX 50W-X2 (approx. 5 g) and Acet2-G2-TSe [5] (25.26 g, 40.18 
mmol, 1 equiv) dissolved in methanol (250 mL) was reacted according to the general 
deprotection procedure. Yield: 20.72 g, white crystals, (99%). 
1
H NMR (400 MHz, CD3OD): 
δ = 1.13 (s, 9H), 2.46 (s, 3H), 3.58 (s, 2H), 3.64 (dd, 4H, J = 11.2 Hz), 4.10 (d, 4H, J = 11.2 
Hz), 4.43 (t, 2H, J = 5.6 Hz), 7.47 (d, 2H, J = 8.2 Hz), 7.82 (d, 2H, J = 8.2 Hz). 
13
C NMR 
(100 MHz, CD3OD): δ = 17.32, 18.46, 21.54, 25.56, 42.05, 46.66, 54.90, 58.35, 65.06, 66.00, 
98.04, 128.15, 130.07, 136.20, 145.22, 172.06, 173.40. Calcd: [M+Na]
+
 (C24H36NaO12S) = 
571.18 Da. Found: ESI-MS: [M+Na]
+
 = 571.20 Da. Anal. Calcd for C24H36O12S: C, 52.54; H, 
6.61; S, 5.84. Found: C, 52.49; H, 6.56; S, 5.31.  
 
[Acet4-G3-TSe];[7]. [(OH)4-G2-TSe];[6] (5.89 g, 11 mmol, 1 equiv.), DMAP (0.81 g, 7 
mmol, 0.62 equiv.), [2] (21.27 g, 64 mmol, 6 equiv.), 53 mL pyridine and 160 mL CH2Cl2 
were reacted according to the general esterification procedure, resulting in a viscous 
colourless oil that was purified by liquid chromatography on silica, eluted from 
EtOAc:hexane (20:80) increasing the polarity to EtOAc:hexane (60:40). Yield: 12.46 g, 
colourless viscous oil, (99%). 
1
H NMR (400 MHz, CDCl3): δ = 1.14 (s, 12H), 1.18 (s, 3H), 
1.27 (s, 6H), 1.35 (s, 12H), 1.41 (s, 12H), 2.46 (s, 3H), 3.46 (t, 2H, J = 6.0 Hz), 3.6 (d, 8H, J 
= 12.1 Hz) 4.08-4.22 (m, 12H), 4.31 (m, 8H), 4.48 (t, 2H, J = 6.0 Hz), 7.39 (d, 2H), 7.82 (d, 
2H).
13
C NMR (100 MHz, CDCl3): δ = 17.25, 17.68, 18.44, 21.67, 22.01, 25.20, 42.05, 46.63, 
46.93, 54.74, 58.32, 64.95, 65.76, 65.93, 65.98, 98.07, 128.15, 130.13, 136.23, 145.11, 
CHAPTER 7 
294 
 
171.67, 171.88, 173.47. Calcd: [M+Na]
+
 (C56H84NaO24S) = 1195.50 Da. Found: ESI-MS: 
[M+Na]
+
 = 1195.50 Da. Anal. Calcd for C56H84O24S: C, 57.32; H, 7.22; S, 2.73. Found: C, 
57.33; H, 7.18; S, 2.35. 
 
[(OH)8-G3-TSe];[8]. DOWEX 50W-X2 (approx. 4 g) and Acet4-G3-TSe [7] (22.66 g, 19 
mmol, 1 equiv) dissolved in methanol (300 mL) was reacted according to the general 
deprotection procedure. Yield: 19.44 g, white crystals, (99%). 
1
H NMR (400 MHz, CD3OD): 
δ = 1.17 (s, 15H), 1.30 (s, 6H), 2.49 (s, 3H), 3.56- 3.73 (m, 18H), 4.14-4.38 (m, 12H), 4.49 (t, 
2H, J = 5.5 Hz), 7.51 (d, 2H), 7.87 (d, 2H). 
13
C NMR (100 MHz, CD3OD): δ = 17.40, 17.71, 
18.35, 21.61, 47.74, 47.88, 51.91, 55.75, 59.77, 65.91, 66.15, 67.06, 129.38, 131.30, 138.01, 
146.83, 173.33, 173.70, 175.97. Calcd: [M+Na]
+
 (C44H68NaO24S) = 1035.37 Da. Found: ESI-
MS: [M+Na]
+
 = 1035.40 Da. Anal. Calcd for C44H68O24S: C, 52.17; H, 6.77; S, 3.17. Found: 
C, 51.97; H, 6.65; S, 3.15.  
 
2-((Ethoxycarbonothioyl)thio)acetic acid [Xan-COOH];[9]. Potassium ethyl xanthogenate 
(53.06 g, 331 mmol) was stirred in acetone (400 mL). A solution of 2-bromoacetic acid 
(38.35 g, 276 mmol) in acetone (100 mL) was added dropwise over 20 minutes. The reaction 
was left to stir overnight at ambient temperature. The precipitated potassium bromide by-
product was filtered off and washed with a small volume of acetone. The solvent was 
removed under vacuum. The residue was then diluted in CH2Cl2 (300 mL) and washed with 
brine (3 x 100 mL). The organic phase was dried over MgSO4 and evaporated to give [9] as a 
pale yellow solid. Yield: 36.35g (73%) 
1
H NMR (400 MHz, CDCl3): δ = 1.43 (t, 3H, J = 7.2 
Hz), 3.96 (s, 2H), 4.66 (q, 2H, J = 7.2 Hz), 9.12 (s, 1H, br). 
13
C NMR (100 MHz, CDCl3): δ 
13.79, 37.56, 70.99, 174.13, 212.0. 
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2-((Ethoxycarbonothioyl)thio)acetic anhydride [Xan-Anhy];[10]. [Xan-COOH];[9] (27.53 g, 
152 mmol, 1 equiv.) was dissolved in 100 mL CH2Cl2. A solution N,Nʹ′-
Dicyclohexylcarbodiimide (DCC) (20.76 g, 101 mmol, 0.5 equiv.) in CH2Cl2 was slowly 
added to the mixture, and the reaction allowed to stir at ambient temperature overnight. The 
reaction was monitored by 
13
C NMR. Determination of reaction completion resulted by the 
appearance of the anhydride carbonyl carbon at 163 ppm and the disappearance of the acid 
carbonyl carbon at 174 ppm. The dicyclohexylurea (DCU) by-product was removed by 
filtration, washed with a small volume of CH2Cl2 and the solvent evaporated under vacuum. 
Yield: 26.00 g, yellow solid, (99%). 
1
H NMR (400 MHz, CDCl3): δ = 1.44 (t, 6H, J = 7.1 Hz) 
4.07 (s, 4H), 4.67 (q, 4H, J = 7.1 Hz). 
13
C NMR (100 MHz, CDCl3): δ = 13.64, 38.51, 71.28, 
163.04, 211.44. 
 
4-(Dimethylamino)pyridinium p-toluenesulfonate [DPTS] – p-toluenesulfonic acid 
monohydrate (7.80 g, 41 mmol, 1 equiv) was dried by azeotropic distillation with 50 mL 
anhydrous toluene using a dean-stark head (approximately 4 hours). [Note: the solution 
turned dusty pink during the loss of water]. Following this, the mixture was cooled to 60 °C 
and 4-dimethylaminopyridine (DMAP) (5 g, 41 mmol, 1 equiv.) in 30 mL of anhydrous 
toluene at 60 °C added slowly. An off-white precipitate immediately formed upon addition, 
and the solution was left to stir at 60 °C for 1 hour. The mixture was then cooled and filtered 
to yield DPTS. The product was recrystallised once from 1,2-dichloroethane to yield white 
crystals. Yield: 11.83 g (98%). 
1
H NMR (400 MHz, CDCl3): δ = 2.34 (s, 3H), 3.17 (s, 6H), 
6.76 (d, J = 7.7 Hz, 2H), 7.16 (d, J = 8.2 Hz, 2H), 7.81 (d, J = 8.2 Hz, 2H), 8.16 (d, J = 7.7 
Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ = 21.34, 40.15, 106.86, 126.00, 128.72, 139.49, 
142.76, 157.26. Anal. Calcd for C14H18N2O3S: C, 57.12; H, 6.16; N, 9.52; S, 10.89. Found: 
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C, 57.30; H, 6.12; N, 9.51; S, 10.84. This compound was prepared by the procedure reported 
by Moore and Stupp. The above spectroscopic data agreed with that reported.
3
 
 
General procedure for functionalisation with Xanthate surface groups using 
DCC/DPTS chemistry, [Xan1-G0-TSe];[11]. Para-toluenesulfonyl ethanol (p-TSe) (2.76 g, 
14 mmol, 1 equiv.), [Xan-COOH];[9] (2.50 g, 14 mmol, 1 equiv.) and DPTS (4.47 g, 15 
mmol, 1.1 equiv.) were dissolved in CH2Cl2 (anhydrous, 35 mL) under a nitrogen 
atmosphere. Dicyclohexylcarbodiimide (DCC) (3.13 g, 15 mmol, 1.1 equiv.) was added in 
CH2Cl2 (anhydrous, 15 mL) whilst cooling in an ice bath. The reaction was allowed to warm 
to ambient temperature and the reaction mixture stirred overnight for 16 hours. The 
precipitated dicyclohexylurea (DCU) by-product was removed by filtration and washed with 
a small volume of CH2Cl2. The crude product was purified by liquid chromatography on 
silica gel, eluting with hexane gradually increasing to 30:70 ethyl acetate:hexane.. Yield: 3.75 
g, yellow oil (75%) 
1
H NMR (400 MHz, CDCl3): δ = 1.13 (t, 3H, J = 7.30 Hz), 2.18 (s, 3H), 
3.18 (t, 2H, J = 6.1 Hz), 3.42 (s, 2H), 4.19 (t, 2H, J = 6.1 Hz), 4.35 (q, 2H, J = 7.1 Hz), 7.10 
(d, 2H, J = 8.1 Hz), 7.52 (d, 2H, J = 8.1 Hz). 
13
C NMR (100 MHz, CDCl3): δ =  13.48, 21.34, 
37.26, 54.52, 58.74, 70.62, 127.96, 129.68, 136.00, 144.83, 167.08, 212.14. Calcd: [M+Na]
+
 
(C14H18NaO5S3) = 385.03. Found ESI-MS: [M+Na]
+
 = 385.0. Calcd for C14H18O5S3: C, 
46.39; H, 5.01; S, 26.53. Found: C, 46.56; H, 5.00; S, 26.40. 
 
[Xan2-G1-TSe];[12]. This compound was prepared by the procedure reported by Auty et al.
4
 
The hydroxyl-terminated dendron [(OH)2-G1-TSe];[4] (10.23 g, 32 mmol, 2.5 equiv.), [Xan-
COOH];[9] (17.55 g, 97 mmol, 7.5 equiv.) and DPTS (3.81 g, 13 mmol, 1 equiv.) were 
dissolved in CH2Cl2 (anhydrous, 100 mL) under a nitrogen atmosphere. DCC (22.01 g, 107 
mmol, 8.25 equiv.) was added in CH2Cl2 (anhydrous, 50 mL) and the reaction mixture stirred 
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overnight for 16 hours. The crude product was purified by liquid chromatography on silica 
gel, eluting with hexane gradually increasing to 40:60 ethyl acetate:hexane to give a viscous 
oil. Yield: 17.36 g, orange viscous oil (84%) 
1
H NMR (400 MHz, CDCl3): δ = 1.16 (s, 3H), 
1.42 (t, 6H, J = 7.1 Hz), 2.46 (s, 3H), 3.44 (t, 2H, J = 6.0 Hz), 3.91 (s, 4H), 4.17 (dd, 4H, J = 
11.0), 4.46 (t, 2H, J = 6.0 Hz), 4.65 (q, 4H, J = 7.1 Hz), 7.39 (d, 2H, J = 8.0 Hz), 7.81 (d, 2H, 
J = 8.0 Hz). 
13
C NMR (100 MHz, CDCl3): δ =  13.80, 17.52, 21.74, 37.77, 46.22, 54.99, 
58.36, 66.13, 70.86, 128.09, 130.12, 136.20, 145.31, 167.26, 171.82, 212.50. Calcd: [M+Na]
+
 
(C24H32NaO10S5) = 663.06. Found ESI-MS: [M+Na]
+
 = 663.0. Calcd for C24H32O10S5: C, 
44.98; H, 5.03; S, 25.02. Found: C, 45.61; H, 5.15; S, 25.68.  
 
[Xan4-G2-TSe];[13]. The hydroxyl-terminated dendron [(OH)4-G2-TSe];[6], [Xan-
COOH];[9], DPTS (3.07 g, 10 mmol) and DCC (17.76 g, 86 mmol) were allowed to react 
according to the general esterification procedure in anhydrous CH2Cl2 (200 mL) for 18 hours. 
The crude product was purified by liquid chromatography on silica gel, eluting with hexane 
gradually increasing to 50:50 ethyl acetate:hexane. Yield: 14.04 g, orange viscous oil (90%). 
1
H NMR (400 MHz, CDCl3): δ = 1.20 (s, 3H), 1.25 (s, 6H), 1.42 (t, 12H, J = 7.1 Hz), 2.46 (s, 
3H), 3.46 (t, 2H, J = 5.9 Hz), 3.94 (s, 8H), 4.20 (s, 4H), 4.26 (dd, 8H, J = 11.0), 4.46 (t, 2H, J 
= 5.9 Hz), 4.64 (q, 8H, J = 7.1 Hz), 7.40 (d, 2H, J = 8.0 Hz), 7.82 (d, 2H, J = 8.0 Hz). 
13
C 
NMR (100 MHz, CDCl3): δ =  13.76, 17.37, 17.90, 21.69, 37.70, 46.44, 46.64 54.85, 58.48, 
65.58, 66.24, 70.85, 128.12, 130.24, 136.35, 145.26, 167.36, 171.65, 171.82, 212.56. Calcd: 
[M+Na]
+
 (C44H60NaO20S9) = 1219.12. Found MALDI-TOF MS: [M+Na]
+
 = 1219.1. Calcd 
for C44H60O20S9: C, 44.13; H, 5.05; S, 24.1. Found: C, 44.83; H, 5.19; S, 24.34. 
 
General procedure for functionalisation with Xanthate surface groups using anhydride 
chemistry, [Xan8-G3-TSe];[14]. This compound was prepared by the procedure reported by 
CHAPTER 7 
298 
 
Auty et al.
5
 [(OH)8-G3-TSe];[8] (7.24 g, 7 mmol, 1 equiv.) and DMAP (1.40 g, 11 mmol, 1.6 
equiv.) were dissolved in anhydrous pyridine (40 mL). After cooling the mixture in an ice 
bath, [Xan-Anhy];[10] (25.41 g, 74 mmol, 10.4 equiv.) in anhydrous CH2Cl2 (80 mL) was 
added slowly under a nitrogen atmosphere. After stirring at ambient temperature for 16 hours, 
approximately 15 mL of distilled water was added and stirred vigorously at ambient 
temperature for an additional 2 hours to quench the excess anhydride. The product was 
isolated by diluting the mixture with CH2Cl2 (350 mL) and washing with 1 M NaHSO4 (3 x 
1200 mL), 1M NaHCO3 (3 x 200 mL), and brine (1 x 200 mL). The organic layer was dried 
over MgSO4 and evaporated to dryness. Purification by liquid chromatography on silica, 
eluted from EtOAc:hexane (15:85) increasing the polarity to EtOAc:hexane (50:50). Residual 
solvent was removed under high vacuum overnight. Yield: 10.10 g, orange viscous oil, 
(61%). 
1
H NMR (400 MHz, CDCl3): δ = 1.20-1.30 (m, 21H), 1.42 (t, 24H, J = 7.2 Hz), 2.47 
(s, 3H), 3.47 (t, 2H, J = 5.8 Hz), 3.94 (s, 16H), 4.16-4.36 (m, 28H), 4.49 (t, 2H, J = 5.8 Hz), 
4.64 (q, 16H, J = 7.2 Hz) 7.40 (d, 2H), 7.81 (d, 2H). 
13
C NMR (100 MHz, CDCl3): δ = 13.67, 
17.28, 17.63, 17.89, 21.73, 37.64, 46.27, 46.51, 46.75, 54.71, 58.35, 65.44, 66.23, 70.82, 
128.15, 130.26, 136.39, 145.22, 167.46, 171.48, 171.63, 171.68, 212.71. Calcd: [M+Na]
+
 
(C84H116NaO40S17) = 2331.22 Da. Found: MALDI-TOF MS: [M+Na]
+
 = 2331.42 Da. Anal. 
Calcd for C84H116O40S17: C, 43.66; H, 5.06; S, 23.59. Found: C, 44.01; H, 5.04; S, 23.86. 
 
General procedure for deprotection of para-toluene sulfonyl ester (TSe) - 1,8- 
diazabicyclo[5.4.0]undec-7-ene (DBU) (1.3 equiv.) added to xanthate functional dendron 
dissolved in anhydrous CH2Cl2. The reaction was stirred under a nitrogen atmosphere for 16 
hours and monitored by using TLC (40:60 ethyl acetate:hexane). The product was isolated by 
diluting the mixture with CH2Cl2 (100 mL) and washing with 1 M NaHSO4 (2 x 100 mL). 
The organic layer was dried over MgSO4 and evaporated to dryness. The product was then 
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precipitated three times into hexane:ethyl acetate (9:1). Any residual solvent was removed 
under high vacuum to yield a viscous oil. 
 
[Xan2-G1-COOH];[15]. The removal of the para-toluene sulfonyl (p-TSe) protecting group 
was carried out as described above with [Xan2-G1-TSe];[12] (4.60 g, 7.18 mmol, 1.0 equiv), 
and DBU (1.40 mL, 9.33 mmol, 1.3 equiv). Yield: 3.10 g, orange viscous oil (94%). 
1
H NMR 
(400 MHz, CDCl3): δ = 1.32 (s, 3H), 1.42 (t, J = 7.10, 6H), 2.47 (s, 3H), 3.94 (s, 4H), 4.30 (d, 
J = 11.1 Hz, 2H), 4.36 (d, J = 11.1 Hz, 2H), 4.64 (q, J = 7.1 Hz, 4H). 
13
C NMR (100 MHz, 
CDCl3): δ = 13.74, 17.86, 37.74, 46.06, 66.13, 70.87, 167.45, 177.80, 212.53. Calcd: 
[M+Na]
+
 (C15H22NaO8S4) m/z = 481.02. Found: ESI-MS: [M+Na]
+
 m/z = 481.00. Anal. 
Calcd for C15H22O8S4: C, 39.29; H, 4.84; S, 27.97. Found: C, 40.06; H, 5.06 S, 25.82. 
 
[Xan4-G2-COOH];[16]. The removal of the para-toluene sulfonyl (p-TSe) protecting group 
was carried out as described above with [Xan4-G2-TSe];[13] (5.02 g, 4.18 mmol, 1.0 equiv), 
and DBU (0.81 mL, 5.43 mmol, 1.3 equiv). Yield: 4.05 g, orange viscous oil (93%). 
1
H NMR 
(400 MHz, CDCl3): δ = 1.27 (s, 6H), 1.33 (s, 3H), 1.42 (t, J = 7.1 Hz, 12H), 3.94 (s, 8H), 
4.21-4.36 (m, 12H), 4.64 (q, J = 7.1 Hz, 8H). 
13
C NMR (100 MHz, CDCl3): δ = 13.67, 17.89, 
37.64, 46.46, 65.83, 66.40, 71.00, 167.46, 171.68, 175.13, 212.71. Calcd: [M+Na]
+
 
(C35H50NaO18S8) m/z = 1037.07. Found ESI-MS: [M+Na]
+
 m/z = 1037.1. Anal. Calcd for 
C35H50O18S8: C, 41.40; H, 4.96; S, 25.27. Found: C, 42.06; H, 5.15; S, 24.82. 
 
[Xan8-G3-COOH];[17]. The removal of the para-toluene sulfonyl (p-TSe) protecting group 
was carried out as described above with [Xan8-G3-TSe];[14] (9.07 g, 3.93 mmol, 1.0 equiv), 
and DBU (0.76 mL, 5.10 mmol, 1.3 equiv). Yield: 7.97 g, orange viscous oil (95%). 
1
H NMR 
(400 MHz, CDCl3): δ = 1.26 (s, 12H), 1.29 (s, 6H), 1.35 (s, 3H), 1.42 (t, J = 7.1 Hz, 24H), 
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3.95 (s, 16H), 4.21-4.36 (m, 28H), 4.64 (q, J = 7.1 Hz, 16H). 
13
C NMR (100 MHz, CDCl3): δ 
= 13.70, 17.98, 37.70, 46.41, 66.30, 70.91, 167.70, 171.65, 172.95, 212.57. Calcd: [M+Na]
+
 
(C75H106NaO38S16) m/z = 2149.19. Found MALDI-TOF: [M+Na]
+
 m/z = 2151.7. Anal. Calcd 
for C75H106O38S16: C, 42.32; H, 5.02; S, 28.56. Found: C, 43.15; H, 5.09; S, 23.79. 
 
Dendrimer synthesis by convergent growth; [Xan12-G2-THPE];[18]. Focal point acid 
functional dendron [Xan4-G2-COOH];[16] (3.94 g, 3.78 mmol, 3.8 equiv.), 1,1,1-tris(4-
hydroxyphenyl)ethane (THPE) (0.304 g, 0.994 mmol, 1 equiv.) and DPTS (0.878 g, 2.98 
mmol, 3 equiv.) were dissolved in CH2Cl2 (anhydrous, 20 mL) under nitrogen. DCC (0.861 g, 
4.17 mmol, 4.2 equiv.) in CH2Cl2 (anhydrous, 10 mL) was added and the reaction left to stir 
at ambient temperature for 16 hours. The precipitated DCU by-product was removed by 
filtration and the product isolated by diluting with CH2Cl2 (100 mL) and washing with 1 M 
NaHSO4 (2 x 100 mL). The organic layer was dried over MgSO4 and the solvent removed in 
vacuo. The product was purified by liquid chromatography on silica gel, eluting with ethyl 
acetate:hexane (10:90, gradually increasing to 50:50). Yield: 1.46 g, orange viscous oil 
(44%). 
1
H NMR (400 MHz, CDCl3): δ = 1.29 (s, 21H), 1.41 (t, J = 7.1 Hz, 36H), 1.44 (s, 
9H), 3.90 (s, 24H), 4.21-4.36 (m, 24H), 4.42 (s, 12H), 4.63 (q, J = 7.1 Hz, 24H), 6.98 (d, J = 
8.8 Hz), 7.11 (d, J = 8.8 Hz). 
13
C NMR (100 MHz, CDCl3): δ = 13.74, 18.02, 37.61, 46.34, 
51.74, 66.26, 70.87, 120.77, 129.82, 146.46, 148.43, 167.53, 171.81, 212.65. Calcd: [M+Na]
+
 
(C125H162NaO54S24) m/z = 3317.3. Found MALDI-TOF: [M+Na]
+
 m/z = 3316.4. 
 
2-Hydroxyethyl-2-bromoisobutyrate, [HEBiB];[19]. Ethylene glycol (272 mL, 4.85 mol, 50 
equiv.) and triethylamine (TEA) (28 mL, 0.20 mol, 2 equiv.) were dissolved in anhydrous 
THF (100 mL). α-Bromoisobutyryl bromide (12 mL, 97.1 mmol, 1 equiv.) was added 
dropwise over 30 minutes whilst cooling with an ice bath. The reaction was left to stir at 
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ambient temperature under a nitrogen atmosphere for 16 hours. The product was isolated by 
pouring the crude mixture into distilled water (800 mL) and extracting the aqueous phase 
with CH2Cl2 (6 x 100 mL). The combined organic layers were washed with 1 M HCl (pH 4) 
(2 x 300mL), dried over MgSO4 and evaporated to dryness. Residual solvent was removed 
under high vacuum overnight. Yield: 15.64 g, pale yellow oil, (76%) 
1
H NMR (400 MHz, 
CDCl3): δ = 1.96 (s, 6H), 3.88 (m, J = 4.7 Hz, 2H), 4.32 (m, J = 4.7 Hz, 2H). 
13
C NMR (100 
MHz, CDCl3): δ = 30.70, 55.86, 60.82, 67.47, 171.94. Calcd: [M+NH4]
+
 (C6H15BrNO3) m/z 
= 228.02. Found: CI MS: [M+NH4]
+
 m/z = 228.02. Anal. Calcd for C6H11BrO3: C, 34.14; H, 
5.25. Found: C, 34.63; H, 5.30. This compound was prepared by Jakubowski et al.
6
 The 
above spectroscopic data agreed with that reported. 
 
General procedure for focal point modification to α-bromoisobutyrate moiety, [Xan1-
G0-BiB];[20]. [Xan-COOH];[9] (2.42 g, 13 mmol, 1 equiv.), [HEBiB];[19] (2.83 g, 13 mmol, 
1 equiv.), and DPTS (4.33 g, 15 mmol, 1.1 equiv.) were dissolved in CH2Cl2 (anhydrous, 35 
mL) under a nitrogen atmosphere. DCC (3.04 g, 15 mmol, 1.1 equiv.) in CH2Cl2 (anhydrous, 
15 mL) was added and the reaction left to stir at ambient temperature for 16 hours. The 
precipitated DCU by-product was removed by filtration and the product isolated by diluting 
the mixture with CH2Cl2 (100 mL), washing with distilled water (2 x 100 mL) and brine (1 x 
100 mL). The organic layer was dried over MgSO4 and evaporated to dryness. The residue 
was purified by liquid chromatography on silica, eluting from ethyl acetate:hexane (10:90), 
gradually increasing the polarity to ethyl acetate:hexane (30:70). Residual solvent was 
removed under high vacuum overnight. Yield: 3.74 g, yellow oil, (75%). 
1
H NMR (400 MHz, 
CDCl3): δ = 1.42 (t, J = 7.1 Hz, 3H), 1.94 (s, 6H), 3.96 (s, 2H), 4.41 (s, 4H), 4.65 (q, J = 7.1 
Hz, 2H). 
13
C NMR (100 MHz, CDCl3): δ = 13.48, 30.36, 37.44, 55.09, 62.95, 70.43, 167.46, 
171.10, 212.14. Calcd: [M+Na]
+
 (C11H17BrNaO5S2) m/z = 394.97. Found: ESI-MS: [M+Na]
+
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m/z = 395.0 Anal. Calcd for C11H17BrO5S2: C, 35.39; H, 4.59; S, 17.18. Found: C, 35.76; H, 
4.57; S, 16.76. 
 
[Xan2-G1-BiB];[21]. [Xan2-G1-COOH];[15] (8.25 g, 18 mmol, 1 equiv.), [19] (5.70 g, 27 
mmol, 1.5 equiv.), DPTS (1.06 g, 3.6 mmol, 0.2 equiv.), DCC (7.43 g, 36 mmol, 2 equiv.) in 
anhydrous CH2Cl2 (80 mL) were reacted according to the general procedure for focal point 
modification resulting in a viscous yellow oil that was purified by liquid chromatography on 
silica, eluting from ethyl acetate:hexane (10:90), gradually increasing the polarity to ethyl 
acetate:hexane (30:70). Yield: 6.39 g, yellow viscous oil, (55%). 
1
H NMR (400 MHz, 
CDCl3): δ = 1.28 (s, 3H), 1.42 (t, J = 7.1 Hz, 6H), 1.94 (s, 6H), 3.93 (s, 4H), 4.31 (d, J = 11.1 
Hz, 2H), 4.35 (d, J = 11.1 Hz, 2H), 4.40 (s, 4H), 4.65 (q, J = 7.1 Hz, 4H). 
13
C NMR (100 
MHz, CDCl3): δ = 13.67, 17.89, 30.74, 37.84, 46.28, 55.28, 62.76, 63.34, 66.21, 70.82, 
167.46, 171.49, 172.06, 212.52. Calcd: [M+Na]
+
 (C21H31BrNaO10S4) m/z = 673.0. Found: 
ESI-MS: [M+Na]
+
 m/z = 673.0 Anal. Calcd for C21H31BrO10S4: C, 38.71; H, 4.80; S, 19.68. 
Found: C, 40.08; H, 4.98; S, 19.50. 
 
[Xan4-G2-BiB];[22]. [Xan4-G2-COOH];[16] (6.52 g, 6.42 mmol, 1 equiv.), [19] (2.03 g, 9.63 
mmol, 1.5 equiv.), DPTS (0.38 g, 1.28 mmol, 0.2 equiv.), DCC (2.65 g, 12.84 mmol, 2 
equiv.) in anhydrous CH2Cl2 (60 mL) were reacted according to the general procedure for 
focal point modification resulting in a viscous orange oil that was purified by liquid 
chromatography on silica, eluting from ethyl acetate:hexane (20:80), gradually increasing the 
polarity to ethyl acetate:hexane (60:40). Yield: 4.53 g, orange viscous oil, (58%). 
1
H NMR 
(400 MHz, CDCl3): δ = 1.26 (s, 6H), 1.29 (s, 3H), 1.42 (t, J = 7.2 Hz, 12H), 1.94 (s, 6H), 
3.95 (s, 8H), 4.19-4.36 (m, 12H), 4.36-4.49 (m, 4H), 4.64 (q, J = 7.1 Hz, 8H). 
13
C NMR (100 
MHz, CDCl3): δ = 13.67, 17.65, 17.87, 30.74, 37.64, 46.27, 46.67, 55.48, 62.90, 63.34, 
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65.66, 66.21, 70.82, 167.46, 171.37, 171.67, 171.86, 212.71. Calcd: [M+Na]
+
 
(C41H59BrNaO12S8) m/z = 1229.04. Found: ESI-MS: [M+Na]
+
 m/z = 1229.17. Anal. Calcd 
for C41H59BrO20S8: C, 40.75; H, 4.92; S, 21.23. Found: C, 39.69; H, 4.92; S, 18.48. 
 
[Xan8-G3-BiB];[23]. [Xan8-G3-COOH];[17] (3.98 g, 1.87 mmol, 1 equiv.), [19] (0.40 g, 1.87 
mmol, 1 equiv.), DPTS (0.61 g, 2.06 mmol, 1.1 equiv.), DCC (0.42 g, 2.06 mmol, 1.1 equiv.) 
in anhydrous CH2Cl2 (40 mL) were reacted according to the general procedure for focal point 
modification resulting in a viscous orange oil that was purified by liquid chromatography on 
silica, eluting from ethyl acetate:hexane (15:85), gradually increasing the polarity to ethyl 
acetate:hexane (50:50). Yield: 2.47 g, orange viscous oil, (57%). 
1
H NMR (400 MHz, 
CDCl3): δ = 1.26 (s, 12H), 1.28 (s, 6H), 1.32 (s, 3H), 1.42 (t, J = 7.1 Hz, 24H), 1.94 (s, 6H), 
3.95 (s, 16H), 4.21-4.38 (m, 28H), 4.21 (s, 4H), 4.64 (q, J = 7.1 Hz, 16H). 
13
C NMR (100 
MHz, CDCl3): δ = 13.67, 17.89, 30.74, 37.64, 46.27, 55.48, 60.85, 66.21, 70.82, 167.46, 
171.67, 212.71. Calcd: [M+Na]
+
 (C81H115BrNaO40S16) m/z = 2341.17. Found: MALDI-TOF: 
[M+Na]
+
 m/z = 2341.4. Anal. Calcd for C81H115BrO40S16: C, 41.91; H, 4.99; S, 22.09. Found: 
C, 43.15; H, 5.14; S, 21.85. 
 
Linear ATRP of tert-butyl methacrylate (tBMA) in IPA/H2O with [Xan2-G1-BiB];[21] or 
[Xan4-G2-BiB];[22]; p[(Xan2-G1)-tBMA50];[25] and p[(Xan4-G2)-tBMA50];[26]. In a 
typical synthesis, targeting DPn = 50 monomer units for the primary chains, [Xan2-G1-
BiB];[21] (0.1744 g, 0.281 mmol, 1 equiv.), tBMA (2 g, 14.1 mmol, 50 equiv.) and bpy 
(0.105 g, 0.563 mmol, 2 equiv.) were placed into a 10 mL round-bottomed flask. IPA/H2O 
(92.5/7.5 v/v) was added (50 wt% based on tBMA; 2g, 2.6 mL) and the solution stirred and 
deoxygenated using a nitrogen purge for 10 minutes. Cu(I)Cl (28 mg, 0.281 mmol, 1 equiv) 
was added to the flask, whilst maintaining a positive flow of nitrogen, and the solution left to 
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polymerise at 30 °C. The reaction was terminated when conversion reached >95%, indicated 
by 
1
H NMR after 18 hours, by exposure to oxygen and addition of THF. The solution was 
passed through a neutral alumina column to remove the catalytic system, and precipitated 
twice into cold hexane. After drying the precipitated sample overnight under high vacuum, 
the polymer was obtained as a white solid. 
 
Branched ATRP of tBMA in IPA/H2O with [Xan2-G1-BiB];[21] or [Xan4-G2-BiB];[22]; 
p[(Xan2-G1)-tBMA50-co-EGDMA0.8];[27] and p[(Xan4-G2)-tBMA50-co-EGDMA0.8];[28]. 
In a typical synthesis, targeting DPn = 50 monomer units for the primary chains, [Xan2-G1-
BiB];[21] (0.1744 g, 0.281 mmol, 1 equiv.), tBMA (2 g, 14.1 mmol, 50 equiv.), bpy (0.105 g, 
0.563 mmol, 2 equiv.) and bifunctional monomer ethylene glycol dimethacrylate (EGDMA) 
(45 mg, 0.225 mmol, 0.8 equiv.) were placed into a 10 mL round-bottomed flask. IPA/H2O 
(92.5/7.5 v/v) was added (50 wt% based on tBMA, 2g, 2.6 mL) and the solution stirred and 
deoxygenated using a nitrogen purge for 10 minutes. Cu(I)Cl (28 mg, 0.281 mmol, 1 equiv) 
was added to the flask, whilst maintaining a positive flow of nitrogen, and the solution was 
left to polymerise at 30 °C. The reaction was terminated when conversion reached >98%, 
indicated by 
1
H NMR after 18 hours, by exposure to oxygen and addition of THF. The 
solution was passed through a neutral alumina column to remove the catalytic system, and 
precipitated twice into cold hexane. After drying the precipitated sample overnight under 
high vacuum, the polymer was obtained as a white solid. 
 
Linear ATRP of n-butyl methacrylate (nBMA) in methanol with [Xan1-G0-BiB];[20], 
[Xan2-G1-BiB];[21], [Xan4-G2-BiB];[22] or [Xan8-G3-BiB];[23], targeting DPn = 50 or 
100 monomer units; p[(Xan2-G1)-nBMA50];[29] and p[(Xan4-G2)-nBMA50];[30], 
p[(Xan8-G3)-nBMA50];[31], p[(Xan1-G0)-nBMA100];[32] , p[(Xan2-G1)-nBMA100];[33] , 
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p[(Xan4-G2)-nBMA100];[34] , p[(Xan8-G3)-nBMA100];[35]. In a typical synthesis, targeting 
DPn = 100 monomer units for the primary chains, [Xan2-G1-BiB];[21] (46 mg, 0.0702 mmol, 
1 equiv.), nBMA (1 g, 7.03 mmol, 100 equiv.) and bpy (22 mg, 0.141 mmol, 2 equiv.) were 
placed into a 5 mL round-bottomed flask. Methanol was added (50 wt% based on nBMA; 2g, 
2.6 mL) and the solution stirred and deoxygenated using a nitrogen purge for 30 minutes. 
Cu(I)Cl (7 mg, 0.0702 mmol, 1 equiv) was added to the flask, whilst maintaining a positive 
flow of nitrogen, and the solution left to polymerise at 60 °C. The reaction was terminated 
when conversion reached >95%, indicated by 
1
H NMR after 21 hours, by exposure to oxygen 
and addition of THF. The solution was passed through a neutral alumina column to remove 
the catalytic system, and precipitated twice into cold petroleum ether (40-60 °C). After drying 
the precipitated sample overnight under high vacuum, the polymer was obtained as a white 
solid. 
 
Branched ATRP of nBMA in methanol with [Xan1-G0-BiB];[20], [Xan2-G1-BiB];[21], 
[Xan4-G2-BiB];[22] or [Xan8-G3-BiB];[23]; p[(Xan1-G0)-nBMA100-co-EGDMA0.7];[36], 
p[(Xan2-G1)-nBMA100-co-EGDMA0.8];[37], p[(Xan4-G2)-nBMA100-co-EGDMA0.8];[38], 
p[(Xan8-G3)-nBMA100-co-EGDMA0.8];[39]. In a typical synthesis, targeting DPn = 100 
monomer units for the primary chains, [Xan2-G1-BiB];[21] (92 mg, 0.141 mmol, 1 equiv.), 
nBMA (2 g, 14.1 mmol, 100 equiv.), bpy (44 mg, 0.281 mmol, 2 equiv.) and EGDMA (22 
mg, 0.113 mmol, 0.8 equiv.) were placed into a 10 mL round-bottomed flask. Methanol was 
added (50 wt% based on nBMA, 2g, 2.6 mL) and the solution stirred and deoxygenated using 
a nitrogen purge for 30 minutes. Cu(I)Cl (14 mg, 0.141 mmol, 1 equiv) was added to the 
flask, whilst maintaining a positive flow of nitrogen, and the solution was left to polymerise 
at 60 °C. The reaction was terminated when conversion reached >98%, indicated by 
1
H NMR 
after 24 hours, by exposure to oxygen and addition of THF. The solution was passed through 
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a neutral alumina column to remove the catalytic system, and precipitated twice into cold 
petroleum ether (40-60 °C). After drying the precipitated sample overnight under high 
vacuum, the polymer was obtained as a white solid. 
 
7.3 Chapter 3 compounds 
General procedure for Sequential Thiol-Michael addition click reactions - Xanthate 
peripheral dendron (200mg) was dissolved in anhydrous THF (2 mL) and degassed for 5 
minutes under a nitrogen atmosphere. n-Butylamine (1 equiv. per xanthate group) was added 
and the reaction left for 1.5 hrs or until completion by TLC (60:40 hexane:ethyl acetate). 2-
(Dimethylamino)ethyl (Am) acrylate (1.5 equiv per thiol) was added and the reaction mixture 
stirred at ambient temperature for 16 hours. The product was isolated by precipitating twice 
into hexane. Residual solvent was removed under high vacuum to yield a viscous oil. The 
partially-functionalised product was then dissolved in anhydrous THF (2 mL) and degassed 
for 5 minutes under a nitrogen atmosphere. n-Butylamine (1.2 equiv per remaining xanthate 
group) was added and the reaction left for 1.5 hrs or until completion by TLC (60:40 
hexane:ethyl acetate). Benzyl (Bz) acrylate (1.5 equiv per thiol) was added and the reaction 
mixture stirred at ambient temperature for 16 hours. The product was isolated by precipitating 
twice into hexane. Residual solvent was removed under high vacuum to yield a viscous oil. 
 
General procedure for Simultaneous Thiol-Michael addition click reactions - Xanthate 
peripheral dendron (200mg) was dissolved in anhydrous THF (2mL) and degassed for 10 
minutes under a nitrogen atmosphere. n-Butylamine (1.2 equiv. per xanthate group) was 
added and the reaction left for 1.5 hrs or until completion by TLC (60:40 hexane:ethyl 
acetate). A stoichiometric mixture of Bz and Am acrylate monomers (1 equiv. per thiol) was 
added and the reaction mixture stirred at ambient temperature for 16 hours. The product was 
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isolated by precipitating twice into hexane. Residual solvent was removed under high 
vacuum to yield a viscous oil. 
 
[Amx-Bzy-G1-TSe]; y=2, [41]; x=1, y=1, [60]; x=2, [40]. The sequential and simultaneous 
thiol Michael addition click procedures were carried out as described above using [Xan2-G1-
TSe];[12], (0.2 g, 0.136 mmol) and n-butylamine (74 μL, 0.7 mmol, 2.4 equiv.) in 2 mL of 
anhydrous THF for 1.5 hr, followed by addition of Bz acrylate and Am acrylate and stirred 
for 16 hours. The product was isolated by precipitating twice into hexane. Residual solvent 
was removed under high vacuum to yield an orange viscous oil. 
1
H NMR (400 MHz, CDCl3): 
δ = 1.14-1.19 (m, 3H), 2.28 (s), 2.45 (s, 3H), 2.54-2.60 (m), 2.62-2.72 (m, 4H), 2.83-2.93 (m, 
4H), 3.20-3.26 (m, 4H), 3.43 (t, 2H, J = 5.8 Hz), 4.12-4.24 (m), 4.45 (t, 2H, J = 5.8 Hz), 5.13 
(s), 7.29-7.41 (m), 7.79 (d, 2H, J = 8.0 Hz). 
 
[Amx-Bzy-G2-TSe]; y=4, [43]; x=1, y=3, [61]; x=2, y=2, [62]; x=3, y=1, [63]; x=4, [42]. 
The sequential and simultaneous thiol Michael addition click procedures were carried out as 
described above using [Xan4-G2-TSe];[13], (0.2 g, 0.136 mmol) and n-butylamine (79 μL, 0.8 
mmol, 4.8 equiv.) in 2 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate 
and Am acrylate and stirred for 16 hours. The product was isolated by precipitating twice into 
hexane. Residual solvent was removed under high vacuum to yield an orange viscous oil. 
1
H 
NMR (400 MHz, CDCl3): δ = 1.15-1.21 (m, 3H), 1.21-1.30 (m, 6H), 2.28 (s), 2.44 (s, 3H), 
2.54-2.61 (m), 2.62-2.73 (m, 4H), 2.83-2.94 (m, 4H), 3.20-3.30 (m, 4H), 3.4-3.48 (m, 2H), 
4.13-4.34 (m), 4.45 (m, 2H), 5.13 (s), 7.28-7.41 (m), 7.80 (d, 2H, J = 8.6 Hz). 
 
[Amx-Bzy-G3-TSe]; y=8, [45]; x=1, y=7, [64]; x=2, y=6, [65]; x=3, y=5, [66]; x=4, y=4, 
[67]; x=5, y=3, [68]; x=6, y=2, [69]; x=7, y=1, [70]; x=8, [44]. The sequential and 
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simultaneous thiol Michael addition click procedures were carried out as described above 
using [Xan8-G3-TSe];[14], (0.2 g, 0.136 mmol) and n-butylamine (82 μL, 0.8 mmol, 9.6 
equiv.) in 2 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate and Am 
acrylate and stirred for 16 hours. The product was isolated by precipitating twice into hexane. 
Residual solvent was removed under high vacuum to yield an orange viscous oil. 
1
H NMR 
(400 MHz, CDCl3): δ = 1.16-1.30 (m, 3H), 2.27 (s), 2.45 (s, 3H), 2.52-2.59 (m), 2.61-2.72 
(m, 4H), 2.82-2.93 (m, 4H), 3.26 (s, br, 4H), 3.43 (m, 2H), 4.11-4.34 (m), 4.47 (m, 2H), 5.13 
(s), 7.28-7.41 (m), 7.80 (d, 2H, J = 7.5 Hz). 
 
[Amx-Bzy-G2-THPE]; x=3, y=9, [96]; x=6, y=6, [97]; x=9, y=3, [98] – The sequential and 
simultaneous thiol Michael addition click procedures were carried out as described above 
using [Xan12-G2-THPE];[18], (0.1 g, 0.0303 mmol, 1 equiv.) and n-butylamine (43 μL, 0.437 
mmol, 14.4 equiv.) in 2 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate 
and Am acrylate and stirred for 16 hours. The product was isolated by precipitating twice into 
hexane. Residual solvent was removed under high vacuum to yield an orange viscous oil. 
1
H 
NMR (400 MHz, CDCl3): δ = 1.16-1.30 (m, 3H), 2.27 (s), 2.45 (s, 3H), 2.52-2.59 (m), 2.61-
2.72 (m, 4H), 2.82-2.93 (m, 4H), 3.26 (s, br, 4H), 3.43 (m, 2H), 4.11-4.34 (m), 4.47 (m, 2H), 
5.13 (s), 7.28-7.41 (m), 7.80 (d, 2H, J = 7.5 Hz). 
 
General procedure to generate pseudo-calibration curves for the sequential deprotection 
of xanthate-functional dendron-polymer hybrids. Xanthate peripheral LDHs and HPDs 
(200 mg) dissolved in anhydrous THF (2 mL) and degassed for 5 minutes under a nitrogen 
atmosphere. Varying molar equivalents of n-butylamine were added, based on the theoretical 
Mn by 
1
H NMR, and the reaction left to stir for 1.5 hrs. The product was analysed by 
1
H 
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NMR and the % of xanthate groups deprotected plotted against equivalents of n-butylamine 
added to generate a pseudo-calibration curve. 
 
p[(Amx-Bzy-G1)-tBMA50]; x=2, [99]; x=1, y=1, [115]; y=2, [100]. Based on the pseudo-
calibration curve generated for this material, the sequential and simultaneous thiol Michael 
addition click procedures were carried out as described above using p[(Xan2-G1)-
tBMA50];[25], and n-butylamine in 2 mL of anhydrous THF for 1.5 hr, followed by addition 
of Bz acrylate and Am acrylate and stirred for 16 hours. The product was isolated by 
precipitating twice into cold petroleum ether (40-60 °C). Residual solvent was removed under 
high vacuum to yield a colourless solid. 
 
p[(Amx-Bzy-G2)-nBMA50]; y=4, [104]; x=1, y=3, [117]; x=2, y=2, [118]; x=3, y=1, [119]; 
x=4, [103]. Based on the pseudo-calibration curve generated for this material, the sequential 
and simultaneous thiol Michael addition click procedures were carried out as described above 
using p[(Xan4-G2)-tBMA50];[26], and n-butylamine in 2 mL of anhydrous THF for 1.5 hr, 
followed by addition of Bz acrylate and Am acrylate and stirred for 16 hours. The product 
was isolated by precipitating twice into cold petroleum ether (40-60 °C). Residual solvent 
was removed under high vacuum to yield a colourless solid. 
 
p[(Amx-Bzy-G1)-nBMA50-co-EGDMA0.8]; x=2, [101]; x=1, y=1, [116]; y=2, [102]. Based 
on the pseudo-calibration curve generated for this material, the sequential and simultaneous 
thiol Michael addition click procedures were carried out as described above using p[(Xan2-
G1)-tBMA50-co-EGDMA0.8];[27], and n-butylamine in 2 mL of anhydrous THF for 1.5 hr, 
followed by addition of Bz acrylate and Am acrylate and stirred for 16 hours. The product 
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was isolated by precipitating twice into cold petroleum ether (40-60 °C). Residual solvent 
was removed under high vacuum to yield a colourless solid. 
 
p[(Amx-Bzy-G2)-nBMA50-co-EGDMA0.8]; y=4, [106]; x=1, y=3, [120]; x=2, y=2, [121]; 
x=3, y=1, [122]; x=4, [105]. Based on the pseudo-calibration curve generated for this 
material, the sequential and simultaneous thiol Michael addition click procedures were 
carried out as described above using p[(Xan4-G2)-tBMA50-co-EGDMA0.8];[28], and n-
butylamine in 2 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate and 
Am acrylate and stirred for 16 hours. The product was isolated by precipitating twice into 
cold petroleum ether (40-60 °C). Residual solvent was removed under high vacuum to yield a 
colourless solid. 
 
p[(Amx-Bzy-G0)-nBMA100-co-EGDMA0.7] (x = 0-1, y = 0-1, x+y = 1);[127]. Based on the 
pseudo-calibration curve generated for this material, the simultaneous thiol Michael addition 
click procedure was carried out as described above using p[(Xan1-G0)-nBMA100-co-
EGDMA0.7];[36] (200 mg, 0.0083 mmol, 1 equiv.), and n-butylamine (10 μL, 0.1 mmol, 12 
equiv.) in 2 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate and Am 
acrylate and stirred for 16 hours. The product was isolated by precipitating twice into hexane. 
Residual solvent was removed under high vacuum to yield a colourless solid. 
 
p[(Amx-Bzy-G1)-nBMA100-co-EGDMA0.8] (x = 0-2, y = 0-2, x+y = 2);[128]. Based on the 
pseudo-calibration curve generated for this material, the simultaneous thiol Michael addition 
click procedure was carried out as described above using p[(Xan2-G1)-nBMA100-co-
EGDMA0.8];[37] (100 mg, 0.0040 mmol, 1 equiv.), and n-butylamine (6 μL, 0.0607 mmol, 
15 equiv.) in 2 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate and Am 
CHAPTER 7 
311 
 
acrylate and stirred for 16 hours. The product was isolated by precipitating twice into hexane. 
Residual solvent was removed under high vacuum to yield a colourless solid. 
 
p[(Amx-Bzy-G2)-nBMA100-co-EGDMA0.8] (x = 0-4, y = 0-4, x+y = 4);[128]. Based on the 
pseudo-calibration curve generated for this material, the simultaneous thiol Michael addition 
click procedure was carried out as described above using p[(Xan4-G2)-nBMA100-co-
EGDMA0.8];[38] (100 mg, 0.0047 mmol, 1 equiv.), and n-butylamine (19 μL, 0.187 mmol, 
40 equiv.) in 2 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate and Am 
acrylate and stirred for 16 hours. The product was isolated by precipitating twice into hexane. 
Residual solvent was removed under high vacuum to yield a colourless solid. 
 
p[(Amx-Bzy-G3)-nBMA100-co-EGDMA0.8] (x = 0-8, y = 0-8, x+y = 8);[129]. Based on the 
pseudo-calibration curve generated for this material, the simultaneous thiol Michael addition 
click procedure was carried out as described above using p[(Xan8-G3)-nBMA100-co-
EGDMA0.8];[39] (100 mg, 0.0051 mmol, 1 equiv.), and n-butylamine (13 μL, 0.133 mmol, 
26 equiv.) in 2 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate and Am 
acrylate and stirred for 16 hours. The product was isolated by precipitating twice into hexane. 
Residual solvent was removed under high vacuum to yield a colourless solid. 
 
7.4 Chapter 4 compounds 
[PEG(2K)-BiB];[131]. Monomethoxy poly(ethylene glycol) (Mw ≈ 2000 g mol
-1
) (10.25 g, 
5.13 mmol, 1 equiv.) was dissolved in THF (anhydrous, 100 mL) at 40 °C, and degassed with 
dry N2 for 20 minutes. DMAP (6.26 mg, 0.0512 mmol, 0.01 equiv.) and TEA (1.57 mL, 11 
mmol, 2.2 equiv.) were added and the reaction cooled to 0 °C in an ice bath.  
α-Bromoisobutyryl bromide (1.27 mL, 10 mmol, 2 equiv.) was added dropwise over 20 
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minutes and a white precipitate immediately formed (Et3NH
+
Br
-
 salt). After 24 hours, the 
precipitate was removed by filtration, THF removed and the crude material precipitated twice 
from acetone into petroleum ether (30-40 °C). 
1
H NMR (400 MHz, D2O): δ = 4.34 (m, 2H), 
3.59-3.80 (m, 186H), 3.35 (s, 3H), 1.93 (s, 6H). 
 
[PEG(2K)-nBMA100]. In a kinetics study, targeting DPn = 100 monomer units for the 
primary chains, [PEG(2K)-BiB];[131] (0.302 g, 0.141 mmol, 1 equiv.), nBMA (2 g, 14 
mmol, 100 equiv.) and bpy (44 mg, 0.282 mmol, 2 equiv.) were placed into a 10 mL round-
bottomed flask. Methanol was added (50 wt% based on nBMA; 2g, 2.6 mL) and the solution 
stirred and deoxygenated using a nitrogen purge for 30 minutes. Cu(I)Cl (14 mg, 0.141 
mmol, 1 equiv) was added to the flask, whilst maintaining a positive flow of nitrogen, and the 
solution left to polymerise at 60 °C. To determine the kinetics of the reaction, samples (~0.1 
mL) were taken at regular intervals and analysed by 
1
H NMR and SEC. The reaction was 
terminated when conversion reached >94%, indicated by 
1
H NMR after 28 hours, by 
exposure to oxygen and addition of THF. The solution was passed through a neutral alumina 
column to remove the catalytic system, and precipitated twice into cold petroleum ether (40-
60 °C). After drying the precipitated sample overnight under high vacuum, the polymer was 
obtained as a white solid. 
 
General procedure for the co-initiated branched copolymerisation of nBMA and 
EGDMA with [Xan1-G0-BiB];[20] and [PEG(2K)-BiB];[131]; p[(PEG(2K))0.99-(Xan1-
G0)0.01-nBMA100-co-EGDMA0.8];[134], p[(PEG(2K))0.925-(Xan1-G0)0.075-nBMA100-co-
EGDMA0.8];[135], p[(PEG(2K))0.9-(Xan1-G0)0.1-nBMA100-co-EGDMA0.8];[136]. The co-
initiated copolymerisation of nBMA and bifunctional monomer EGDMA was carried out 
with varying molar equivalents of [PEG(2K)-BiB];[131] and [Xan1-G0-BiB];[20] (99:1, 
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92.5:7.5, 90:10). In a typical synthesis, targeting DPn = 100 monomer units for the primary 
chains, [PEG(2K)-BiB];[131], [Xan1-G0-BiB];[20], nBMA (5 g, 35 mmol, 100 equiv.), bpy 
(110 mg, 0.703 mmol, 2 equiv.) and EGDMA (56 mg, 0.280 mmol, 0.8 equiv.) were placed 
into a 20 mL round-bottomed flask. Methanol was added (50 wt% based on nBMA, 5g, 7.5 
mL) and the solution stirred and deoxygenated using a nitrogen purge for 30 minutes. Cu(I)Cl 
(35 mg, 0.352 mmol, 1 equiv) was added to the flask, whilst maintaining a positive flow of 
nitrogen, and the solution was left to polymerise at 60 °C. The reaction was terminated when 
conversion reached >98%, indicated by 
1
H NMR after 70 hours, by exposure to oxygen and 
addition of THF. The solution was passed through a neutral alumina column to remove the 
catalytic system, and precipitated twice into cold petroleum ether (40-60 °C). After drying the 
precipitated sample overnight under high vacuum, the polymer was obtained as a white solid. 
 
General procedure for the co-initiated branched copolymerisation of nBMA and 
EGDMA with [Xan8-G3-BiB];[23] and [PEG(2K)-BiB];[131]; p[(PEG(2K))0.99-(Xan8-
G3)0.01-nBMA100-co-EGDMA0.8];[137], p[(PEG(2K))0.986-(Xan8-G3)0.014-nBMA100-co-
EGDMA0.8];[138], p[(PEG(2K))0.95-(Xan8-G3)0.05-nBMA100-co-EGDMA0.8];[139]. The co-
initiated copolymerisation of nBMA and bifunctional monomer EGDMA was carried out 
with varying molar equivalents of [PEG(2K)-BiB];[131] and [Xan8-G3-BiB];[23] (99:1, 
98.6:1.4, 95:5). In a typical synthesis, targeting DPn = 100 monomer units for the primary 
chains, [PEG(2K)-BiB];[131], [Xan8-G3-BiB];[23], nBMA (5 g, 35 mmol, 100 equiv.), bpy 
(110 mg, 0.703 mmol, 2 equiv.) and EGDMA (56 mg, 0.280 mmol, 0.8 equiv.) were placed 
into a 20 mL round-bottomed flask. Methanol was added (50 wt% based on nBMA, 5g, 7.5 
mL) and the solution stirred and deoxygenated using a nitrogen purge for 30 minutes. Cu(I)Cl 
(35 mg, 0.352 mmol, 1 equiv) was added to the flask, whilst maintaining a positive flow of 
nitrogen, and the solution was left to polymerise at 60 °C. The reaction was terminated when 
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conversion reached >98%, indicated by 
1
H NMR after 72 hours, by exposure to oxygen and 
addition of THF. The solution was passed through a neutral alumina column to remove the 
catalytic system, and precipitated twice into cold petroleum ether (40-60 °C). After drying the 
precipitated sample overnight under high vacuum, the polymer was obtained as a white solid. 
 
General procedure for the deprotection of peripheral xanthate groups of co-initiated 
HPDs, and subsequent nanoprecipitation and coordination of 3 nm GNPs. Peripheral 
xanthate groups of each polymer (200 mg, 1 equiv.) were deprotected with excess n-
butylamine (10 equiv.) in THF (anhydrous, 2 mL) for 1.5 hours. The deprotected polymer 
was precipitated twice into hexane and dried under vacuum. The deprotected polymer was 
dissolved in acetone at an initial concentration of 5 mg/mL. The dissolved polymer was 
rapidly added to water with stirring at ambient temperature. The solvent was allowed to 
evaporate overnight to give nanoprecipitates with a final concentration of 1 mg/mL of 
polymer in water. A 1:9 ratio of polymer nanoprecipitates:3 nm GNPs was mixed and stirred 
for 24 hours, before imaging by TEM. 
 
TEM preparation. TEM grids (3 mm, 400 mesh Cu(holey carbon)) were prepared by 
pipetting 10 μL of the polymer/GNP samples directly onto the carbon coated side of the grid, 
and immediately wicking away excess water with filter paper. The grids were allowed to dry 
for 24 hours before imaging. 
 
7.5 Chapter 5 compounds 
Simultaneous multifunctionalisation of p[(PEG(2K))0.9-(Xan1-G0)0.1-nBMA100-co-
EGDMA0.8];[136] to generate p[(PEG(2K))0.9-(Am0.5-Bz0.5-G0)0.1-nBMA100-co-
EGDMA0.8];[140]. A pseudo-calibration curve was generated as described previously, and 
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applied to the simultaneous thiol Michael addition using p[(PEG(2K))0.9-(Xan1-G0)0.1-
nBMA100-co-EGDMA0.8];[136] (1 g, 0.0602 mmol, 1 equiv.) and n-butylamine (59 μL, 0.602 
mmol, 10 equiv.) in 10 mL of anhydrous THF for 1.5 hr, followed by addition of Bz acrylate 
(10 μL, 0.0662 mmol, 1.1 equiv.) and Am acrylate (10 μL, 0.0662 mmol, 1.1 equiv.) and 
stirred for 16 hours. The product was isolated by precipitating twice into hexane. Residual 
solvent was removed under high vacuum to yield a colourless solid. 
 
[Bz8-G3-COOH];[141]. 1,8- diazabicyclo[5.4.0]undec-7-ene (DBU) (1.3 equiv.) was added 
to benzyl functional G3 dendron [Bz8-G3-TSe];[45] (5.82 g, 2 mmol, 1 equiv.) dissolved in 
anhydrous CH2Cl2 (50 mL). The reaction was stirred under a nitrogen atmosphere for 16 
hours and monitored by using TLC (40:60 ethyl acetate:hexane). The product was isolated by 
diluting the mixture with CH2Cl2 (350 mL) and washing with 1 M NaHSO4 (2 x 300 mL) and 
brine (1 x 300 mL). The organic layer was dried over MgSO4 and evaporated to dryness. The 
product was then precipitated three times into hexane:ethyl acetate (9:1). Any residual 
solvent was removed under high vacuum to yield a viscous oil. 
1
H NMR (400 MHz, CDCl3): 
δ = 1.24 (s, 18H), 1.31 (s, 3H), 2.67 (t, J = 7.1 Hz, 16H), 2.88 (t, J = 7.1 Hz, 16H), 3.24 (s, 
16H), 4.13-4.39 (m, 28H), 5.12 (s, 16H), 7.34 (s, 40H). 
13
C NMR (100 MHz, CDCl3): δ = 
17.71, 27.58, 33.43, 34.34, 65.76, 66.67, 128.59, 170.06, 171.52. 
 
[Bz8-G3-BiB];[142]. [Bz8-G3-COOH];[141] (5.14 g, 1.89 mmol, 1 equiv.), [HEBiB];[19] 
(0.798 g, 3.78 mmol, 2 equiv.), DPTS (0.611 g, 2.08 mmol, 1.1 equiv.), DCC (0.429 g, 2.08 
mmol, 1.1 equiv.) in anhydrous CH2Cl2 (50 mL) were reacted according to the general 
procedure for focal point modification resulting in an orange viscous oil that was purified by 
liquid chromatography on silica, eluting from DCM, gradually increasing the polarity to 
methanol:DCM (3:97). Yield: 4.06 g, orange viscous oil, (74%). 
1
H NMR (400 MHz, 
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CDCl3): δ = 1.24 (s, 21H), 1.92 (s, 6H), 2.59-2.73 (m, 16H), 2.82-2.95 (m, 16H), 3.24 (s, 
16H), 4.11-4.43 (m, 32H), 5.12 (s, 16H), 7.34 (s, 40H). 
13
C NMR (100 MHz, CDCl3): δ = 
17.81, 27.60, 30.83, 33.44, 34.37, 46.56, 49.27, 55.93, 65.73, 66.66, 135.71, 169.80, 171.46.  
 
p[(Bz8-G3)-nBMA100];[143]. A polymerisation, targeting DPn = 100 monomer units, was 
carried out with [Bz8-G3-BiB];[142] (0.205 g, 0.0703 mmol, 1 equiv.), nBMA (1 g, 7 mmol, 
100 equiv.) and bpy (22 mg, 0.141 mmol, 2 equiv.) were placed into a 5 mL round-bottomed 
flask. Methanol was added (50 wt% based on nBMA; 1g, 1.6 mL) and the solution stirred and 
deoxygenated using a nitrogen purge for 30 minutes. Cu(I)Cl (7 mg, 0.0703 mmol, 1 equiv) 
was added to the flask, whilst maintaining a positive flow of nitrogen, and the solution left to 
polymerise at 60 °C. The reaction was terminated when conversion reached >95%, indicated 
by 
1
H NMR after 70 hours, by exposure to oxygen and addition of THF. The solution was 
passed through a neutral alumina column to remove the catalytic system, and precipitated 
twice into cold petroleum ether (40-60 °C). After drying the precipitated sample overnight 
under high vacuum, the polymer was obtained as a white solid. 
 
Co-initiated branched copolymerisation of nBMA and EGDMA with [Xan8-G3-
BiB];[23], [Bz8-G3-BiB];[142] and [PEG(2K)-BiB];[131] to generate p[(PEG(2K))0.986-
(Xan8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8];[144] The co-initiated 
copolymerisation of nBMA and bifunctional monomer EGDMA was carried out with 
[PEG(2K)-BiB];[131] (0.745 g, 0.347 mmol, 0.986 equiv.), [Xan8-G3-BiB];[23] (5.7 mg, 
0.00246 mmol, 0.007 equiv.) and [Bz8-G3-BiB];[142] (7.2 mg, 0.00246 mmol, 0.007 equiv.), 
in a typical synthesis, targeting DPn = 100 monomer units for the primary chains, nBMA (5 g, 
35 mmol, 100 equiv.), bpy (110 mg, 0.703 mmol, 2 equiv.) and EGDMA (56 mg, 0.280 
mmol, 0.8 equiv.) were placed into a 20 mL round-bottomed flask. Methanol was added (50 
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wt% based on nBMA, 5g, 7.5 mL) and the solution stirred and deoxygenated using a nitrogen 
purge for 30 minutes. Cu(I)Cl (35 mg, 0.352 mmol, 1 equiv) was added to the flask, whilst 
maintaining a positive flow of nitrogen, and the solution was left to polymerise at 60 °C. The 
reaction was terminated when conversion reached >98%, indicated by 
1
H NMR after 72 
hours, by exposure to oxygen and addition of THF. The solution was passed through a neutral 
alumina column to remove the catalytic system, and precipitated twice into cold petroleum 
ether (40-60 °C). After drying the precipitated sample overnight under high vacuum, the 
polymer was obtained as a white solid. 
 
p[(PEG(2K))0.986-(Am8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8];[145]. Thiol-
acrylate Michael addition was carried out as described previously, using p[(PEG(2K))0.986-
(Xan8-G3)0.007-(Bz8-G3)0.007-nBMA100-co-EGDMA0.8];[144] (1 g, 0.0611 mmol, 1 equiv.), 
with an excess of n-butylamine (60 μL, 0.611 mmol, 10 equiv.) in 1 mL of anhydrous THF at 
ambient temperature for 1.5 hr, followed by addition of Am acrylate (139 μL, 0.916 mmol, 
15 equiv.) and stirred for 16 hours. The product was isolated by precipitating twice into 
hexane. Residual solvent was removed under high vacuum to yield a colourless solid. 
 
Cellular accumulation studies 
ATHP-1. Collagenated 6-well plates were seeded with 2 x 10
6
 THP-1 cells (human 
monocytic cell line) in Roswell Park Memorial Institute (RPMI) medium supplemented with 
200 nM phorbol 12-myristate 13-acetate (PMA) and incubated for 3 days. After 3 days the 
media was aspirated and replaced with an equal volume of fresh RPMI without PMA and 
incubated for a further 5 days. Following differentiation, media was aspirated, cells washed 
(x 3) and replaced with Hanks’ balanced salt solution (HBSS) containing each treatment so 
that the final volume of each nanoformulation was less than 0.5% of the final total volume. 
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Selected wells were pre-incubated (30 min) and co-incubated with cytochalasin B (5 µg/ml) 
and the particles, to investigate the mechanisms of particle uptake into ATHP-1 cells. 
Following 1 or 6 hour incubation extracellular samples were obtained, cells washed with ice-
cold HBSS (x 3) and detached/lysed using scintillation fluid and the CAR determined by 
measuring [
3
H] radioactivity in the cell lysate via liquid scintillation counting. 
THP-1. THP-1 cells were treated as previously described for ATHP-1 cells, but without 
differentiation (ie without PMA) in collagenated plates. Multiple centrifugation steps were 
carried out to allow washing of the suspension cells. 
Cell-free particle adhesion. Particle adhesion to collagenated and non-collagenated plates 
was studied for the patchy and statistically multifunctional materials, as previously described, 
but without the presence of ATHP-1/THP-1 cells. 
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